{
    "orderChoiceId": 12345634,
    "partnerOrder": {
        "orderId": "16114141",
        "orderStatusId": 60,
        "orderReviewStatusId": 2,
        "signingLabId": 1,
        "orderDateTime": "2016-11-30T10:12:00",
        "assessionerFirstName": "Ann",
        "assessionerLastName": "Grenko",
        "patientKey": 247669,
        "providerKey": 16003,
        "locationKey": 8061,
        "headerId": 2,
        "additionalRecipients": [],
        "orderAnswers": [],
        "orderChoices": [],
        "orderInsurances": [],
        "samples": [],
        "location": {
            "locationKey": 8061,
            "locationId": "5370001",
            "practiceKey": 3421,
            "practice": {
                "practiceKey": 3421,
                "practiceId": "5370000",
                "name": "Susan Morrison",
                "concurrencyId": 1
            },
            "name": "Susan Morrison",
            "address": "",
            "state": "CA",
            "locationFax": "323-933-6334",
            "concurrencyId": 1,
            "whiteGlove": false,
            "faxOnFinal": false
        },
        "orderStatus": {
            "orderStatusId": 60,
            "name": "Reported"
        },
        "patient": {
            "patientKey": 247669,
            "patientId": "av00257767",
            "firstName": "Seventeen",
            "lastName": "Test",
            "middleName": "",
            "dob": "1982-05-11T00:00:00",
            "address": "",
            "city": "",
            "state": "",
            "zipCode": "",
            "sex": "F",
            "concurrencyId": 1,
            "ethnicityId": 4,
            "ethnicity": {
                "ethnicityId": 4,
                "ethnicityName": "Caucasian/White",
                "concurrencyId": 0
            }
        },
        "provider": {
            "providerKey": 16003,
            "providerId": "5370011",
            "name": "Susan Morrison MD",
            "signature": "",
            "npi": "1285758433",
            "concurrencyId": 1
        },
        "signingLab": {
            "signingLabId": 1,
            "name": "Progenity",
            "address1": "5230 S. State Road",
            "address2": "",
            "city": "Ann Arbor",
            "state": "MI",
            "zipCode": "48108     ",
            "phoneNumber": "1 855-293-2639",
            "faxNumber": "1 248-848-1623",
            "cliaNumber": "23D2018899",
            "labDirector": "John Tazelaar, MD",
            "active": true,
            "concurrencyId": 803
        },
        "aoEs": []
    },
    "patients": {
        "femalePatient": {
            "patientKey": 247669,
            "patientId": "av00257767",
            "firstName": "Seventeen",
            "lastName": "Test",
            "middleName": "",
            "dob": "1982-05-11T00:00:00",
            "address": "",
            "city": "",
            "state": "",
            "zipCode": "",
            "sex": "F",
            "concurrencyId": 1,
            "ethnicityId": 4,
            "ethnicity": {
                "ethnicityId": 4,
                "ethnicityName": "Caucasian/White",
                "concurrencyId": 0
            }
        },
        "malePatient": {
            "patientKey": 247232,
            "patientId": "av00257330",
            "firstName": "Gcsv543",
            "lastName": "Test",
            "middleName": "",
            "dob": "1998-01-03T00:00:00",
            "address": "",
            "city": "",
            "state": "",
            "zipCode": "",
            "sex": "M",
            "concurrencyId": 1,
            "ethnicityId": 3,
            "ethnicity": {
                "ethnicityId": 3,
                "ethnicityName": "N/A",
                "concurrencyId": 0
            }
        }
    },
    "choices": [
        {
            "female": {
                "resultFlag": "Normal",
                "globos": [],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330583,
                        "componentDefId": 23467,
                        "result": "N",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330584,
                        "componentDefId": 23463,
                        "result": "RED BLOOD CELL COUNT",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330585,
                        "componentDefId": 23466,
                        "result": "3.80-5.10",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330586,
                        "componentDefId": 23464,
                        "result": "4.5",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330587,
                        "componentDefId": 23465,
                        "result": "Million/uL",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330672,
                        "componentDefId": 23468,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "male": {
                "globos": [],
                "reportTexts": [],
                "results": []
            },
            "partner": {
                "globos": [],
                "reportTexts": [],
                "results": []
            },
            "perfLabId": "104",
            "componentDefs": [],
            "rules": [],
            "name": "HGBELRBC",
            "description": "Hemoglobin Electrophoresis Red Blood Cell Count",
            "placeHolderCode": "",
            "reportDescriptionIndividual": "Hemoglobin Electrophoresis Red Blood Cell Count",
            "reportDescriptionPanel": "<p>Hemoglobin Electrophoresis Red Blood Cell Count<\/p>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 18,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": true,
            "doNotBillSubChoice": true,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "requiredInterpretation": false,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Normal",
                "globos": [],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330636,
                        "componentDefId": 23525,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330637,
                        "componentDefId": 23521,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330638,
                        "componentDefId": 23526,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330639,
                        "componentDefId": 23524,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330640,
                        "componentDefId": 23522,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330641,
                        "componentDefId": 23523,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "male": {
                "globos": [],
                "reportTexts": [],
                "results": []
            },
            "partner": {
                "globos": [],
                "reportTexts": [],
                "results": []
            },
            "perfLabId": "104",
            "componentDefs": [],
            "rules": [],
            "name": "HGBELHGBS",
            "description": "Hemoglobin Electrophoresis Hemoglobin S",
            "placeHolderCode": "",
            "reportDescriptionIndividual": "Hemoglobin Electrophoresis Hemoglobin S",
            "reportDescriptionPanel": "<p>Hemoglobin Electrophoresis Hemoglobin S<\/p>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 6,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": true,
            "doNotBillSubChoice": true,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "requiredInterpretation": false,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Normal",
                "globos": [],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330642,
                        "componentDefId": 23531,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330643,
                        "componentDefId": 23527,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330644,
                        "componentDefId": 23532,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330645,
                        "componentDefId": 23530,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330646,
                        "componentDefId": 23528,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330647,
                        "componentDefId": 23529,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "male": {
                "globos": [],
                "reportTexts": [],
                "results": []
            },
            "partner": {
                "globos": [],
                "reportTexts": [],
                "results": []
            },
            "perfLabId": "104",
            "componentDefs": [],
            "rules": [],
            "name": "HGBELHGBC",
            "description": "Hemoglobin Electrophoresis Hemoglobin C",
            "placeHolderCode": "",
            "reportDescriptionIndividual": "Hemoglobin Electrophoresis Hemoglobin C",
            "reportDescriptionPanel": "<p>Hemoglobin Electrophoresis Hemoglobin C<\/p>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 8,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": true,
            "doNotBillSubChoice": true,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "requiredInterpretation": false,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Normal",
                "globos": [],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330648,
                        "componentDefId": 23537,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330649,
                        "componentDefId": 23533,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330650,
                        "componentDefId": 23538,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330651,
                        "componentDefId": 23536,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330652,
                        "componentDefId": 23534,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330653,
                        "componentDefId": 23535,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "male": {
                "globos": [],
                "reportTexts": [],
                "results": []
            },
            "partner": {
                "globos": [],
                "reportTexts": [],
                "results": []
            },
            "perfLabId": "104",
            "componentDefs": [],
            "rules": [],
            "name": "HGBELHGBE",
            "description": "Hemoglobin Electrophoresis Hemoglobin E",
            "placeHolderCode": "",
            "reportDescriptionIndividual": "Hemoglobin Electrophoresis Hemoglobin E",
            "reportDescriptionPanel": "<p>Hemoglobin Electrophoresis Hemoglobin E<\/p>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 6,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": true,
            "doNotBillSubChoice": true,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "requiredInterpretation": false,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Normal",
                "globos": [],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330654,
                        "componentDefId": 23543,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330655,
                        "componentDefId": 23539,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330656,
                        "componentDefId": 23544,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330657,
                        "componentDefId": 23542,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330658,
                        "componentDefId": 23540,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330659,
                        "componentDefId": 23541,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "male": {
                "globos": [],
                "reportTexts": [],
                "results": []
            },
            "partner": {
                "resultFlag": "Normal",
                "globos": [],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330654,
                        "componentDefId": 23543,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330655,
                        "componentDefId": 23539,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330656,
                        "componentDefId": 23544,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330657,
                        "componentDefId": 23542,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330658,
                        "componentDefId": 23540,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330659,
                        "componentDefId": 23541,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "perfLabId": "104",
            "componentDefs": [],
            "rules": [],
            "name": "HGBELHGBO1",
            "description": "Hemoglobin Electrophoresis Abnormal Hemoglobin 1",
            "placeHolderCode": "",
            "reportDescriptionIndividual": "Hemoglobin Electrophoresis&nbsp;Abnormal Hemoglobin 1",
            "reportDescriptionPanel": "<p>Hemoglobin Electrophoresis&nbsp;Abnormal Hemoglobin 1<\/p>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 6,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": true,
            "doNotBillSubChoice": true,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "requiredInterpretation": false,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Normal",
                "globos": [],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330660,
                        "componentDefId": 23549,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330661,
                        "componentDefId": 23545,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330662,
                        "componentDefId": 23550,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330663,
                        "componentDefId": 23548,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330664,
                        "componentDefId": 23546,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330665,
                        "componentDefId": 23547,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "male": {
                "globos": [],
                "reportTexts": [],
                "results": []
            },
            "partner": {
                "resultFlag": "Normal",
                "globos": [],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330660,
                        "componentDefId": 23549,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330661,
                        "componentDefId": 23545,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330662,
                        "componentDefId": 23550,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330663,
                        "componentDefId": 23548,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330664,
                        "componentDefId": 23546,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330665,
                        "componentDefId": 23547,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "perfLabId": "104",
            "componentDefs": [],
            "rules": [],
            "name": "HGBELHGBO2",
            "description": "Hemoglobin Electrophoresis Abnormal Hemoglobin 2",
            "placeHolderCode": "",
            "reportDescriptionIndividual": "Hemoglobin Electrophoresis&nbsp;Abnormal Hemoglobin 2",
            "reportDescriptionPanel": "<p>Hemoglobin Electrophoresis&nbsp;Abnormal Hemoglobin 2<\/p>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 6,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": true,
            "doNotBillSubChoice": true,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "requiredInterpretation": false,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Normal",
                "globos": [],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330666,
                        "componentDefId": 23555,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330667,
                        "componentDefId": 23551,
                        "result": "INTERPRETATION",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330668,
                        "componentDefId": 23556,
                        "result": "Normal hemoglobin distribution",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330669,
                        "componentDefId": 23554,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330670,
                        "componentDefId": 23552,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330671,
                        "componentDefId": 23553,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "male": {
                "globos": [],
                "reportTexts": [],
                "results": []
            },
            "partner": {
                "resultFlag": "Normal",
                "globos": [],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330666,
                        "componentDefId": 23555,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330667,
                        "componentDefId": 23551,
                        "result": "INTERPRETATION",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330668,
                        "componentDefId": 23556,
                        "result": "Normal hemoglobin distribution",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330669,
                        "componentDefId": 23554,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330670,
                        "componentDefId": 23552,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330671,
                        "componentDefId": 23553,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "perfLabId": "104",
            "componentDefs": [],
            "rules": [],
            "name": "HGBELINT",
            "description": "Hemoglobin Electrophoresis Interpretation",
            "placeHolderCode": "",
            "reportDescriptionIndividual": "Hemoglobin Electrophoresis Interpretation",
            "reportDescriptionPanel": "<p>Hemoglobin Electrophoresis Interpretation<\/p>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 27,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": true,
            "doNotBillSubChoice": true,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "requiredInterpretation": false,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Normal",
                "globos": [],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330588,
                        "componentDefId": 23474,
                        "result": "N",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330589,
                        "componentDefId": 23470,
                        "result": "HEMOGLOBIN",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330590,
                        "componentDefId": 23475,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330591,
                        "componentDefId": 23473,
                        "result": "11.7-15.5",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330592,
                        "componentDefId": 23471,
                        "result": "13.9",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330593,
                        "componentDefId": 23472,
                        "result": "g/dl",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "male": {
                "globos": [],
                "reportTexts": [],
                "results": []
            },
            "partner": {
                "resultFlag": "Normal",
                "globos": [],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330588,
                        "componentDefId": 23474,
                        "result": "N",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330589,
                        "componentDefId": 23470,
                        "result": "HEMOGLOBIN",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330590,
                        "componentDefId": 23475,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330591,
                        "componentDefId": 23473,
                        "result": "11.7-15.5",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330592,
                        "componentDefId": 23471,
                        "result": "13.9",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330593,
                        "componentDefId": 23472,
                        "result": "g/dl",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "perfLabId": "104",
            "componentDefs": [],
            "rules": [],
            "name": "HGBELHGB",
            "description": "Hemoglobin Electrophoresis Hemoglobin",
            "placeHolderCode": "",
            "reportDescriptionIndividual": "Hemoglobin Electrophoresis Hemoglobin",
            "reportDescriptionPanel": "<p>Hemoglobin Electrophoresis Hemoglobin<\/p>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 11,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": true,
            "doNotBillSubChoice": true,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "requiredInterpretation": false,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Normal",
                "globos": [],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330594,
                        "componentDefId": 23482,
                        "result": "N",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330595,
                        "componentDefId": 23478,
                        "result": "HEMATOCRIT",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330596,
                        "componentDefId": 23483,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330597,
                        "componentDefId": 23481,
                        "result": "35.0-45.0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330598,
                        "componentDefId": 23479,
                        "result": "42.3",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330599,
                        "componentDefId": 23480,
                        "result": "%",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "male": {
                "globos": [],
                "reportTexts": [],
                "results": []
            },
            "partner": {
                "resultFlag": "Normal",
                "globos": [],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330594,
                        "componentDefId": 23482,
                        "result": "N",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330595,
                        "componentDefId": 23478,
                        "result": "HEMATOCRIT",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330596,
                        "componentDefId": 23483,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330597,
                        "componentDefId": 23481,
                        "result": "35.0-45.0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330598,
                        "componentDefId": 23479,
                        "result": "42.3",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330599,
                        "componentDefId": 23480,
                        "result": "%",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "perfLabId": "104",
            "componentDefs": [],
            "rules": [],
            "name": "HGBELHCT",
            "description": "Hemoglobin Electrophoresis Hematocrit",
            "placeHolderCode": "",
            "reportDescriptionIndividual": "Hemoglobin Electrophoresis Hematocrit",
            "reportDescriptionPanel": "<p>Hemoglobin Electrophoresis Hematocrit<\/p>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 8,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": true,
            "doNotBillSubChoice": true,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "requiredInterpretation": false,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Normal",
                "globos": [],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330600,
                        "componentDefId": 23489,
                        "result": "N",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330601,
                        "componentDefId": 23485,
                        "result": "MCV",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330602,
                        "componentDefId": 23490,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330603,
                        "componentDefId": 23488,
                        "result": "80.0-100.0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330604,
                        "componentDefId": 23486,
                        "result": "92.1",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330605,
                        "componentDefId": 23487,
                        "result": "fL",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "male": {
                "globos": [],
                "reportTexts": [],
                "results": []
            },
            "partner": {
                "resultFlag": "Normal",
                "globos": [],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330600,
                        "componentDefId": 23489,
                        "result": "N",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330601,
                        "componentDefId": 23485,
                        "result": "MCV",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330602,
                        "componentDefId": 23490,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330603,
                        "componentDefId": 23488,
                        "result": "80.0-100.0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330604,
                        "componentDefId": 23486,
                        "result": "92.1",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330605,
                        "componentDefId": 23487,
                        "result": "fL",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "perfLabId": "104",
            "componentDefs": [],
            "rules": [],
            "name": "HGBELMCV",
            "description": "Hemoglobin Electrophoresis MCV",
            "placeHolderCode": "",
            "reportDescriptionIndividual": "Hemoglobin Electrophoresis MCV",
            "reportDescriptionPanel": "<p>Hemoglobin Electrophoresis MCV<\/p>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 7,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": true,
            "doNotBillSubChoice": true,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "requiredInterpretation": false,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Normal",
                "globos": [],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330606,
                        "componentDefId": 23495,
                        "result": "N",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330607,
                        "componentDefId": 23491,
                        "result": "MCH",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330608,
                        "componentDefId": 23496,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330609,
                        "componentDefId": 23494,
                        "result": "27.0-33.0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330610,
                        "componentDefId": 23492,
                        "result": "30.3",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330611,
                        "componentDefId": 23493,
                        "result": "pg",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "male": {
                "globos": [],
                "reportTexts": [],
                "results": []
            },
            "partner": {
                "resultFlag": "Normal",
                "globos": [],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330606,
                        "componentDefId": 23495,
                        "result": "N",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330607,
                        "componentDefId": 23491,
                        "result": "MCH",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330608,
                        "componentDefId": 23496,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330609,
                        "componentDefId": 23494,
                        "result": "27.0-33.0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330610,
                        "componentDefId": 23492,
                        "result": "30.3",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330611,
                        "componentDefId": 23493,
                        "result": "pg",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "perfLabId": "104",
            "componentDefs": [],
            "rules": [],
            "name": "HGBELMCH",
            "description": "Hemoglobin Electrophoresis MCH",
            "placeHolderCode": "",
            "reportDescriptionIndividual": "Hemoglobin Electrophoresis MCH",
            "reportDescriptionPanel": "<p>Hemoglobin Electrophoresis MCH<\/p>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 6,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": true,
            "doNotBillSubChoice": true,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "requiredInterpretation": false,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Normal",
                "globos": [],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330612,
                        "componentDefId": 23501,
                        "result": "N",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330613,
                        "componentDefId": 23497,
                        "result": "RDW",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330614,
                        "componentDefId": 23502,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330615,
                        "componentDefId": 23500,
                        "result": "11.0-15.0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330616,
                        "componentDefId": 23498,
                        "result": "13.1",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330617,
                        "componentDefId": 23499,
                        "result": "%",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "male": {
                "globos": [],
                "reportTexts": [],
                "results": []
            },
            "partner": {
                "globos": [],
                "reportTexts": [],
                "results": []
            },
            "perfLabId": "104",
            "componentDefs": [],
            "rules": [],
            "name": "HGBELRDW",
            "description": "Hemoglobin Electrophoresis RDW",
            "placeHolderCode": "",
            "reportDescriptionIndividual": "Hemoglobin Electrophoresis RDW",
            "reportDescriptionPanel": "<p>Hemoglobin Electrophoresis RDW<\/p>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 6,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": true,
            "doNotBillSubChoice": true,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "requiredInterpretation": false,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Normal",
                "globos": [],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330618,
                        "componentDefId": 23507,
                        "result": "N",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330619,
                        "componentDefId": 23503,
                        "result": "HEMOGLOBIN A",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330620,
                        "componentDefId": 23508,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330621,
                        "componentDefId": 23506,
                        "result": ">96.0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330622,
                        "componentDefId": 23504,
                        "result": "97.3",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330623,
                        "componentDefId": 23505,
                        "result": "%",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "male": {
                "globos": [],
                "reportTexts": [],
                "results": []
            },
            "partner": {
                "globos": [],
                "reportTexts": [],
                "results": []
            },
            "perfLabId": "104",
            "componentDefs": [],
            "rules": [],
            "name": "HGBELHGBA",
            "description": "Hemoglobin Electrophoresis Hemoglobin A",
            "placeHolderCode": "",
            "reportDescriptionIndividual": "Hemoglobin Electrophoresis Hemoglobin A",
            "reportDescriptionPanel": "<p>Hemoglobin Electrophoresis Hemoglobin A<\/p>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 7,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": true,
            "doNotBillSubChoice": true,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "requiredInterpretation": false,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Normal",
                "globos": [],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330624,
                        "componentDefId": 23513,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330625,
                        "componentDefId": 23509,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330626,
                        "componentDefId": 23514,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330627,
                        "componentDefId": 23512,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330628,
                        "componentDefId": 23510,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330629,
                        "componentDefId": 23511,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "male": {
                "globos": [],
                "reportTexts": [],
                "results": []
            },
            "partner": {
                "globos": [],
                "reportTexts": [],
                "results": []
            },
            "perfLabId": "104",
            "componentDefs": [],
            "rules": [],
            "name": "HGBELHGBF",
            "description": "Hemoglobin Electrophoresis Fetal Hemoglobin",
            "placeHolderCode": "",
            "reportDescriptionIndividual": "Hemoglobin Electrophoresis Fetal Hemoglobin",
            "reportDescriptionPanel": "<p>Hemoglobin Electrophoresis Fetal Hemoglobin<\/p>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 6,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": true,
            "doNotBillSubChoice": true,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "requiredInterpretation": false,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Normal",
                "globos": [],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330630,
                        "componentDefId": 23519,
                        "result": "N",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330631,
                        "componentDefId": 23515,
                        "result": "HEMOGLOBIN A2 (QUANT)",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330632,
                        "componentDefId": 23520,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330633,
                        "componentDefId": 23518,
                        "result": "1.8-3.5",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330634,
                        "componentDefId": 23516,
                        "result": "2.7",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330635,
                        "componentDefId": 23517,
                        "result": "%",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "male": {
                "globos": [],
                "reportTexts": [],
                "results": []
            },
            "partner": {
                "globos": [],
                "reportTexts": [],
                "results": []
            },
            "perfLabId": "104",
            "componentDefs": [],
            "rules": [],
            "name": "HGBELHGBA2",
            "description": "Hemoglobin Electrophoresis Hemoglobin A2 (Quant)",
            "placeHolderCode": "",
            "reportDescriptionIndividual": "Hemoglobin Electrophoresis Hemoglobin A2 (Quant)",
            "reportDescriptionPanel": "<p>Hemoglobin Electrophoresis Hemoglobin A2 (Quant)<\/p>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 6,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": true,
            "doNotBillSubChoice": true,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "requiredInterpretation": false,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071945,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071946,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071947,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071948,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071949,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330408,
                        "componentDefId": 24286,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330409,
                        "componentDefId": 24287,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330410,
                        "componentDefId": 24284,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330411,
                        "componentDefId": 24285,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 69
            },
            "male": {
                "resultFlag": "Positive",
                "globos": [
                    {
                        "globalTextId": 3926458,
                        "description": "PKU How Common Content",
                        "longText": "<p>Worldwide, phenylalanine hydroxylase deficiency affects about 1 in 15,000 births. However, the frequency varies between populations. It is particularly common in individuals from Turkey, Ireland, some other Northern European countries, and East Asia.<\/p>"
                    },
                    {
                        "globalTextId": 3926459,
                        "description": "PKU How Common Title",
                        "longText": "<p><strong>HOW COMMON IS PHENYLALANINE HYDROXYLASE DEFICIENCY?<\/strong><\/p>"
                    },
                    {
                        "globalTextId": 3926460,
                        "description": "PKU Inheritance Content",
                        "longText": "<ul><li> Phenylalanine hydroxylase deficiency is inherited in an autosomal recessive pattern.<\/li><li> A patient who has only one mutation in this gene is a carrier.  Carriers typically have no signs or symptoms of disease.<\/li><li> The family history is usually negative.<\/li><li> Carriers have an increased chance to have an affected child.  If both parents are carriers of mutations in the <em>PAH<\/em> gene, there is a 1 in 4 (25%) chance for each child to inherit two mutations and be affected with the disease.<\/li><\/ul>"
                    },
                    {
                        "globalTextId": 3926461,
                        "description": "PKU Inheritance Title",
                        "longText": "<p><strong>INHERITANCE OF PHENYLALANINE HYDROXYLASE DEFICIENCY<\/strong><\/p>"
                    },
                    {
                        "globalTextId": 3926462,
                        "description": "PKU Positive Interpretation",
                        "longText": "<p>These results indicate that this patient has a higher chance to have a child affected with Phenylalanine hydroxylase deficiency.<\/p>"
                    },
                    {
                        "globalTextId": 3926463,
                        "description": "Autosomal Recessive Next Steps Content",
                        "longText": "<p> Genetic counseling is an option to discuss the potential clinical and reproductive implications of these results, as well as testing additional at-risk family members.<\/p>\r\n<p> Evaluate partner carrier status.<\/p>\r\n<ul>\r\n    <li>Offer carrier screening if the partner has not yet been tested. Consider the pros and cons of different test methodologies. Partners of a known carrier may benefit from more comprehensive, sensitive testing.<\/li>\r\n    <li>If the partner has had carrier screening for this condition, review the results. If results were negative, evaluate the detection rate of the test for this condition. Some tests or conditions have low detection rates. In some cases, offering additional testing may be appropriate.<\/li>\r\n<\/ul>\r\n<p> If at-risk, offer appropriate preconception or prenatal testing options. If both partners are carriers for this condition, any pregnancy has a 1 in 4 (25%) risk to be affected.<\/p>"
                    },
                    {
                        "globalTextId": 3926464,
                        "description": "PKU Next Steps Title",
                        "longText": "<p><strong>Phenylalanine hydroxylase deficiency carrier status<\/strong><\/p>"
                    },
                    {
                        "globalTextId": 3926465,
                        "description": "PKU What Is Content",
                        "longText": "<p>Phenylalanine hydroxylase deficiency refers to the group of disorders caused by intolerance to dietary phenylalanine. These include phenylketonuria (PKU), non-PKU hyperphenylalaninemia, and variant PKU. Without avoidance of phenylalanine, children with PKU historically developed progressive severe intellectual disability. Other forms are associated with varying risk.<\/p><br /><p>Phenylalanine hydroxylase deficiency is now detected through newborn screening in almost all cases. Phe-free medical formula and a low protein diet from early in life avoids most serious complications. Women with phenylalanine hydroxylase deficiency need to maintain a well controlled Phe-restricted diet from several months before conception through pregnancy to avoid fetal exposure to high levels.<\/p> "
                    },
                    {
                        "globalTextId": 3926466,
                        "description": "PKU What Is Title",
                        "longText": "<p><strong>WHAT IS PHENYLALANINE HYDROXYLASE DEFICIENCY?<\/strong><\/p>"
                    },
                    {
                        "globalTextId": 3926467,
                        "description": "Panel Reproductive Options Title",
                        "longText": "<p><strong>REPRODUCTIVE OPTIONS FOR CARRIERS<\/strong><\/p>"
                    },
                    {
                        "globalTextId": 3926468,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926469,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926470,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926471,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926472,
                        "description": "Autosomal Recessive Reproductive Options Content",
                        "longText": "<p><strong>If both partners are carriers of this disorder<\/strong>, there is a 1 in 4 (25%) chance for any pregnancy to be affected.  Reproductive options are available for couples that wish to lower or avoid the risk.<\/p><br /><p><strong>If this patient is pregnant, options include:<\/strong><\/p><ul><li>Continuing the pregnancy without any prenatal testing. Testing should be performed after delivery to diagnose or rule out the condition.<\/li><li>Prenatal diagnosis with chorionic villus sampling (CVS) or amniocentesis, depending on the gestational age. When the parental mutations are known, prenatal diagnosis is available. Results may be important for parents for preparation purposes, or for reproductive decision-making.<\/li><\/ul><br /><p><strong>If this patient is not yet pregnant, options include:<\/strong><\/p><ul><li>Becoming pregnant naturally, and considering the options listed above<\/li><li>Preimplantation genetic diagnosis (PGD)<\/li><li>Gamete donation<\/li><li>Adoption<\/li><\/ul>"
                    },
                    {
                        "globalTextId": 3926473,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256952,
                        "componentDefId": 24284,
                        "result": "1222C>T",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256953,
                        "componentDefId": 24287,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256954,
                        "componentDefId": 24285,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256955,
                        "componentDefId": 24286,
                        "result": "1",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 69
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071945,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071946,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071947,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071948,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071949,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330408,
                        "componentDefId": 24286,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330409,
                        "componentDefId": 24287,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330410,
                        "componentDefId": 24284,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330411,
                        "componentDefId": 24285,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 69
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "PKUA1",
            "description": "Progenity - Phenylalanine hydroxylase deficiency",
            "placeHolderCode": "3698A1P",
            "reportDescriptionIndividual": "<strong>Phenylalanine hydroxylase deficiency<\/strong>",
            "reportDescriptionPanel": "<strong>Phenylalanine hydroxylase deficiency<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071037,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071038,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071039,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071040,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071041,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329707,
                        "componentDefId": 23606,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329708,
                        "componentDefId": 23607,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329709,
                        "componentDefId": 23604,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329710,
                        "componentDefId": 23605,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925692,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925693,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925694,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925695,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925696,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256332,
                        "componentDefId": 23606,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256333,
                        "componentDefId": 23607,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256334,
                        "componentDefId": 23604,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256335,
                        "componentDefId": 23605,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071037,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071038,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071039,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071040,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071041,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329707,
                        "componentDefId": 23606,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329708,
                        "componentDefId": 23607,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329709,
                        "componentDefId": 23604,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329710,
                        "componentDefId": 23605,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "17OHA1",
            "description": "Progenity - 17-alpha-hydroxylase deficiency",
            "placeHolderCode": "3525A1P",
            "reportDescriptionIndividual": "<strong>17-alpha-hydroxylase deficiency<\/strong>",
            "reportDescriptionPanel": "<strong>17-alpha-hydroxylase deficiency<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 11,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "assayTypeId": 1,
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071042,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071043,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071044,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071045,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071046,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329711,
                        "componentDefId": 23610,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329712,
                        "componentDefId": 23611,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329713,
                        "componentDefId": 23608,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329714,
                        "componentDefId": 23609,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 213
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925672,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925673,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925674,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925675,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925676,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256336,
                        "componentDefId": 23610,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256337,
                        "componentDefId": 23611,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256338,
                        "componentDefId": 23608,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256341,
                        "componentDefId": 23609,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 213
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071042,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071043,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071044,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071045,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071046,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329711,
                        "componentDefId": 23610,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329712,
                        "componentDefId": 23611,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329713,
                        "componentDefId": 23608,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329714,
                        "componentDefId": 23609,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 213
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "BHSDA1",
            "description": "Progenity - 17-beta-hydroxysteroid dehydrogenase deficiency, type III ",
            "placeHolderCode": "3526A1P",
            "reportDescriptionIndividual": "<strong>17-beta-hydroxysteroid dehydrogenase deficiency, type III <\/strong>",
            "reportDescriptionPanel": "<strong>17-beta-hydroxysteroid dehydrogenase deficiency, type III <\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 2,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071047,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071048,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071049,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071050,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071051,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329715,
                        "componentDefId": 23614,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329716,
                        "componentDefId": 23615,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329717,
                        "componentDefId": 23612,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329718,
                        "componentDefId": 23613,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925657,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925658,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925659,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925660,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925661,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256339,
                        "componentDefId": 23614,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256340,
                        "componentDefId": 23615,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256342,
                        "componentDefId": 23612,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256345,
                        "componentDefId": 23613,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071047,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071048,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071049,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071050,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071051,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329715,
                        "componentDefId": 23614,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329716,
                        "componentDefId": 23615,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329717,
                        "componentDefId": 23612,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329718,
                        "componentDefId": 23613,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "HSDA1",
            "description": "Progenity - 3-Beta-hydroxysteroid dehydrogenase deficiency, type II",
            "placeHolderCode": "3527A1P",
            "reportDescriptionIndividual": "<strong>3-beta-hydroxysteroid dehydrogenase deficiency, type II<\/strong>",
            "reportDescriptionPanel": "<strong>3-beta-hydroxysteroid dehydrogenase deficiency, type II<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071052,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071053,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071054,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071055,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071056,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329719,
                        "componentDefId": 23618,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329720,
                        "componentDefId": 23619,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329721,
                        "componentDefId": 23616,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329722,
                        "componentDefId": 23617,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 176
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926046,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926047,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926048,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926049,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926050,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256343,
                        "componentDefId": 23618,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256344,
                        "componentDefId": 23619,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256346,
                        "componentDefId": 23616,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256347,
                        "componentDefId": 23617,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 176
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071052,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071053,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071054,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071055,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071056,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329719,
                        "componentDefId": 23618,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329720,
                        "componentDefId": 23619,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329721,
                        "componentDefId": 23616,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329722,
                        "componentDefId": 23617,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 176
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "HMGCLDA1",
            "description": "Progenity - 3-hydroxy-3-methylglutaryl CoA lyase deficiency",
            "placeHolderCode": "3528A1P",
            "reportDescriptionIndividual": "<strong>3-hydroxy-3-methylglutaryl CoA lyase deficiency<\/strong>",
            "reportDescriptionPanel": "<strong>3-hydroxy-3-methylglutaryl CoA lyase deficiency<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071057,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071058,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071059,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071060,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071061,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329723,
                        "componentDefId": 23630,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329724,
                        "componentDefId": 23631,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329725,
                        "componentDefId": 23628,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329726,
                        "componentDefId": 23629,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925662,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925663,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925664,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925665,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925666,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256348,
                        "componentDefId": 23630,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256349,
                        "componentDefId": 23628,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256350,
                        "componentDefId": 23629,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256351,
                        "componentDefId": 23631,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071057,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071058,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071059,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071060,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071061,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329723,
                        "componentDefId": 23630,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329724,
                        "componentDefId": 23631,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329725,
                        "componentDefId": 23628,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329726,
                        "componentDefId": 23629,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "MGA3A1",
            "description": "Progenity - 3-methylglutaconic aciduria,type III",
            "placeHolderCode": "3531A1P",
            "reportDescriptionIndividual": "<strong>3-methylglutaconic aciduria, type III<\/strong>",
            "reportDescriptionPanel": "<strong>3-methylglutaconic aciduria, type III<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 2,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071062,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071063,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071064,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071065,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071066,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329727,
                        "componentDefId": 23634,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329728,
                        "componentDefId": 23635,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329729,
                        "componentDefId": 23632,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329730,
                        "componentDefId": 23633,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 2936
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925637,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925638,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925642,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925644,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925646,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256352,
                        "componentDefId": 23634,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256353,
                        "componentDefId": 23632,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256354,
                        "componentDefId": 23635,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256355,
                        "componentDefId": 23633,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 2936
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071062,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071063,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071064,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071065,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071066,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329727,
                        "componentDefId": 23634,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329728,
                        "componentDefId": 23635,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329729,
                        "componentDefId": 23632,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329730,
                        "componentDefId": 23633,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 2936
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "3PGDA1",
            "description": "Progenity - 3-phosphoglycerate dehydrogenase deficiency",
            "placeHolderCode": "3532A1P",
            "reportDescriptionIndividual": "<strong>3-phosphoglycerate dehydrogenase deficiency<\/strong>",
            "reportDescriptionPanel": "<strong>3-phosphoglycerate dehydrogenase deficiency<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071067,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071068,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071069,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071070,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071071,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329731,
                        "componentDefId": 23638,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329732,
                        "componentDefId": 23639,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329733,
                        "componentDefId": 23636,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329734,
                        "componentDefId": 23637,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925667,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925668,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925669,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925670,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925671,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256356,
                        "componentDefId": 23638,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256357,
                        "componentDefId": 23639,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256358,
                        "componentDefId": 23636,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256359,
                        "componentDefId": 23637,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071067,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071068,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071069,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071070,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071071,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329731,
                        "componentDefId": 23638,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329732,
                        "componentDefId": 23639,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329733,
                        "componentDefId": 23636,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329734,
                        "componentDefId": 23637,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "ABLA1",
            "description": "Progenity - Abetalipoproteinemia",
            "placeHolderCode": "3533A1P",
            "reportDescriptionIndividual": "<strong>Abetalipoproteinemia<\/strong>",
            "reportDescriptionPanel": "<strong>Abetalipoproteinemia<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071072,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071073,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071074,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071075,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071076,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329735,
                        "componentDefId": 23642,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329736,
                        "componentDefId": 23643,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329737,
                        "componentDefId": 23640,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329738,
                        "componentDefId": 23641,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925639,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925640,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925641,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925643,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925645,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256360,
                        "componentDefId": 23642,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256361,
                        "componentDefId": 23643,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256362,
                        "componentDefId": 23640,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256363,
                        "componentDefId": 23641,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925639,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925640,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925641,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925643,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925645,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256360,
                        "componentDefId": 23642,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256361,
                        "componentDefId": 23643,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256362,
                        "componentDefId": 23640,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256363,
                        "componentDefId": 23641,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "AAAA1",
            "description": "Progenity - Achalasia-addisonianism-alacrima syndrome ",
            "placeHolderCode": "3534A1P",
            "reportDescriptionIndividual": "<strong>Achalasia-addisonianism-alacrima syndrome <\/strong>",
            "reportDescriptionPanel": "<strong>Achalasia-addisonianism-alacrima syndrome <\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071077,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071078,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071079,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071080,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071081,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329739,
                        "componentDefId": 23646,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329740,
                        "componentDefId": 23647,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329741,
                        "componentDefId": 23644,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329742,
                        "componentDefId": 23645,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 192
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925687,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925688,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925689,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925690,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925691,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256364,
                        "componentDefId": 23646,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256365,
                        "componentDefId": 23647,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256366,
                        "componentDefId": 23644,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256367,
                        "componentDefId": 23645,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 192
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925687,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925688,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925689,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925690,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925691,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256364,
                        "componentDefId": 23646,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256365,
                        "componentDefId": 23647,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256366,
                        "componentDefId": 23644,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256367,
                        "componentDefId": 23645,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 192
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "CNGA3A1",
            "description": "Progenity - Achromatopsia, CNGA3-related",
            "placeHolderCode": "3535A1P",
            "reportDescriptionIndividual": "<strong>Achromatopsia, CNGA3-related<\/strong>",
            "reportDescriptionPanel": "<strong>Achromatopsia, CNGA3-related<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 4,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071082,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071083,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071084,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071085,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071086,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329743,
                        "componentDefId": 23650,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329744,
                        "componentDefId": 23651,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329745,
                        "componentDefId": 23648,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329746,
                        "componentDefId": 23649,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 556
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925716,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925717,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925718,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925719,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925720,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256368,
                        "componentDefId": 23650,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256369,
                        "componentDefId": 23651,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256370,
                        "componentDefId": 23648,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256371,
                        "componentDefId": 23649,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 556
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925716,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925717,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925718,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925719,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925720,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256368,
                        "componentDefId": 23650,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256369,
                        "componentDefId": 23651,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256370,
                        "componentDefId": 23648,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256371,
                        "componentDefId": 23649,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 556
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "CNGB3A1",
            "description": "Progenity - Achromatopsia, CNGB3-related",
            "placeHolderCode": "3536A1P",
            "reportDescriptionIndividual": "<strong>Achromatopsia, CNGB3-related<\/strong>",
            "reportDescriptionPanel": "<strong>Achromatopsia, CNGB3-related<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 2,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071087,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071088,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071089,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071090,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071091,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329747,
                        "componentDefId": 23654,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329748,
                        "componentDefId": 23655,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329749,
                        "componentDefId": 23652,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329750,
                        "componentDefId": 23653,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 393
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925761,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925762,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925763,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925764,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925765,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256372,
                        "componentDefId": 23655,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256373,
                        "componentDefId": 23654,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256374,
                        "componentDefId": 23652,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256375,
                        "componentDefId": 23653,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 393
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925761,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925762,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925763,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925764,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925765,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256372,
                        "componentDefId": 23655,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256373,
                        "componentDefId": 23654,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256374,
                        "componentDefId": 23652,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256375,
                        "componentDefId": 23653,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 393
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "AEZA1",
            "description": "Progenity - Acrodermatitis enteropathica",
            "placeHolderCode": "3537A1P",
            "reportDescriptionIndividual": "<strong>Acrodermatitis enteropathica<\/strong>",
            "reportDescriptionPanel": "<strong>Acrodermatitis enteropathica<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071092,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071093,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071094,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071095,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071096,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329751,
                        "componentDefId": 23658,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329752,
                        "componentDefId": 23659,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329753,
                        "componentDefId": 23656,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329754,
                        "componentDefId": 23657,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 476
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925771,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925772,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925773,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925774,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925775,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256376,
                        "componentDefId": 23658,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256377,
                        "componentDefId": 23659,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256378,
                        "componentDefId": 23656,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256379,
                        "componentDefId": 23657,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 476
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925771,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925772,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925773,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925774,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925775,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256376,
                        "componentDefId": 23658,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256377,
                        "componentDefId": 23659,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256378,
                        "componentDefId": 23656,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256379,
                        "componentDefId": 23657,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 476
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "ADAA1",
            "description": "Progenity - Adenosine deaminase deficiency ",
            "placeHolderCode": "3538A1P",
            "reportDescriptionIndividual": "<strong>Adenosine deaminase deficiency <\/strong>",
            "reportDescriptionPanel": "<strong>Adenosine deaminase deficiency <\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 2,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071097,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071098,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071099,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071100,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 4071101,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329755,
                        "componentDefId": 23662,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329756,
                        "componentDefId": 23663,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329757,
                        "componentDefId": 23660,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329758,
                        "componentDefId": 23661,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 46667
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925711,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925712,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925713,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925714,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3925715,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256380,
                        "componentDefId": 23662,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256381,
                        "componentDefId": 23663,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256382,
                        "componentDefId": 23660,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256383,
                        "componentDefId": 23661,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 46667
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925711,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925712,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925713,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925714,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3925715,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256380,
                        "componentDefId": 23662,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256381,
                        "componentDefId": 23663,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256382,
                        "componentDefId": 23660,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256383,
                        "componentDefId": 23661,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 46667
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "ALDA1",
            "description": "Progenity - Adrenoleukodystrophy (X-linked)",
            "placeHolderCode": "3539A1P",
            "reportDescriptionIndividual": "<strong>Adrenoleukodystrophy (X-linked)<\/strong>",
            "reportDescriptionPanel": "<strong>Adrenoleukodystrophy (X-linked)<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 6,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071102,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071103,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071104,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071105,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071106,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329759,
                        "componentDefId": 23666,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329760,
                        "componentDefId": 23667,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329761,
                        "componentDefId": 23664,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329762,
                        "componentDefId": 23665,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925776,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925777,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925778,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925779,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925780,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256384,
                        "componentDefId": 23666,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256385,
                        "componentDefId": 23664,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256386,
                        "componentDefId": 23667,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256387,
                        "componentDefId": 23665,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925776,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925777,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925778,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925779,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925780,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256384,
                        "componentDefId": 23666,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256385,
                        "componentDefId": 23664,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256386,
                        "componentDefId": 23667,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256387,
                        "componentDefId": 23665,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "AGSRA1",
            "description": "Progenity - Aicardi-Goutieres syndrome, RNASEH2C-related",
            "placeHolderCode": "3540A1P",
            "reportDescriptionIndividual": "<strong>Aicardi-Goutieres syndrome, RNASEH2C-related<\/strong>",
            "reportDescriptionPanel": "<strong>Aicardi-Goutieres syndrome, RNASEH2C-related<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071107,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071108,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071109,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071110,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071111,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329767,
                        "componentDefId": 23670,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329768,
                        "componentDefId": 23671,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329769,
                        "componentDefId": 23668,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329770,
                        "componentDefId": 23669,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925731,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925732,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925733,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925734,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925735,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256388,
                        "componentDefId": 23670,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256389,
                        "componentDefId": 23669,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256390,
                        "componentDefId": 23668,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256391,
                        "componentDefId": 23671,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925731,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925732,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925733,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925734,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925735,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256388,
                        "componentDefId": 23670,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256389,
                        "componentDefId": 23669,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256390,
                        "componentDefId": 23668,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256391,
                        "componentDefId": 23671,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "AGS1A1",
            "description": "Progenity - Aicardi-Goutieres syndrome, TREX1-related",
            "placeHolderCode": "3541A1P",
            "reportDescriptionIndividual": "<strong>Aicardi-Goutieres syndrome, TREX1-related<\/strong>",
            "reportDescriptionPanel": "<strong>Aicardi-Goutieres syndrome, TREX1-related<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071112,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071113,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071114,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071115,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071116,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329763,
                        "componentDefId": 23674,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329764,
                        "componentDefId": 23675,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329765,
                        "componentDefId": 23672,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329766,
                        "componentDefId": 23673,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925726,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925727,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925728,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925729,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925730,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256392,
                        "componentDefId": 23674,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256393,
                        "componentDefId": 23672,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256394,
                        "componentDefId": 23675,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256396,
                        "componentDefId": 23673,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071112,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071113,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071114,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071115,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071116,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329763,
                        "componentDefId": 23674,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329764,
                        "componentDefId": 23675,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329765,
                        "componentDefId": 23672,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329766,
                        "componentDefId": 23673,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "DCIPA1",
            "description": "Progenity - Aicardi-Goutieres syndrome, SAMHD1-related",
            "placeHolderCode": "3542A1P",
            "reportDescriptionIndividual": "<strong>Aicardi-Goutieres syndrome, SAMHD1-related<\/strong>",
            "reportDescriptionPanel": "<strong>Aicardi-Goutieres syndrome, SAMHD1-related<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 4,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071117,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071118,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071119,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071120,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071121,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329771,
                        "componentDefId": 23678,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329772,
                        "componentDefId": 23679,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329773,
                        "componentDefId": 23676,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329774,
                        "componentDefId": 23677,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 312
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925746,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925747,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925748,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925749,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925750,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256395,
                        "componentDefId": 23678,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256397,
                        "componentDefId": 23679,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256398,
                        "componentDefId": 23676,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256399,
                        "componentDefId": 23677,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 278
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071117,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071118,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071119,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071120,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071121,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329771,
                        "componentDefId": 23678,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329772,
                        "componentDefId": 23679,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329773,
                        "componentDefId": 23676,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329774,
                        "componentDefId": 23677,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 312
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "AKUA1",
            "description": "Progenity - Alkaptonuria",
            "placeHolderCode": "3543A1P",
            "reportDescriptionIndividual": "<strong>Alkaptonuria<\/strong>",
            "reportDescriptionPanel": "<strong>Alkaptonuria<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071122,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071123,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071124,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071125,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071126,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329815,
                        "componentDefId": 23682,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329816,
                        "componentDefId": 23683,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329817,
                        "componentDefId": 23680,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329818,
                        "componentDefId": 23681,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 164
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925741,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925742,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925743,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925744,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925745,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256400,
                        "componentDefId": 23682,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256401,
                        "componentDefId": 23683,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256402,
                        "componentDefId": 23680,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256403,
                        "componentDefId": 23681,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 164
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071122,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071123,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071124,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071125,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071126,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329815,
                        "componentDefId": 23682,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329816,
                        "componentDefId": 23683,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329817,
                        "componentDefId": 23680,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329818,
                        "componentDefId": 23681,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 164
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "ANSA1",
            "description": "Progenity - Ataxia neuropathy spectrum",
            "placeHolderCode": "3544A1P",
            "reportDescriptionIndividual": "<strong>Ataxia neuropathy spectrum<\/strong>",
            "reportDescriptionPanel": "<strong>Ataxia neuropathy spectrum<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071127,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071128,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071129,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071130,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071131,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329775,
                        "componentDefId": 23690,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329776,
                        "componentDefId": 23691,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329777,
                        "componentDefId": 23688,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329778,
                        "componentDefId": 23689,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 544
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925796,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925797,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925798,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925799,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925800,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256404,
                        "componentDefId": 23690,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256405,
                        "componentDefId": 23691,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256406,
                        "componentDefId": 23688,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256407,
                        "componentDefId": 23689,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 544
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071127,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071128,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071129,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071130,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071131,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329775,
                        "componentDefId": 23690,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329776,
                        "componentDefId": 23691,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329777,
                        "componentDefId": 23688,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329778,
                        "componentDefId": 23689,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 544
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "MANBA1",
            "description": "Progenity - Alpha-mannosidosis",
            "placeHolderCode": "3546A1P",
            "reportDescriptionIndividual": "<strong>Alpha-mannosidosis<\/strong>",
            "reportDescriptionPanel": "<strong>Alpha-mannosidosis<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072131,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072132,
                        "description": "IMG Alpha Thal Methodology",
                        "longText": "<p>Analysis of the alpha globin gene cluster was performed on purified genomic DNA using multiplex ligation-dependent probe amplification (MLPA), capillary electrophoresis on an ABI Genetic Analyzer, and manual analysis of fragment profiles using Coffalyser.net version 140721.1958. The probe mix used in the assay (P140-C1; MRC Holland, Amsterdam, The Netherlands) targets HBA1, HBA2, several regions up- and downstream of the two alpha globin genes, and 11 reference probes required for normalization. The following seven deletions (-&alpha;<sup>3.7<\/sup>, -&alpha;<sup>4.2<\/sup>, --<sup>SEA<\/sup>, --<sup>FIL<\/sup>, --<sup>THAI<\/sup>, --<sup>MED<\/sup>, and -&alpha;<sup>20.5<\/sup>) are analyzed and reported. Probe ratios less than 0.8 were interpreted as copy number losses and ratios greater than 1.2 as copy number gains. Analytic sensitivity and specificity of the assay have been calculated as &gt;99% (95% CI: 99.18% to 100.00%) and &gt;99% (95% CI: 99.53% to 100.00%), respectively.<\/p>"
                    },
                    {
                        "globalTextId": 4072133,
                        "description": "IMG Alpha Thal Limitations",
                        "longText": "<p>Multiplex ligation-dependent probe amplification (MLPA) is designed to determine relative copy number at specific target sequences. MLPA will not detect most inversions, balanced translocations, or copy number changes that lie outside (or only partially inside) the sequence detected by an MLPA probe. Furthermore, a deletion may not be detected when a similarly sized duplication is present on the other allele. Only the following seven deletions (-&alpha;<sup>3.7<\/sup>, -&alpha;<sup>4.2<\/sup>, --<sup>SEA<\/sup>, --<sup>FIL<\/sup>, --<sup>THAI<\/sup>, --<sup>MED<\/sup>, and -&alpha;<sup>20.5<\/sup>) are analyzed and reported. Other deletions, deleterious point mutations, or small sequence variants will not be detected. It should be noted that there are potential sources of diagnostic error, including somatic heterogeneity of the sample, misidentification of samples prior to receipt, and polymorphisms or other rare genetic variants that interfere with analysis.  Due to the limitations of the assay, there is a chance of a false negative result.<\/p>"
                    },
                    {
                        "globalTextId": 4072134,
                        "description": "IMG Alpha Thal Extra Methodology",
                        "longText": "<p><strong>Alpha-Thalassemia:<\/strong> Analysis of the alpha globin gene cluster was performed on purified genomic DNA using multiplex ligation-dependent probe amplification (MLPA), capillary electrophoresis on an ABI Genetic Analyzer, and manual analysis of fragment profiles using Coffalyser.net version 140721.1958. The probe mix used in the assay (P140-C1; MRC Holland, Amsterdam, The Netherlands) targets HBA1, HBA2, several regions up- and downstream of the two alpha globin genes, and 11 reference probes required for normalization. The following seven deletions (-&alpha;<sup>3.7<\/sup>, -&alpha;<sup>4.2<\/sup>, --<sup>SEA<\/sup>, --<sup>FIL<\/sup>, --<sup>THAI<\/sup>, --<sup>MED<\/sup>, and -&alpha;<sup>20.5<\/sup>) are analyzed and reported. Probe ratios less than 0.8 were interpreted as copy number losses and ratios greater than 1.2 as copy number gains. Analytic sensitivity and specificity of the assay have been calculated as &gt;99% (95% CI: 99.18% to 100.00%) and &gt;99% (95% CI: 99.53% to 100.00%), respectively.<\/p>"
                    },
                    {
                        "globalTextId": 4072135,
                        "description": "IMG Alpha Thal Extra Limitations",
                        "longText": "<p><strong>Alpha-Thalassemia:<\/strong> Multiplex ligation-dependent probe amplification (MLPA) is designed to determine relative copy number at specific target sequences. MLPA will not detect most inversions, balanced translocations, or copy number changes that lie outside (or only partially inside) the sequence detected by an MLPA probe. Furthermore, a deletion may not be detected when a similarly sized duplication is present on the other allele. Only the following seven deletions (-&alpha;<sup>3.7<\/sup>, -&alpha;<sup>4.2<\/sup>, --<sup>SEA<\/sup>, --<sup>FIL<\/sup>, --<sup>THAI<\/sup>, --<sup>MED<\/sup>, and -&alpha;<sup>20.5<\/sup>) are analyzed and reported. Other deletions, deleterious point mutations, or small sequence variants will not be detected. It should be noted that there are potential sources of diagnostic error, including somatic heterogeneity of the sample, misidentification of samples prior to receipt, and polymorphisms or other rare genetic variants that interfere with analysis.  Due to the limitations of the assay, there is a chance of a false negative result.<\/p>"
                    },
                    {
                        "globalTextId": 4072136,
                        "description": "GCS V4 Global + Additional Info",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-global-102016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global 102016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072137,
                        "description": "IMG Alpha Thal FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This test has not been cleared or approved by the U.S. Food and Drug Administration (FDA) but the FDA has determined that clearance or approval is not necessary, in that, pursuant to the requirements of CLIA'88, IMG has established and verified the test's accuracy and precision. Performing Laboratory: Insight Medical Genetics, LLC, 680 N Lake Shore Drive, Suite 1230, Chicago, IL 60611<\/span><\/p>"
                    },
                    {
                        "globalTextId": 4072138,
                        "description": "IMG Alpha Thal Extra FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\"><strong>Alpha-Thalassemia:<\/strong>&nbsp;This test has not been cleared or approved by the U.S. Food and Drug Administration (FDA) but the FDA has determined that clearance or approval is not necessary, in that, pursuant to the requirements of CLIA'88, IMG has established and verified the test's accuracy and precision. Performing Laboratory: Insight Medical Genetics, LLC, 680 N Lake Shore Drive, Suite 1230, Chicago, IL 60611<\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [{
                    "componentResultId": 2330582,
                    "componentDefId": 24618,
                    "result": "No deletions detected",
                    "resultsDateTime": "2016-11-30T00:00:00",
                    "concurrencyId": 1,
                    "amended": false
                }],
                "reproRisk": 4991
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926734,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926735,
                        "description": "IMG Alpha Thal Methodology",
                        "longText": "<p>Analysis of the alpha globin gene cluster was performed on purified genomic DNA using multiplex ligation-dependent probe amplification (MLPA), capillary electrophoresis on an ABI Genetic Analyzer, and manual analysis of fragment profiles using Coffalyser.net version 140721.1958. The probe mix used in the assay (P140-C1; MRC Holland, Amsterdam, The Netherlands) targets HBA1, HBA2, several regions up- and downstream of the two alpha globin genes, and 11 reference probes required for normalization. The following seven deletions (-&alpha;<sup>3.7<\/sup>, -&alpha;<sup>4.2<\/sup>, --<sup>SEA<\/sup>, --<sup>FIL<\/sup>, --<sup>THAI<\/sup>, --<sup>MED<\/sup>, and -&alpha;<sup>20.5<\/sup>) are analyzed and reported. Probe ratios less than 0.8 were interpreted as copy number losses and ratios greater than 1.2 as copy number gains. Analytic sensitivity and specificity of the assay have been calculated as &gt;99% (95% CI: 99.18% to 100.00%) and &gt;99% (95% CI: 99.53% to 100.00%), respectively.<\/p>"
                    },
                    {
                        "globalTextId": 3926736,
                        "description": "IMG Alpha Thal Limitations",
                        "longText": "<p>Multiplex ligation-dependent probe amplification (MLPA) is designed to determine relative copy number at specific target sequences. MLPA will not detect most inversions, balanced translocations, or copy number changes that lie outside (or only partially inside) the sequence detected by an MLPA probe. Furthermore, a deletion may not be detected when a similarly sized duplication is present on the other allele. Only the following seven deletions (-&alpha;<sup>3.7<\/sup>, -&alpha;<sup>4.2<\/sup>, --<sup>SEA<\/sup>, --<sup>FIL<\/sup>, --<sup>THAI<\/sup>, --<sup>MED<\/sup>, and -&alpha;<sup>20.5<\/sup>) are analyzed and reported. Other deletions, deleterious point mutations, or small sequence variants will not be detected. It should be noted that there are potential sources of diagnostic error, including somatic heterogeneity of the sample, misidentification of samples prior to receipt, and polymorphisms or other rare genetic variants that interfere with analysis.  Due to the limitations of the assay, there is a chance of a false negative result.<\/p>"
                    },
                    {
                        "globalTextId": 3926737,
                        "description": "IMG Alpha Thal Extra Methodology",
                        "longText": "<p><strong>Alpha-Thalassemia:<\/strong> Analysis of the alpha globin gene cluster was performed on purified genomic DNA using multiplex ligation-dependent probe amplification (MLPA), capillary electrophoresis on an ABI Genetic Analyzer, and manual analysis of fragment profiles using Coffalyser.net version 140721.1958. The probe mix used in the assay (P140-C1; MRC Holland, Amsterdam, The Netherlands) targets HBA1, HBA2, several regions up- and downstream of the two alpha globin genes, and 11 reference probes required for normalization. The following seven deletions (-&alpha;<sup>3.7<\/sup>, -&alpha;<sup>4.2<\/sup>, --<sup>SEA<\/sup>, --<sup>FIL<\/sup>, --<sup>THAI<\/sup>, --<sup>MED<\/sup>, and -&alpha;<sup>20.5<\/sup>) are analyzed and reported. Probe ratios less than 0.8 were interpreted as copy number losses and ratios greater than 1.2 as copy number gains. Analytic sensitivity and specificity of the assay have been calculated as &gt;99% (95% CI: 99.18% to 100.00%) and &gt;99% (95% CI: 99.53% to 100.00%), respectively.<\/p>"
                    },
                    {
                        "globalTextId": 3926738,
                        "description": "IMG Alpha Thal Extra Limitations",
                        "longText": "<p><strong>Alpha-Thalassemia:<\/strong> Multiplex ligation-dependent probe amplification (MLPA) is designed to determine relative copy number at specific target sequences. MLPA will not detect most inversions, balanced translocations, or copy number changes that lie outside (or only partially inside) the sequence detected by an MLPA probe. Furthermore, a deletion may not be detected when a similarly sized duplication is present on the other allele. Only the following seven deletions (-&alpha;<sup>3.7<\/sup>, -&alpha;<sup>4.2<\/sup>, --<sup>SEA<\/sup>, --<sup>FIL<\/sup>, --<sup>THAI<\/sup>, --<sup>MED<\/sup>, and -&alpha;<sup>20.5<\/sup>) are analyzed and reported. Other deletions, deleterious point mutations, or small sequence variants will not be detected. It should be noted that there are potential sources of diagnostic error, including somatic heterogeneity of the sample, misidentification of samples prior to receipt, and polymorphisms or other rare genetic variants that interfere with analysis.  Due to the limitations of the assay, there is a chance of a false negative result.<\/p>"
                    },
                    {
                        "globalTextId": 3926739,
                        "description": "GCS V4 Global + Additional Info",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-global-042016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global 042016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926740,
                        "description": "IMG Alpha Thal FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This test has not been cleared or approved by the U.S. Food and Drug Administration (FDA) but the FDA has determined that clearance or approval is not necessary, in that, pursuant to the requirements of CLIA'88, IMG has established and verified the test's accuracy and precision. Performing Laboratory: Insight Medical Genetics, LLC, 680 N Lake Shore Drive, Suite 1230, Chicago, IL 60611<\/span><\/p>"
                    },
                    {
                        "globalTextId": 3926741,
                        "description": "IMG Alpha Thal Extra FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\"><strong>Alpha-Thalassemia:<\/strong>&nbsp;This test has not been cleared or approved by the U.S. Food and Drug Administration (FDA) but the FDA has determined that clearance or approval is not necessary, in that, pursuant to the requirements of CLIA'88, IMG has established and verified the test's accuracy and precision. Performing Laboratory: Insight Medical Genetics, LLC, 680 N Lake Shore Drive, Suite 1230, Chicago, IL 60611<\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [{
                    "componentResultId": 2211660,
                    "componentDefId": 24618,
                    "result": "No deletions detected",
                    "resultsDateTime": "2016-07-15T15:29:00",
                    "concurrencyId": 1,
                    "amended": false
                }],
                "reproRisk": 4991
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072131,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072132,
                        "description": "IMG Alpha Thal Methodology",
                        "longText": "<p>Analysis of the alpha globin gene cluster was performed on purified genomic DNA using multiplex ligation-dependent probe amplification (MLPA), capillary electrophoresis on an ABI Genetic Analyzer, and manual analysis of fragment profiles using Coffalyser.net version 140721.1958. The probe mix used in the assay (P140-C1; MRC Holland, Amsterdam, The Netherlands) targets HBA1, HBA2, several regions up- and downstream of the two alpha globin genes, and 11 reference probes required for normalization. The following seven deletions (-&alpha;<sup>3.7<\/sup>, -&alpha;<sup>4.2<\/sup>, --<sup>SEA<\/sup>, --<sup>FIL<\/sup>, --<sup>THAI<\/sup>, --<sup>MED<\/sup>, and -&alpha;<sup>20.5<\/sup>) are analyzed and reported. Probe ratios less than 0.8 were interpreted as copy number losses and ratios greater than 1.2 as copy number gains. Analytic sensitivity and specificity of the assay have been calculated as &gt;99% (95% CI: 99.18% to 100.00%) and &gt;99% (95% CI: 99.53% to 100.00%), respectively.<\/p>"
                    },
                    {
                        "globalTextId": 4072133,
                        "description": "IMG Alpha Thal Limitations",
                        "longText": "<p>Multiplex ligation-dependent probe amplification (MLPA) is designed to determine relative copy number at specific target sequences. MLPA will not detect most inversions, balanced translocations, or copy number changes that lie outside (or only partially inside) the sequence detected by an MLPA probe. Furthermore, a deletion may not be detected when a similarly sized duplication is present on the other allele. Only the following seven deletions (-&alpha;<sup>3.7<\/sup>, -&alpha;<sup>4.2<\/sup>, --<sup>SEA<\/sup>, --<sup>FIL<\/sup>, --<sup>THAI<\/sup>, --<sup>MED<\/sup>, and -&alpha;<sup>20.5<\/sup>) are analyzed and reported. Other deletions, deleterious point mutations, or small sequence variants will not be detected. It should be noted that there are potential sources of diagnostic error, including somatic heterogeneity of the sample, misidentification of samples prior to receipt, and polymorphisms or other rare genetic variants that interfere with analysis.  Due to the limitations of the assay, there is a chance of a false negative result.<\/p>"
                    },
                    {
                        "globalTextId": 4072134,
                        "description": "IMG Alpha Thal Extra Methodology",
                        "longText": "<p><strong>Alpha-Thalassemia:<\/strong> Analysis of the alpha globin gene cluster was performed on purified genomic DNA using multiplex ligation-dependent probe amplification (MLPA), capillary electrophoresis on an ABI Genetic Analyzer, and manual analysis of fragment profiles using Coffalyser.net version 140721.1958. The probe mix used in the assay (P140-C1; MRC Holland, Amsterdam, The Netherlands) targets HBA1, HBA2, several regions up- and downstream of the two alpha globin genes, and 11 reference probes required for normalization. The following seven deletions (-&alpha;<sup>3.7<\/sup>, -&alpha;<sup>4.2<\/sup>, --<sup>SEA<\/sup>, --<sup>FIL<\/sup>, --<sup>THAI<\/sup>, --<sup>MED<\/sup>, and -&alpha;<sup>20.5<\/sup>) are analyzed and reported. Probe ratios less than 0.8 were interpreted as copy number losses and ratios greater than 1.2 as copy number gains. Analytic sensitivity and specificity of the assay have been calculated as &gt;99% (95% CI: 99.18% to 100.00%) and &gt;99% (95% CI: 99.53% to 100.00%), respectively.<\/p>"
                    },
                    {
                        "globalTextId": 4072135,
                        "description": "IMG Alpha Thal Extra Limitations",
                        "longText": "<p><strong>Alpha-Thalassemia:<\/strong> Multiplex ligation-dependent probe amplification (MLPA) is designed to determine relative copy number at specific target sequences. MLPA will not detect most inversions, balanced translocations, or copy number changes that lie outside (or only partially inside) the sequence detected by an MLPA probe. Furthermore, a deletion may not be detected when a similarly sized duplication is present on the other allele. Only the following seven deletions (-&alpha;<sup>3.7<\/sup>, -&alpha;<sup>4.2<\/sup>, --<sup>SEA<\/sup>, --<sup>FIL<\/sup>, --<sup>THAI<\/sup>, --<sup>MED<\/sup>, and -&alpha;<sup>20.5<\/sup>) are analyzed and reported. Other deletions, deleterious point mutations, or small sequence variants will not be detected. It should be noted that there are potential sources of diagnostic error, including somatic heterogeneity of the sample, misidentification of samples prior to receipt, and polymorphisms or other rare genetic variants that interfere with analysis.  Due to the limitations of the assay, there is a chance of a false negative result.<\/p>"
                    },
                    {
                        "globalTextId": 4072136,
                        "description": "GCS V4 Global + Additional Info",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-global-102016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global 102016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072137,
                        "description": "IMG Alpha Thal FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This test has not been cleared or approved by the U.S. Food and Drug Administration (FDA) but the FDA has determined that clearance or approval is not necessary, in that, pursuant to the requirements of CLIA'88, IMG has established and verified the test's accuracy and precision. Performing Laboratory: Insight Medical Genetics, LLC, 680 N Lake Shore Drive, Suite 1230, Chicago, IL 60611<\/span><\/p>"
                    },
                    {
                        "globalTextId": 4072138,
                        "description": "IMG Alpha Thal Extra FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\"><strong>Alpha-Thalassemia:<\/strong>&nbsp;This test has not been cleared or approved by the U.S. Food and Drug Administration (FDA) but the FDA has determined that clearance or approval is not necessary, in that, pursuant to the requirements of CLIA'88, IMG has established and verified the test's accuracy and precision. Performing Laboratory: Insight Medical Genetics, LLC, 680 N Lake Shore Drive, Suite 1230, Chicago, IL 60611<\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [{
                    "componentResultId": 2330582,
                    "componentDefId": 24618,
                    "result": "No deletions detected",
                    "resultsDateTime": "2016-11-30T00:00:00",
                    "concurrencyId": 1,
                    "amended": false
                }],
                "reproRisk": 4991
            },
            "perfLabId": "110",
            "componentDefs": [],
            "rules": [],
            "name": "ATHALI2",
            "description": "IMG - Alpha-thalassemia",
            "placeHolderCode": "3547I2P",
            "reportDescriptionIndividual": "<strong>Alpha-thalassemia<\/strong>",
            "reportDescriptionPanel": "<strong>Alpha-thalassemia<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 80,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": true,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": true,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": true,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": false,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071132,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071133,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071134,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071135,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 4071136,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329783,
                        "componentDefId": 23698,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329784,
                        "componentDefId": 23699,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329785,
                        "componentDefId": 23696,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329786,
                        "componentDefId": 23697,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 35919
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925766,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925767,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925768,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925769,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3925770,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256408,
                        "componentDefId": 23698,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256409,
                        "componentDefId": 23699,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256410,
                        "componentDefId": 23696,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256411,
                        "componentDefId": 23697,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 35919
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071132,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071133,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071134,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071135,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 4071136,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329783,
                        "componentDefId": 23698,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329784,
                        "componentDefId": 23699,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329785,
                        "componentDefId": 23696,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329786,
                        "componentDefId": 23697,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 35919
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "ALPXA1",
            "description": "Progenity - Alport syndrome, X-linked",
            "placeHolderCode": "3548A1P",
            "reportDescriptionIndividual": "<strong>Alport syndrome, X-linked<\/strong>",
            "reportDescriptionPanel": "<strong>Alport syndrome, X-linked<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 8,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071137,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071138,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071139,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071140,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071141,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329779,
                        "componentDefId": 23702,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329780,
                        "componentDefId": 23703,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329781,
                        "componentDefId": 23700,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329782,
                        "componentDefId": 23701,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 319
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925752,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925754,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925756,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925758,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925760,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256412,
                        "componentDefId": 23702,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256413,
                        "componentDefId": 23703,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256414,
                        "componentDefId": 23700,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256415,
                        "componentDefId": 23701,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 319
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071137,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071138,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071139,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071140,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071141,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329779,
                        "componentDefId": 23702,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329780,
                        "componentDefId": 23703,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329781,
                        "componentDefId": 23700,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329782,
                        "componentDefId": 23701,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 319
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "ALPRA1",
            "description": "Progenity - Alport syndrome, autosomal recessive",
            "placeHolderCode": "3549A1P",
            "reportDescriptionIndividual": "<strong>Alport syndrome, autosomal recessive<\/strong>",
            "reportDescriptionPanel": "<strong>Alport syndrome, autosomal recessive<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 2,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071142,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071143,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071144,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071145,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071146,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329787,
                        "componentDefId": 23706,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329788,
                        "componentDefId": 23707,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329789,
                        "componentDefId": 23704,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329790,
                        "componentDefId": 23705,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925721,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925722,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925723,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925724,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925725,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256416,
                        "componentDefId": 23706,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256417,
                        "componentDefId": 23704,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256418,
                        "componentDefId": 23707,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256419,
                        "componentDefId": 23705,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071142,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071143,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071144,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071145,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071146,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329787,
                        "componentDefId": 23706,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329788,
                        "componentDefId": 23707,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329789,
                        "componentDefId": 23704,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329790,
                        "componentDefId": 23705,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "GM3A1",
            "description": "Progenity - Amish infantile epilepsy syndrome",
            "placeHolderCode": "3550A1P",
            "reportDescriptionIndividual": "<strong>Amish infantile epilepsy syndrome<\/strong>",
            "reportDescriptionPanel": "<strong>Amish infantile epilepsy syndrome<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071147,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071148,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071149,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071150,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071151,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329791,
                        "componentDefId": 23710,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329792,
                        "componentDefId": 23711,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329793,
                        "componentDefId": 23708,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329794,
                        "componentDefId": 23709,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925781,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925782,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925783,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925784,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925785,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256420,
                        "componentDefId": 23710,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256421,
                        "componentDefId": 23711,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256422,
                        "componentDefId": 23708,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256423,
                        "componentDefId": 23709,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071147,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071148,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071149,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071150,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071151,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329791,
                        "componentDefId": 23710,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329792,
                        "componentDefId": 23711,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329793,
                        "componentDefId": 23708,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329794,
                        "componentDefId": 23709,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "ANDERA1",
            "description": "Progenity - Andermann syndrome ",
            "placeHolderCode": "3551A1P",
            "reportDescriptionIndividual": "<strong>Andermann syndrome <\/strong>",
            "reportDescriptionPanel": "<strong>Andermann syndrome <\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071152,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071153,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071154,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071155,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071156,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329795,
                        "componentDefId": 23714,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329796,
                        "componentDefId": 23715,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329797,
                        "componentDefId": 23712,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329798,
                        "componentDefId": 23713,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 152
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925736,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925737,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925738,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925739,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925740,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256424,
                        "componentDefId": 23714,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256425,
                        "componentDefId": 23715,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256426,
                        "componentDefId": 23712,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256427,
                        "componentDefId": 23713,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 152
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071152,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071153,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071154,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071155,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071156,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329795,
                        "componentDefId": 23714,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329796,
                        "componentDefId": 23715,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329797,
                        "componentDefId": 23712,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329798,
                        "componentDefId": 23713,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 152
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "ASAA1",
            "description": "Progenity - Argininosuccinic aciduria",
            "placeHolderCode": "3552A1P",
            "reportDescriptionIndividual": "<strong>Argininosuccinic aciduria<\/strong>",
            "reportDescriptionPanel": "<strong>Argininosuccinic aciduria<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071157,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071158,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071159,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071160,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071161,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329799,
                        "componentDefId": 23718,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329800,
                        "componentDefId": 23719,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329801,
                        "componentDefId": 23716,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329802,
                        "componentDefId": 23717,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925786,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925787,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925788,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925789,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925790,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256428,
                        "componentDefId": 23718,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256429,
                        "componentDefId": 23719,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256430,
                        "componentDefId": 23716,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256431,
                        "componentDefId": 23717,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071157,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071158,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071159,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071160,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071161,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329799,
                        "componentDefId": 23718,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329800,
                        "componentDefId": 23719,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329801,
                        "componentDefId": 23716,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329802,
                        "componentDefId": 23717,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "ARMDA1",
            "description": "Progenity - Aromatase deficiency",
            "placeHolderCode": "3553A1P",
            "reportDescriptionIndividual": "<strong>Aromatase deficiency<\/strong>",
            "reportDescriptionPanel": "<strong>Aromatase deficiency<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071162,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071163,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071164,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071165,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071166,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329803,
                        "componentDefId": 23722,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329804,
                        "componentDefId": 23723,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329805,
                        "componentDefId": 23720,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329806,
                        "componentDefId": 23721,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925791,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925792,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925793,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925794,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925795,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256432,
                        "componentDefId": 23722,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256433,
                        "componentDefId": 23723,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256434,
                        "componentDefId": 23720,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256440,
                        "componentDefId": 23721,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925791,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925792,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925793,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925794,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925795,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256432,
                        "componentDefId": 23722,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256433,
                        "componentDefId": 23723,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256434,
                        "componentDefId": 23720,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256440,
                        "componentDefId": 23721,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "AMRSA1",
            "description": "Progenity - Arthrogryposis, mental retardation and seizures ",
            "placeHolderCode": "3554A1P",
            "reportDescriptionIndividual": "<strong>Arthrogryposis, mental retardation and seizures <\/strong>",
            "reportDescriptionPanel": "<strong>Arthrogryposis, mental retardation and seizures <\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071167,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071168,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071169,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071170,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 4071171,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329807,
                        "componentDefId": 23726,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329808,
                        "componentDefId": 23727,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329809,
                        "componentDefId": 23724,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329810,
                        "componentDefId": 23725,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925751,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925753,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925755,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925757,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3925759,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256435,
                        "componentDefId": 23726,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256436,
                        "componentDefId": 23727,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256437,
                        "componentDefId": 23724,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256447,
                        "componentDefId": 23725,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925751,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925753,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925755,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925757,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3925759,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256435,
                        "componentDefId": 23726,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256436,
                        "componentDefId": 23727,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256437,
                        "componentDefId": 23724,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256447,
                        "componentDefId": 23725,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "ARTSA1",
            "description": "Progenity - ARTS syndrome",
            "placeHolderCode": "3555A1P",
            "reportDescriptionIndividual": "<strong>Arts syndrome<\/strong>",
            "reportDescriptionPanel": "<strong>Arts syndrome<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 9,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071172,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071173,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071174,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071175,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071176,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329811,
                        "componentDefId": 23730,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329812,
                        "componentDefId": 23731,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329813,
                        "componentDefId": 23728,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329814,
                        "componentDefId": 23729,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925801,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925802,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925803,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925804,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925805,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256438,
                        "componentDefId": 23728,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256439,
                        "componentDefId": 23729,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256442,
                        "componentDefId": 23730,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256444,
                        "componentDefId": 23731,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925801,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925802,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925803,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925804,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925805,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256438,
                        "componentDefId": 23728,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256439,
                        "componentDefId": 23729,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256442,
                        "componentDefId": 23730,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256444,
                        "componentDefId": 23731,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "AGUA1",
            "description": "Progenity - Aspartylglycosaminuria ",
            "placeHolderCode": "3556A1P",
            "reportDescriptionIndividual": "<strong>Aspartylglycosaminuria <\/strong>",
            "reportDescriptionPanel": "<strong>Aspartylglycosaminuria <\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071177,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071178,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071179,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071180,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071181,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329827,
                        "componentDefId": 23734,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329828,
                        "componentDefId": 23735,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329829,
                        "componentDefId": 23732,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329830,
                        "componentDefId": 23733,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 861
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925821,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925822,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925823,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925824,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925825,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256441,
                        "componentDefId": 23735,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256445,
                        "componentDefId": 23732,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256446,
                        "componentDefId": 23733,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256448,
                        "componentDefId": 23734,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925821,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925822,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925823,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925824,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925825,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256441,
                        "componentDefId": 23735,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256445,
                        "componentDefId": 23732,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256446,
                        "componentDefId": 23733,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256448,
                        "componentDefId": 23734,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "AVEDA1",
            "description": "Progenity - Ataxia with vitamin E deficiency",
            "placeHolderCode": "3557A1P",
            "reportDescriptionIndividual": "<strong>Ataxia with vitamin E deficiency<\/strong>",
            "reportDescriptionPanel": "<strong>Ataxia with vitamin E deficiency<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071182,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071183,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071184,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071185,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071186,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329819,
                        "componentDefId": 23738,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329820,
                        "componentDefId": 23739,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329821,
                        "componentDefId": 23736,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329822,
                        "componentDefId": 23737,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 111
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925826,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925827,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925828,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925829,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925830,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256443,
                        "componentDefId": 23738,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256449,
                        "componentDefId": 23739,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256450,
                        "componentDefId": 23736,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256451,
                        "componentDefId": 23737,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 111
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925826,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925827,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925828,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925829,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925830,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256443,
                        "componentDefId": 23738,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256449,
                        "componentDefId": 23739,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256450,
                        "componentDefId": 23736,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256451,
                        "componentDefId": 23737,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 111
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "ATA1",
            "description": "Progenity - Ataxia-telangiectasia",
            "placeHolderCode": "3558A1P",
            "reportDescriptionIndividual": "<strong>Ataxia-telangiectasia<\/strong>",
            "reportDescriptionPanel": "<strong>Ataxia-telangiectasia<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071187,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071188,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071189,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071190,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071191,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329823,
                        "componentDefId": 23742,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329824,
                        "componentDefId": 23743,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329825,
                        "componentDefId": 23740,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329826,
                        "componentDefId": 23741,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925921,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925922,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925923,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925924,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925925,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256452,
                        "componentDefId": 23742,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256453,
                        "componentDefId": 23743,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256454,
                        "componentDefId": 23741,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256456,
                        "componentDefId": 23740,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925921,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925922,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925923,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925924,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925925,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256452,
                        "componentDefId": 23742,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256453,
                        "componentDefId": 23743,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256454,
                        "componentDefId": 23741,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256456,
                        "componentDefId": 23740,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "ATLDA1",
            "description": "Progenity - Ataxia-telangiectasia-like disorder ",
            "placeHolderCode": "3559A1P",
            "reportDescriptionIndividual": "<strong>Ataxia-telangiectasia-like disorder <\/strong>",
            "reportDescriptionPanel": "<strong>Ataxia-telangiectasia-like disorder <\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 3,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071192,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071193,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071194,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071195,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071196,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329839,
                        "componentDefId": 23746,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329840,
                        "componentDefId": 23747,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329841,
                        "componentDefId": 23744,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329842,
                        "componentDefId": 23745,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 610
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925836,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925837,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925838,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925839,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925840,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256455,
                        "componentDefId": 23746,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256457,
                        "componentDefId": 23747,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256459,
                        "componentDefId": 23744,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256460,
                        "componentDefId": 23745,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 610
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071192,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071193,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071194,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071195,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071196,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329839,
                        "componentDefId": 23746,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329840,
                        "componentDefId": 23747,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329841,
                        "componentDefId": 23744,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329842,
                        "componentDefId": 23745,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 610
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "BBS1A1",
            "description": "Progenity - Bardet-Biedl syndrome, BBS1-related",
            "placeHolderCode": "3560A1P",
            "reportDescriptionIndividual": "<strong>Bardet-Biedl syndrome, BBS1-related<\/strong>",
            "reportDescriptionPanel": "<strong>Bardet-Biedl syndrome, BBS1-related<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071197,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071198,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071199,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071200,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071201,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329843,
                        "componentDefId": 23750,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329844,
                        "componentDefId": 23751,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329845,
                        "componentDefId": 23748,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329846,
                        "componentDefId": 23749,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 655
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925816,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925817,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925818,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925819,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925820,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256458,
                        "componentDefId": 23750,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256461,
                        "componentDefId": 23748,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256462,
                        "componentDefId": 23751,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256463,
                        "componentDefId": 23749,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 655
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071197,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071198,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071199,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071200,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071201,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329843,
                        "componentDefId": 23750,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329844,
                        "componentDefId": 23751,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329845,
                        "componentDefId": 23748,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329846,
                        "componentDefId": 23749,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 655
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "BBS10A1",
            "description": "Progenity - Bardet-Biedl syndrome, BBS10-related",
            "placeHolderCode": "3561A1P",
            "reportDescriptionIndividual": "<strong>Bardet-Biedl syndrome, BBS10-related<\/strong>",
            "reportDescriptionPanel": "<strong>Bardet-Biedl syndrome, BBS10-related<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071202,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071203,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071204,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071205,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071206,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329847,
                        "componentDefId": 23754,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329848,
                        "componentDefId": 23755,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329849,
                        "componentDefId": 23752,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329850,
                        "componentDefId": 23753,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 778
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925876,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925877,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925878,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925879,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925880,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256464,
                        "componentDefId": 23754,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256465,
                        "componentDefId": 23755,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256466,
                        "componentDefId": 23752,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256467,
                        "componentDefId": 23753,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 778
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071202,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071203,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071204,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071205,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071206,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329847,
                        "componentDefId": 23754,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329848,
                        "componentDefId": 23755,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329849,
                        "componentDefId": 23752,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329850,
                        "componentDefId": 23753,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 778
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "BBS12A1",
            "description": "Progenity - Bardet-Biedl syndrome, BBS12-related",
            "placeHolderCode": "3562A1P",
            "reportDescriptionIndividual": "<strong>Bardet-Biedl syndrome, BBS12-related<\/strong>",
            "reportDescriptionPanel": "<strong>Bardet-Biedl syndrome, BBS12-related<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071207,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071208,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071209,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071210,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071211,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329851,
                        "componentDefId": 23758,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329852,
                        "componentDefId": 23759,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329853,
                        "componentDefId": 23756,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329854,
                        "componentDefId": 23757,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 50000
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925811,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925812,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925813,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925814,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925815,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256468,
                        "componentDefId": 23758,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256469,
                        "componentDefId": 23759,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256470,
                        "componentDefId": 23756,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256471,
                        "componentDefId": 23757,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 50000
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071207,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071208,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071209,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071210,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071211,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329851,
                        "componentDefId": 23758,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329852,
                        "componentDefId": 23759,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329853,
                        "componentDefId": 23756,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329854,
                        "componentDefId": 23757,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 50000
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "BSNDA1",
            "description": "Progenity - Bartter syndrome, type IV ",
            "placeHolderCode": "3563A1P",
            "reportDescriptionIndividual": "<strong>Bartter syndrome, type IV <\/strong>",
            "reportDescriptionPanel": "<strong>Bartter syndrome, type IV <\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 2,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071330,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071331,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071332,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071333,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071334,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329855,
                        "componentDefId": 23762,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329856,
                        "componentDefId": 23763,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329857,
                        "componentDefId": 23760,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329858,
                        "componentDefId": 23761,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925831,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925832,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925833,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925834,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925835,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256472,
                        "componentDefId": 23762,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256473,
                        "componentDefId": 23763,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256474,
                        "componentDefId": 23760,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256475,
                        "componentDefId": 23761,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071330,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071331,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071332,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071333,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071334,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329855,
                        "componentDefId": 23762,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329856,
                        "componentDefId": 23763,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329857,
                        "componentDefId": 23760,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329858,
                        "componentDefId": 23761,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "T2A1",
            "description": "Progenity - Beta-ketothiolase deficiency",
            "placeHolderCode": "3564A1P",
            "reportDescriptionIndividual": "<strong>Beta-ketothiolase deficiency<\/strong>",
            "reportDescriptionPanel": "<strong>Beta-ketothiolase deficiency<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071335,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071336,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071337,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071338,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071339,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329859,
                        "componentDefId": 23766,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329860,
                        "componentDefId": 23767,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329861,
                        "componentDefId": 23764,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329862,
                        "componentDefId": 23765,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 396
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925856,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925857,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925858,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925859,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925860,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256476,
                        "componentDefId": 23766,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256477,
                        "componentDefId": 23767,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256478,
                        "componentDefId": 23764,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256479,
                        "componentDefId": 23765,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 396
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925856,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925857,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925858,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925859,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925860,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256476,
                        "componentDefId": 23766,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256477,
                        "componentDefId": 23767,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256478,
                        "componentDefId": 23764,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256479,
                        "componentDefId": 23765,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 396
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "BTHALA1",
            "description": "Progenity - Beta-thalassemia",
            "placeHolderCode": "3565A1P",
            "reportDescriptionIndividual": "<strong>Beta-thalassemia<\/strong>",
            "reportDescriptionPanel": "<strong>Beta-thalassemia<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071340,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071341,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071342,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071343,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071344,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329863,
                        "componentDefId": 23770,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329864,
                        "componentDefId": 23771,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329865,
                        "componentDefId": 23768,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329866,
                        "componentDefId": 23769,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925806,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925807,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925808,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925809,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925810,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256480,
                        "componentDefId": 23770,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256481,
                        "componentDefId": 23771,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256482,
                        "componentDefId": 23768,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256483,
                        "componentDefId": 23769,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925806,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925807,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925808,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925809,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925810,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256480,
                        "componentDefId": 23770,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256481,
                        "componentDefId": 23771,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256482,
                        "componentDefId": 23768,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256483,
                        "componentDefId": 23769,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "BFPPA1",
            "description": "Progenity - Bilateral frontoparietal polymicrogyria",
            "placeHolderCode": "3566A1P",
            "reportDescriptionIndividual": "<strong>Bilateral frontoparietal polymicrogyria<\/strong>",
            "reportDescriptionPanel": "<strong>Bilateral frontoparietal polymicrogyria<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071345,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071346,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071347,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071348,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071349,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329867,
                        "componentDefId": 23774,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329868,
                        "componentDefId": 23775,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329869,
                        "componentDefId": 23772,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329870,
                        "componentDefId": 23773,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 272
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925936,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925937,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925938,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925939,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925940,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256484,
                        "componentDefId": 23774,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256485,
                        "componentDefId": 23775,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256486,
                        "componentDefId": 23772,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256489,
                        "componentDefId": 23773,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 272
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925936,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925937,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925938,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925939,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925940,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256484,
                        "componentDefId": 23774,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256485,
                        "componentDefId": 23775,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256486,
                        "componentDefId": 23772,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256489,
                        "componentDefId": 23773,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 272
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "BTDA1",
            "description": "Progenity - Biotinidase deficiency",
            "placeHolderCode": "3567A1P",
            "reportDescriptionIndividual": "<strong>Biotinidase deficiency<\/strong>",
            "reportDescriptionPanel": "<strong>Biotinidase deficiency<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071350,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071351,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071352,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071353,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071354,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330533,
                        "componentDefId": 23778,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330534,
                        "componentDefId": 23779,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330535,
                        "componentDefId": 23776,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330536,
                        "componentDefId": 23777,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925866,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925867,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925868,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925869,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925870,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256487,
                        "componentDefId": 23778,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256488,
                        "componentDefId": 23779,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256490,
                        "componentDefId": 23776,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256491,
                        "componentDefId": 23777,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925866,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925867,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925868,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925869,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925870,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256487,
                        "componentDefId": 23778,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256488,
                        "componentDefId": 23779,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256490,
                        "componentDefId": 23776,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256491,
                        "componentDefId": 23777,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "CTNA1",
            "description": "Progenity - Tumoral calcinosis normophosphatemic",
            "placeHolderCode": "3568A1P",
            "reportDescriptionIndividual": "<strong>Tumoral calcinosis, normophosphatemic<\/strong>",
            "reportDescriptionPanel": "<strong>Tumoral calcinosis, normophosphatemic<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 2,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071355,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071356,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071357,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071358,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071359,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329879,
                        "componentDefId": 23782,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329880,
                        "componentDefId": 23783,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329881,
                        "componentDefId": 23780,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329882,
                        "componentDefId": 23781,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925906,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925907,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925908,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925909,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925910,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256492,
                        "componentDefId": 23782,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256493,
                        "componentDefId": 23783,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256494,
                        "componentDefId": 23781,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256496,
                        "componentDefId": 23780,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925906,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925907,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925908,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925909,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925910,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256492,
                        "componentDefId": 23782,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256493,
                        "componentDefId": 23783,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256494,
                        "componentDefId": 23781,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256496,
                        "componentDefId": 23780,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "CPT1AA1",
            "description": "Progenity - Carnitine palmitoyltransferase I deficiency",
            "placeHolderCode": "3569A1P",
            "reportDescriptionIndividual": "<strong>Carnitine palmitoyltransferase I deficiency<\/strong>",
            "reportDescriptionPanel": "<strong>Carnitine palmitoyltransferase I deficiency<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 4,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071360,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071361,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071362,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071363,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071364,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329883,
                        "componentDefId": 23786,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329884,
                        "componentDefId": 23787,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329885,
                        "componentDefId": 23784,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329886,
                        "componentDefId": 23785,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 2171
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925931,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925932,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925933,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925934,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925935,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256495,
                        "componentDefId": 23786,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256497,
                        "componentDefId": 23784,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256499,
                        "componentDefId": 23787,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256501,
                        "componentDefId": 23785,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 2171
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925931,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925932,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925933,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925934,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925935,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256495,
                        "componentDefId": 23786,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256497,
                        "componentDefId": 23784,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256499,
                        "componentDefId": 23787,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256501,
                        "componentDefId": 23785,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 2171
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "CPT2A1",
            "description": "Progenity - Carnitine palmitoyltransferase II deficiency",
            "placeHolderCode": "3570A1P",
            "reportDescriptionIndividual": "<strong>Carnitine palmitoyltransferase II deficiency<\/strong>",
            "reportDescriptionPanel": "<strong>Carnitine palmitoyltransferase II deficiency<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071365,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071366,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071367,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071368,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071369,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329887,
                        "componentDefId": 23790,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329888,
                        "componentDefId": 23791,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329889,
                        "componentDefId": 23788,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329890,
                        "componentDefId": 23789,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 1783
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925841,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925842,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925843,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925844,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925845,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256498,
                        "componentDefId": 23789,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256500,
                        "componentDefId": 23788,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256503,
                        "componentDefId": 23791,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256504,
                        "componentDefId": 23790,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 1783
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925841,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925842,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925843,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925844,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925845,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256498,
                        "componentDefId": 23789,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256500,
                        "componentDefId": 23788,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256503,
                        "componentDefId": 23791,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256504,
                        "componentDefId": 23790,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 1783
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "ACPS2A1",
            "description": "Progenity - Carpenter syndrome",
            "placeHolderCode": "3571A1P",
            "reportDescriptionIndividual": "<strong>Carpenter syndrome<\/strong>",
            "reportDescriptionPanel": "<strong>Carpenter syndrome<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071370,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071371,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071372,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071373,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071374,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329891,
                        "componentDefId": 23794,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329892,
                        "componentDefId": 23795,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329893,
                        "componentDefId": 23792,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329894,
                        "componentDefId": 23793,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 961
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925871,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925872,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925873,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925874,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925875,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256502,
                        "componentDefId": 23794,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256505,
                        "componentDefId": 23795,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256506,
                        "componentDefId": 23792,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256507,
                        "componentDefId": 23793,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 961
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071370,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071371,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071372,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071373,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071374,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329891,
                        "componentDefId": 23794,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329892,
                        "componentDefId": 23795,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329893,
                        "componentDefId": 23792,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329894,
                        "componentDefId": 23793,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 961
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "CHHA1",
            "description": "Progenity - Cartilage-hair hypoplasia",
            "placeHolderCode": "3572A1P",
            "reportDescriptionIndividual": "<strong>Cartilage-hair hypoplasia<\/strong>",
            "reportDescriptionPanel": "<strong>Cartilage-hair hypoplasia<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071375,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071376,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071377,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071378,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 4071379,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329895,
                        "componentDefId": 23798,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329896,
                        "componentDefId": 23799,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329897,
                        "componentDefId": 23796,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329898,
                        "componentDefId": 23797,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 22917
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925896,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925897,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925898,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925899,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3925900,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256508,
                        "componentDefId": 23799,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256509,
                        "componentDefId": 23798,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256510,
                        "componentDefId": 23797,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256511,
                        "componentDefId": 23796,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 22917
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071375,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071376,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071377,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071378,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 4071379,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329895,
                        "componentDefId": 23798,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329896,
                        "componentDefId": 23799,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329897,
                        "componentDefId": 23796,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329898,
                        "componentDefId": 23797,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 22917
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "CMTX1A1",
            "description": "Progenity - Charcot-Marie-Tooth disease, GJB1-related ",
            "placeHolderCode": "3573A1P",
            "reportDescriptionIndividual": "<strong>Charcot-Marie-Tooth disease, GJB1-related <\/strong>",
            "reportDescriptionPanel": "<strong>Charcot-Marie-Tooth disease, GJB1-related <\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 6,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071380,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071381,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071382,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071383,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 4071384,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329899,
                        "componentDefId": 23802,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329900,
                        "componentDefId": 23803,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329901,
                        "componentDefId": 23800,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329902,
                        "componentDefId": 23801,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925926,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925927,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925928,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925929,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3925930,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256512,
                        "componentDefId": 23802,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256513,
                        "componentDefId": 23803,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256514,
                        "componentDefId": 23801,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256516,
                        "componentDefId": 23800,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071380,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071381,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071382,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071383,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 4071384,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329899,
                        "componentDefId": 23802,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329900,
                        "componentDefId": 23803,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329901,
                        "componentDefId": 23800,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329902,
                        "componentDefId": 23801,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "CMTX5A1",
            "description": "Progenity - Charcot-Marie-Tooth disease, PRPS1-related",
            "placeHolderCode": "3574A1P",
            "reportDescriptionIndividual": "<strong>Charcot-Marie-Tooth disease, PRPS1-related<\/strong>",
            "reportDescriptionPanel": "<strong>Charcot-Marie-Tooth disease, PRPS1-related<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 8,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071385,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071386,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071387,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071388,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071389,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329903,
                        "componentDefId": 23806,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329904,
                        "componentDefId": 23807,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329905,
                        "componentDefId": 23804,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329906,
                        "componentDefId": 23805,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925911,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925912,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925913,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925914,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925915,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256515,
                        "componentDefId": 23807,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256517,
                        "componentDefId": 23804,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256518,
                        "componentDefId": 23806,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256519,
                        "componentDefId": 23805,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071385,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071386,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071387,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071388,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071389,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329903,
                        "componentDefId": 23806,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329904,
                        "componentDefId": 23807,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329905,
                        "componentDefId": 23804,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329906,
                        "componentDefId": 23805,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "CHSA1",
            "description": "Progenity - Chediak-Higashi syndrome",
            "placeHolderCode": "3575A1P",
            "reportDescriptionIndividual": "<strong>Chediak-Higashi syndrome<\/strong>",
            "reportDescriptionPanel": "<strong>Chediak-Higashi syndrome<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071390,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071391,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071392,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071393,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071394,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329907,
                        "componentDefId": 23810,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329908,
                        "componentDefId": 23811,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329909,
                        "componentDefId": 23808,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329910,
                        "componentDefId": 23809,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 329
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925886,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925887,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925888,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925889,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925890,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256520,
                        "componentDefId": 23810,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256521,
                        "componentDefId": 23811,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256522,
                        "componentDefId": 23808,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256523,
                        "componentDefId": 23809,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 329
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071390,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071391,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071392,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071393,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071394,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329907,
                        "componentDefId": 23810,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329908,
                        "componentDefId": 23811,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329909,
                        "componentDefId": 23808,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329910,
                        "componentDefId": 23809,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 329
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "CESDA1",
            "description": "Progenity - Cholesteryl ester storage disease",
            "placeHolderCode": "3576A1P",
            "reportDescriptionIndividual": "<strong>Cholesteryl ester storage disease<\/strong>",
            "reportDescriptionPanel": "<strong>Cholesteryl ester storage disease<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071395,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071396,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071397,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071398,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 4071399,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329911,
                        "componentDefId": 23814,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329912,
                        "componentDefId": 23815,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329913,
                        "componentDefId": 23812,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329914,
                        "componentDefId": 23813,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 32222
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925901,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925902,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925903,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925904,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3925905,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256524,
                        "componentDefId": 23814,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256525,
                        "componentDefId": 23815,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256526,
                        "componentDefId": 23812,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256527,
                        "componentDefId": 23813,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 32222
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071395,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071396,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071397,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071398,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 4071399,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329911,
                        "componentDefId": 23814,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329912,
                        "componentDefId": 23815,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329913,
                        "componentDefId": 23812,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329914,
                        "componentDefId": 23813,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 32222
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "CHMA1",
            "description": "Progenity - Choroideremia",
            "placeHolderCode": "3577A1P",
            "reportDescriptionIndividual": "<strong>Choroideremia<\/strong>",
            "reportDescriptionPanel": "<strong>Choroideremia<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 13,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071400,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071401,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071402,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071403,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071404,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329915,
                        "componentDefId": 23818,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329916,
                        "componentDefId": 23819,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329917,
                        "componentDefId": 23816,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329918,
                        "componentDefId": 23817,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 184
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925960,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925961,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925962,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925963,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925964,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256528,
                        "componentDefId": 23818,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256529,
                        "componentDefId": 23819,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256530,
                        "componentDefId": 23816,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256531,
                        "componentDefId": 23817,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 184
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071400,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071401,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071402,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071403,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071404,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329915,
                        "componentDefId": 23818,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329916,
                        "componentDefId": 23819,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329917,
                        "componentDefId": 23816,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329918,
                        "componentDefId": 23817,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 184
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "CTLN1A1",
            "description": "Progenity - Citrullinemia, type I ",
            "placeHolderCode": "3578A1P",
            "reportDescriptionIndividual": "<strong>Citrullinemia, type I <\/strong>",
            "reportDescriptionPanel": "<strong>Citrullinemia, type I <\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071405,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071406,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071407,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071408,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071409,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329919,
                        "componentDefId": 23822,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329920,
                        "componentDefId": 23823,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329921,
                        "componentDefId": 23820,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329922,
                        "componentDefId": 23821,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925916,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925917,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925918,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925919,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925920,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256532,
                        "componentDefId": 23822,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256533,
                        "componentDefId": 23823,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256534,
                        "componentDefId": 23820,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256535,
                        "componentDefId": 23821,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071405,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071406,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071407,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071408,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071409,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329919,
                        "componentDefId": 23822,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329920,
                        "componentDefId": 23823,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329921,
                        "componentDefId": 23820,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329922,
                        "componentDefId": 23821,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "CAHA1",
            "description": "Progenity - Congenital adrenal hyperplasia",
            "placeHolderCode": "3580A1P",
            "reportDescriptionIndividual": "<strong>Congenital adrenal hyperplasia<\/strong>",
            "reportDescriptionPanel": "<strong>Congenital adrenal hyperplasia<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071410,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071411,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071412,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071413,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071414,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329923,
                        "componentDefId": 23826,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329924,
                        "componentDefId": 23827,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329925,
                        "componentDefId": 23824,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329926,
                        "componentDefId": 23825,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925881,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925882,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925883,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925884,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925885,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256536,
                        "componentDefId": 23827,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256537,
                        "componentDefId": 23826,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256538,
                        "componentDefId": 23824,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256539,
                        "componentDefId": 23825,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071410,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071411,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071412,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071413,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071414,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329923,
                        "componentDefId": 23826,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329924,
                        "componentDefId": 23827,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329925,
                        "componentDefId": 23824,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329926,
                        "componentDefId": 23825,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "CAMTA1",
            "description": "Progenity - Congenital amegakaryocytic thrombocytopenia ",
            "placeHolderCode": "3581A1P",
            "reportDescriptionIndividual": "<strong>Congenital amegakaryocytic thrombocytopenia <\/strong>",
            "reportDescriptionPanel": "<strong>Congenital amegakaryocytic thrombocytopenia <\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071415,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071416,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071417,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071418,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071419,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329927,
                        "componentDefId": 23830,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329928,
                        "componentDefId": 23831,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329929,
                        "componentDefId": 23828,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329930,
                        "componentDefId": 23829,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 251
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925861,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925862,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925863,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925864,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925865,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256540,
                        "componentDefId": 23830,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256541,
                        "componentDefId": 23831,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256542,
                        "componentDefId": 23828,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256543,
                        "componentDefId": 23829,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 79
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071415,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071416,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071417,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071418,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071419,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329927,
                        "componentDefId": 23830,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329928,
                        "componentDefId": 23831,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329929,
                        "componentDefId": 23828,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329930,
                        "componentDefId": 23829,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 251
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "CDG1AA1",
            "description": "Progenity - Congenital disorder of glycosylation, type IA ",
            "placeHolderCode": "3582A1P",
            "reportDescriptionIndividual": "<strong>Congenital disorder of glycosylation, type IA <\/strong>",
            "reportDescriptionPanel": "<strong>Congenital disorder of glycosylation, type IA <\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071420,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071421,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071422,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071423,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071424,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329931,
                        "componentDefId": 23834,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329932,
                        "componentDefId": 23835,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329933,
                        "componentDefId": 23832,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329934,
                        "componentDefId": 23833,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925846,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925847,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925848,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925849,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925850,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256544,
                        "componentDefId": 23834,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256545,
                        "componentDefId": 23835,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256546,
                        "componentDefId": 23833,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256547,
                        "componentDefId": 23832,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071420,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071421,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071422,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071423,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071424,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329931,
                        "componentDefId": 23834,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329932,
                        "componentDefId": 23835,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329933,
                        "componentDefId": 23832,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329934,
                        "componentDefId": 23833,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "CDG1BA1",
            "description": "Progenity - Congenital disorder of glycosylation, type IB",
            "placeHolderCode": "3583A1P",
            "reportDescriptionIndividual": "<strong>Congenital disorder of glycosylation, type IB<\/strong>",
            "reportDescriptionPanel": "<strong>Congenital disorder of glycosylation, type IB<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071425,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071426,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071427,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071428,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071429,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329935,
                        "componentDefId": 23838,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329936,
                        "componentDefId": 23839,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329937,
                        "componentDefId": 23836,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329938,
                        "componentDefId": 23837,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925941,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925942,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925943,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925944,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925945,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256548,
                        "componentDefId": 23838,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256549,
                        "componentDefId": 23839,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256550,
                        "componentDefId": 23837,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256551,
                        "componentDefId": 23836,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925941,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925942,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925943,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925944,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925945,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256548,
                        "componentDefId": 23838,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256549,
                        "componentDefId": 23839,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256550,
                        "componentDefId": 23837,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256551,
                        "componentDefId": 23836,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "CLAHA1",
            "description": "Progenity - Congenital lipoid adrenal hyperplasia",
            "placeHolderCode": "3584A1P",
            "reportDescriptionIndividual": "<strong>Congenital lipoid adrenal hyperplasia<\/strong>",
            "reportDescriptionPanel": "<strong>Congenital lipoid adrenal hyperplasia<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071430,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071431,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071432,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071433,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071434,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329939,
                        "componentDefId": 23842,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329940,
                        "componentDefId": 23843,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329941,
                        "componentDefId": 23840,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329942,
                        "componentDefId": 23841,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925891,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925892,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925893,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925894,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925895,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256552,
                        "componentDefId": 23842,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256553,
                        "componentDefId": 23843,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256554,
                        "componentDefId": 23840,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256555,
                        "componentDefId": 23841,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925891,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925892,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925893,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925894,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925895,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256552,
                        "componentDefId": 23842,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256553,
                        "componentDefId": 23843,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256554,
                        "componentDefId": 23840,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256555,
                        "componentDefId": 23841,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "CNPA1",
            "description": "Progenity - Congenital neutropenia, autosomal recessive",
            "placeHolderCode": "3585A1P",
            "reportDescriptionIndividual": "<strong>Congenital neutropenia, autosomal recessive<\/strong>",
            "reportDescriptionPanel": "<strong>Congenital neutropenia, autosomal recessive<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071435,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071436,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071437,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071438,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071439,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329943,
                        "componentDefId": 23846,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329944,
                        "componentDefId": 23847,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329945,
                        "componentDefId": 23844,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329946,
                        "componentDefId": 23845,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925851,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925852,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925853,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925854,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925855,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256556,
                        "componentDefId": 23847,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256557,
                        "componentDefId": 23844,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256558,
                        "componentDefId": 23846,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256559,
                        "componentDefId": 23845,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925851,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925852,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925853,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925854,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925855,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256556,
                        "componentDefId": 23847,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256557,
                        "componentDefId": 23844,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256558,
                        "componentDefId": 23846,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256559,
                        "componentDefId": 23845,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "CDPDA1",
            "description": "Progenity - Corneal dystrophy and perceptive deafness syndrome",
            "placeHolderCode": "3586A1P",
            "reportDescriptionIndividual": "<strong>Corneal dystrophy and perceptive deafness syndrome<\/strong>",
            "reportDescriptionPanel": "<strong>Corneal dystrophy and perceptive deafness syndrome<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071440,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071441,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071442,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071443,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071444,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329947,
                        "componentDefId": 23850,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329948,
                        "componentDefId": 23851,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329949,
                        "componentDefId": 23848,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329950,
                        "componentDefId": 23849,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925951,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925952,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925953,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925954,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925955,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256560,
                        "componentDefId": 23848,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256561,
                        "componentDefId": 23850,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256563,
                        "componentDefId": 23849,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256566,
                        "componentDefId": 23851,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925951,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925952,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925953,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925954,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925955,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256560,
                        "componentDefId": 23848,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256561,
                        "componentDefId": 23850,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256563,
                        "componentDefId": 23849,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256566,
                        "componentDefId": 23851,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "COM2A1",
            "description": "Progenity - Corticosterone methyloxidase deficiency",
            "placeHolderCode": "3587A1P",
            "reportDescriptionIndividual": "<strong>Corticosterone methyloxidase deficiency<\/strong>",
            "reportDescriptionPanel": "<strong>Corticosterone methyloxidase deficiency<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 7,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071445,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071446,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071447,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 4071448,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 4071449,
                        "description": "GCS V4 Global + Additional Info",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-global-102016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global 102016. Original report is on file and available upon request.<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329951,
                        "componentDefId": 24641,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329952,
                        "componentDefId": 24642,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329953,
                        "componentDefId": 24639,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329954,
                        "componentDefId": 24640,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925971,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925972,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925973,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3925974,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 3925975,
                        "description": "GCS V4 Global + Additional Info",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-global-042016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global 042016. Original report is on file and available upon request.<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256562,
                        "componentDefId": 24641,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256564,
                        "componentDefId": 24642,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256565,
                        "componentDefId": 24639,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256567,
                        "componentDefId": 24640,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925971,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925972,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925973,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3925974,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 3925975,
                        "description": "GCS V4 Global + Additional Info",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-global-042016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global 042016. Original report is on file and available upon request.<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256562,
                        "componentDefId": 24641,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256564,
                        "componentDefId": 24642,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256565,
                        "componentDefId": 24639,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256567,
                        "componentDefId": 24640,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "CRTA3",
            "description": "Progenity - Creatine transporter defect, SLC6A8-related V3",
            "placeHolderCode": "3588A3P",
            "reportDescriptionIndividual": "<strong>Creatine transporter defect, SLC6A8-related <\/strong>",
            "reportDescriptionPanel": "<strong>Creatine transporter defect, SLC6A8-related <\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 5,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": true,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071450,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071451,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071452,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071453,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071454,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329955,
                        "componentDefId": 23862,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329956,
                        "componentDefId": 23863,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329957,
                        "componentDefId": 23860,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329958,
                        "componentDefId": 23861,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925956,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925957,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925958,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925959,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925965,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256568,
                        "componentDefId": 23862,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256569,
                        "componentDefId": 23863,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256570,
                        "componentDefId": 23860,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256572,
                        "componentDefId": 23861,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925956,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925957,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925958,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925959,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925965,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256568,
                        "componentDefId": 23862,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256569,
                        "componentDefId": 23863,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256570,
                        "componentDefId": 23860,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256572,
                        "componentDefId": 23861,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "CNSA1",
            "description": "Progenity - Crigler-Najjar syndrome",
            "placeHolderCode": "3590A1P",
            "reportDescriptionIndividual": "<strong>Crigler-Najjar syndrome<\/strong>",
            "reportDescriptionPanel": "<strong>Crigler-Najjar syndrome<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071455,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071456,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071457,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071458,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071459,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329967,
                        "componentDefId": 24708,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329968,
                        "componentDefId": 24709,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329969,
                        "componentDefId": 24706,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329970,
                        "componentDefId": 24707,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 216
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925946,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925947,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925948,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925949,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925950,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256571,
                        "componentDefId": 24708,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256574,
                        "componentDefId": 24706,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256578,
                        "componentDefId": 24707,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2258251,
                        "componentDefId": 24709,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 216
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925946,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925947,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925948,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925949,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925950,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256571,
                        "componentDefId": 24708,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256574,
                        "componentDefId": 24706,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256578,
                        "componentDefId": 24707,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2258251,
                        "componentDefId": 24709,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 216
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "CTNSA2",
            "description": "Progenity - Cystinosis",
            "placeHolderCode": "3591A2P",
            "reportDescriptionIndividual": "<strong>Cystinosis<\/strong>",
            "reportDescriptionPanel": "<strong>Cystinosis<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 4,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-07-11T00:00:00",
            "assayTypeId": 1,
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071460,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071461,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071462,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071463,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071464,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329971,
                        "componentDefId": 23870,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329972,
                        "componentDefId": 23871,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329973,
                        "componentDefId": 23868,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329974,
                        "componentDefId": 23869,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 243
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925966,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925967,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925968,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925969,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925970,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256573,
                        "componentDefId": 23869,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256577,
                        "componentDefId": 23868,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256579,
                        "componentDefId": 23871,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2258252,
                        "componentDefId": 23870,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 243
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925966,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925967,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925968,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925969,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925970,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256573,
                        "componentDefId": 23869,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256577,
                        "componentDefId": 23868,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256579,
                        "componentDefId": 23871,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2258252,
                        "componentDefId": 23870,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 243
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "DBPDA1",
            "description": "Progenity - D-bifunctional protein deficiency",
            "placeHolderCode": "3592A1P",
            "reportDescriptionIndividual": "<strong>D-bifunctional protein deficiency<\/strong>",
            "reportDescriptionPanel": "<strong>D-bifunctional protein deficiency<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071465,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071466,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071467,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071468,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071469,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329975,
                        "componentDefId": 23874,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329976,
                        "componentDefId": 23875,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329977,
                        "componentDefId": 23872,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329978,
                        "componentDefId": 23873,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 641
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925976,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925977,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925978,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925979,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925980,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256580,
                        "componentDefId": 23874,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256581,
                        "componentDefId": 23875,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256582,
                        "componentDefId": 23872,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256583,
                        "componentDefId": 23873,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 641
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925976,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925977,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925978,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925979,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925980,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256580,
                        "componentDefId": 23874,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256581,
                        "componentDefId": 23875,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256582,
                        "componentDefId": 23872,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256583,
                        "componentDefId": 23873,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 641
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "DBQD1A1",
            "description": "Progenity - Desbuquois dysplasia, type I",
            "placeHolderCode": "3593A1P",
            "reportDescriptionIndividual": "<strong>Desbuquois dysplasia, type I<\/strong>",
            "reportDescriptionPanel": "<strong>Desbuquois dysplasia, type I<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071470,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071471,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071472,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071473,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071474,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329983,
                        "componentDefId": 23878,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329984,
                        "componentDefId": 23879,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329985,
                        "componentDefId": 23876,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329986,
                        "componentDefId": 23877,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 103
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925981,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925982,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925983,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925984,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925985,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256584,
                        "componentDefId": 23878,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256585,
                        "componentDefId": 23879,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256586,
                        "componentDefId": 23876,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256587,
                        "componentDefId": 23877,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 103
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071470,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071471,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071472,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071473,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071474,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329983,
                        "componentDefId": 23878,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329984,
                        "componentDefId": 23879,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329985,
                        "componentDefId": 23876,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329986,
                        "componentDefId": 23877,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 103
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "DPYDA1",
            "description": "Progenity - Dihydropyrimidine dehydrogenase deficiency ",
            "placeHolderCode": "3594A1P",
            "reportDescriptionIndividual": "<strong>Dihydropyrimidine dehydrogenase deficiency <\/strong>",
            "reportDescriptionPanel": "<strong>Dihydropyrimidine dehydrogenase deficiency <\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071475,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071476,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071477,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071478,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071479,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329987,
                        "componentDefId": 23882,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329988,
                        "componentDefId": 23883,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329989,
                        "componentDefId": 23880,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329990,
                        "componentDefId": 23881,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925991,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925992,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925993,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925994,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925995,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256588,
                        "componentDefId": 23882,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256589,
                        "componentDefId": 23883,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256590,
                        "componentDefId": 23881,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256591,
                        "componentDefId": 23880,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071475,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071476,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071477,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071478,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071479,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329987,
                        "componentDefId": 23882,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329988,
                        "componentDefId": 23883,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329989,
                        "componentDefId": 23880,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329990,
                        "componentDefId": 23881,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "DPSA1",
            "description": "Progenity - Du Pan syndrome",
            "placeHolderCode": "3595A1P",
            "reportDescriptionIndividual": "<strong>Du Pan syndrome<\/strong>",
            "reportDescriptionPanel": "<strong>Du Pan syndrome<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071480,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071481,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071482,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071483,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071484,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329991,
                        "componentDefId": 24704,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329992,
                        "componentDefId": 24705,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329993,
                        "componentDefId": 24702,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329994,
                        "componentDefId": 24703,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 833
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926006,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926007,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926008,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926009,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926010,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2243286,
                        "componentDefId": 24704,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 2,
                        "amended": false
                    },
                    {
                        "componentResultId": 2243287,
                        "componentDefId": 24705,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2243288,
                        "componentDefId": 24702,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2243289,
                        "componentDefId": 24703,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 833
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071480,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071481,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071482,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071483,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071484,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329991,
                        "componentDefId": 24704,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329992,
                        "componentDefId": 24705,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329993,
                        "componentDefId": 24702,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329994,
                        "componentDefId": 24703,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 833
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "RTELA2",
            "description": "Progenity - Dyskeratosis congenita, autosomal recessive",
            "placeHolderCode": "3596A2P",
            "reportDescriptionIndividual": "<strong>Dyskeratosis congenita, autosomal recessive<\/strong>",
            "reportDescriptionPanel": "<strong>Dyskeratosis congenita, autosomal recessive<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 4,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-07-11T00:00:00",
            "assayTypeId": 1,
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071485,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071486,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071487,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071488,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 4071489,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329995,
                        "componentDefId": 23890,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329996,
                        "componentDefId": 23891,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329997,
                        "componentDefId": 23888,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329998,
                        "componentDefId": 23889,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926016,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926017,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926018,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926019,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3926020,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256592,
                        "componentDefId": 23890,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256593,
                        "componentDefId": 23891,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256594,
                        "componentDefId": 23888,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256595,
                        "componentDefId": 23889,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071485,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071486,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071487,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071488,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 4071489,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329995,
                        "componentDefId": 23890,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329996,
                        "componentDefId": 23891,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329997,
                        "componentDefId": 23888,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329998,
                        "componentDefId": 23889,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "DKCXA1",
            "description": "Progenity - Dyskeratosis congenita, X-linked",
            "placeHolderCode": "3597A1P",
            "reportDescriptionIndividual": "<strong>Dyskeratosis congenita, X-linked<\/strong>",
            "reportDescriptionPanel": "<strong>Dyskeratosis congenita, X-linked<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 4,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071490,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071491,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071492,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071493,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071494,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329999,
                        "componentDefId": 23894,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330000,
                        "componentDefId": 23895,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330001,
                        "componentDefId": 23892,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330002,
                        "componentDefId": 23893,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 383
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926011,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926012,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926013,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926014,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926015,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256596,
                        "componentDefId": 23894,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256597,
                        "componentDefId": 23892,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256598,
                        "componentDefId": 23895,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256599,
                        "componentDefId": 23893,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 383
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071490,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071491,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071492,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071493,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071494,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329999,
                        "componentDefId": 23894,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330000,
                        "componentDefId": 23895,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330001,
                        "componentDefId": 23892,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330002,
                        "componentDefId": 23893,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 383
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "COL7A1A1",
            "description": "Progenity - Dystrophic epidermolysis bullosa, autosomal recessive",
            "placeHolderCode": "3598A1P",
            "reportDescriptionIndividual": "<strong>Dystrophic epidermolysis bullosa, autosomal recessive<\/strong>",
            "reportDescriptionPanel": "<strong>Dystrophic epidermolysis bullosa, autosomal recessive<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071495,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071496,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071497,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071498,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071499,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330003,
                        "componentDefId": 23898,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330004,
                        "componentDefId": 23899,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330005,
                        "componentDefId": 23896,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330006,
                        "componentDefId": 23897,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926026,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926027,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926028,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926029,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926030,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256600,
                        "componentDefId": 23898,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256601,
                        "componentDefId": 23899,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256602,
                        "componentDefId": 23896,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256603,
                        "componentDefId": 23897,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071495,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071496,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071497,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071498,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071499,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330003,
                        "componentDefId": 23898,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330004,
                        "componentDefId": 23899,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330005,
                        "componentDefId": 23896,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330006,
                        "componentDefId": 23897,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "EOMFCA1",
            "description": "Progenity - Early onset myopathy with fatal cardiomyopathy",
            "placeHolderCode": "3599A1P",
            "reportDescriptionIndividual": "<strong>Early onset myopathy with fatal cardiomyopathy<\/strong>",
            "reportDescriptionPanel": "<strong>Early onset myopathy with fatal cardiomyopathy<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071500,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071501,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071502,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071503,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071504,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330007,
                        "componentDefId": 23902,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330008,
                        "componentDefId": 23903,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330009,
                        "componentDefId": 23900,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330010,
                        "componentDefId": 23901,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 2936
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925986,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925987,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925988,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925989,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925990,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256604,
                        "componentDefId": 23902,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256605,
                        "componentDefId": 23903,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256606,
                        "componentDefId": 23900,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256607,
                        "componentDefId": 23901,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 2936
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071500,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071501,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071502,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071503,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071504,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330007,
                        "componentDefId": 23902,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330008,
                        "componentDefId": 23903,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330009,
                        "componentDefId": 23900,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330010,
                        "componentDefId": 23901,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 2936
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "EDS7CA1",
            "description": "Progenity - Ehlers Danlos syndrome, type VIIC ",
            "placeHolderCode": "3600A1P",
            "reportDescriptionIndividual": "<strong>Ehlers Danlos syndrome, type VIIC <\/strong>",
            "reportDescriptionPanel": "<strong>Ehlers Danlos syndrome, type VIIC <\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071505,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071506,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071507,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071508,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 4071509,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330011,
                        "componentDefId": 23906,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330012,
                        "componentDefId": 23907,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330013,
                        "componentDefId": 23904,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330014,
                        "componentDefId": 23905,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 91111
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926036,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926037,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926038,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926039,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3926040,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256608,
                        "componentDefId": 23906,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256609,
                        "componentDefId": 23907,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256610,
                        "componentDefId": 23905,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256611,
                        "componentDefId": 23904,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 91111
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926036,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926037,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926038,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926039,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3926040,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256608,
                        "componentDefId": 23906,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256609,
                        "componentDefId": 23907,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256610,
                        "componentDefId": 23905,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256611,
                        "componentDefId": 23904,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 91111
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "EDMD1A1",
            "description": "Progenity - Emery-Dreifuss muscular dystrophy",
            "placeHolderCode": "3601A1P",
            "reportDescriptionIndividual": "<strong>Emery-Dreifuss muscular dystrophy<\/strong>",
            "reportDescriptionPanel": "<strong>Emery-Dreifuss muscular dystrophy<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 6,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071510,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071511,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071512,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071513,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071514,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330015,
                        "componentDefId": 23910,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330016,
                        "componentDefId": 23911,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330017,
                        "componentDefId": 23908,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330018,
                        "componentDefId": 23909,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 806
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925996,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925997,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925998,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925999,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926000,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256612,
                        "componentDefId": 23910,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256613,
                        "componentDefId": 23911,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256614,
                        "componentDefId": 23909,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256616,
                        "componentDefId": 23908,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 806
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925996,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925997,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925998,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925999,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926000,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256612,
                        "componentDefId": 23910,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256613,
                        "componentDefId": 23911,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256614,
                        "componentDefId": 23909,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256616,
                        "componentDefId": 23908,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 806
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "NR2E3A1",
            "description": "Progenity - Enhanced S-cone syndrome",
            "placeHolderCode": "3602A1P",
            "reportDescriptionIndividual": "<strong>Enhanced S-cone syndrome<\/strong>",
            "reportDescriptionPanel": "<strong>Enhanced S-cone syndrome<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071515,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071516,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071517,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071518,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071519,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330019,
                        "componentDefId": 23914,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330020,
                        "componentDefId": 23915,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330021,
                        "componentDefId": 23912,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330022,
                        "componentDefId": 23913,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926031,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926032,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926033,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926034,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926035,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256615,
                        "componentDefId": 23914,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256617,
                        "componentDefId": 23915,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256618,
                        "componentDefId": 23912,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256619,
                        "componentDefId": 23913,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926031,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926032,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926033,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926034,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926035,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256615,
                        "componentDefId": 23914,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256617,
                        "componentDefId": 23915,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256618,
                        "componentDefId": 23912,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256619,
                        "componentDefId": 23913,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "ETHE1A1",
            "description": "Progenity - Ethylmalonic encephalopathy",
            "placeHolderCode": "3603A1P",
            "reportDescriptionIndividual": "<strong>Ethylmalonic encephalopathy<\/strong>",
            "reportDescriptionPanel": "<strong>Ethylmalonic encephalopathy<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 4,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071520,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071521,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071522,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071523,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 4071524,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330023,
                        "componentDefId": 23918,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330024,
                        "componentDefId": 23919,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330025,
                        "componentDefId": 23916,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330026,
                        "componentDefId": 23917,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 27778
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926021,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926022,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926023,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926024,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3926025,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256620,
                        "componentDefId": 23918,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256621,
                        "componentDefId": 23919,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256622,
                        "componentDefId": 23916,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256623,
                        "componentDefId": 23917,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 27778
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926021,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926022,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926023,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926024,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3926025,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256620,
                        "componentDefId": 23918,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256621,
                        "componentDefId": 23919,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256622,
                        "componentDefId": 23916,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256623,
                        "componentDefId": 23917,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 27778
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "GLAA1",
            "description": "Progenity - Fabry disease",
            "placeHolderCode": "3604A1P",
            "reportDescriptionIndividual": "<strong>Fabry disease<\/strong>",
            "reportDescriptionPanel": "<strong>Fabry disease<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 6,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071525,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071526,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071527,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071528,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071529,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330035,
                        "componentDefId": 23922,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330036,
                        "componentDefId": 23923,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330037,
                        "componentDefId": 23920,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330038,
                        "componentDefId": 23921,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926001,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926002,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926003,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926004,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926005,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256624,
                        "componentDefId": 23922,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256625,
                        "componentDefId": 23923,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256626,
                        "componentDefId": 23920,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256627,
                        "componentDefId": 23921,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071525,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071526,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071527,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071528,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071529,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330035,
                        "componentDefId": 23922,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330036,
                        "componentDefId": 23923,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330037,
                        "componentDefId": 23920,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330038,
                        "componentDefId": 23921,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "KCNJ11A1",
            "description": "Progenity - Familial hyperinsulinism, KCNJ11-related",
            "placeHolderCode": "3605A1P",
            "reportDescriptionIndividual": "<strong>Familial hyperinsulinism, KCNJ11-related<\/strong>",
            "reportDescriptionPanel": "<strong>Familial hyperinsulinism, KCNJ11-related<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071530,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071531,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071532,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071533,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071534,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330039,
                        "componentDefId": 23926,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330040,
                        "componentDefId": 23927,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330041,
                        "componentDefId": 23924,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330042,
                        "componentDefId": 23925,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 55
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926041,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926042,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926043,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926044,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926045,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256628,
                        "componentDefId": 23924,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256629,
                        "componentDefId": 23926,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256630,
                        "componentDefId": 23925,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256635,
                        "componentDefId": 23927,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 55
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071530,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071531,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071532,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071533,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071534,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330039,
                        "componentDefId": 23926,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330040,
                        "componentDefId": 23927,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330041,
                        "componentDefId": 23924,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330042,
                        "componentDefId": 23925,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 55
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "FMFA1",
            "description": "Progenity - Familial Mediterranean fever",
            "placeHolderCode": "3606A1P",
            "reportDescriptionIndividual": "<strong>Familial Mediterranean fever<\/strong>",
            "reportDescriptionPanel": "<strong>Familial Mediterranean fever<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 3,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071535,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071536,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071537,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071538,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071539,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330047,
                        "componentDefId": 23930,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330048,
                        "componentDefId": 23931,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330049,
                        "componentDefId": 23928,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330050,
                        "componentDefId": 23929,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 431
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926095,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 3926091,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926092,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926093,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926094,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256634,
                        "componentDefId": 23931,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256637,
                        "componentDefId": 23930,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256641,
                        "componentDefId": 23929,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256642,
                        "componentDefId": 23928,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 431
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071535,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071536,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071537,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071538,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071539,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330047,
                        "componentDefId": 23930,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330048,
                        "componentDefId": 23931,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330049,
                        "componentDefId": 23928,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330050,
                        "componentDefId": 23929,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 431
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "FANCAA1",
            "description": "Progenity - Fanconi anemia, type A",
            "placeHolderCode": "3607A1P",
            "reportDescriptionIndividual": "<strong>Fanconi anemia, type A<\/strong>",
            "reportDescriptionPanel": "<strong>Fanconi anemia, type A<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071540,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071541,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071542,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071543,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071544,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330051,
                        "componentDefId": 24700,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330052,
                        "componentDefId": 24701,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330053,
                        "componentDefId": 24698,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330054,
                        "componentDefId": 24699,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926070,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 3926069,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926068,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926067,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926066,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2243290,
                        "componentDefId": 24701,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2243291,
                        "componentDefId": 24700,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 2,
                        "amended": false
                    },
                    {
                        "componentResultId": 2243294,
                        "componentDefId": 24699,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2243297,
                        "componentDefId": 24698,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071540,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071541,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071542,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071543,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071544,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330051,
                        "componentDefId": 24700,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330052,
                        "componentDefId": 24701,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330053,
                        "componentDefId": 24698,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330054,
                        "componentDefId": 24699,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "FADSA2",
            "description": "Progenity - Fetal akinesia deformation sequence, DOK7-related",
            "placeHolderCode": "3608A2P",
            "reportDescriptionIndividual": "<strong>Fetal akinesia deformation sequence, DOK7-related<\/strong>",
            "reportDescriptionPanel": "<strong>Fetal akinesia deformation sequence, DOK7-related<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 3,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-07-11T00:00:00",
            "assayTypeId": 1,
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071545,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071546,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071547,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071548,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071549,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330060,
                        "componentDefId": 23938,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330061,
                        "componentDefId": 23939,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330062,
                        "componentDefId": 23936,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330063,
                        "componentDefId": 23937,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 633
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926116,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926117,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926118,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926119,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926120,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256631,
                        "componentDefId": 23938,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256633,
                        "componentDefId": 23937,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256638,
                        "componentDefId": 23939,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256639,
                        "componentDefId": 23936,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 633
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071545,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071546,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071547,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071548,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071549,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330060,
                        "componentDefId": 23938,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330061,
                        "componentDefId": 23939,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330062,
                        "componentDefId": 23936,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330063,
                        "componentDefId": 23937,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 633
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "FHA1",
            "description": "Progenity - Fumarase deficiency ",
            "placeHolderCode": "3609A1P",
            "reportDescriptionIndividual": "<strong>Fumarase deficiency <\/strong>",
            "reportDescriptionPanel": "<strong>Fumarase deficiency <\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071550,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071551,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071552,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071553,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071554,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330064,
                        "componentDefId": 23942,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330065,
                        "componentDefId": 23943,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330066,
                        "componentDefId": 23940,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330067,
                        "componentDefId": 23941,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926065,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 3926064,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926063,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926062,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926061,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256632,
                        "componentDefId": 23940,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256636,
                        "componentDefId": 23943,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256640,
                        "componentDefId": 23942,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256643,
                        "componentDefId": 23941,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071550,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071551,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071552,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071553,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071554,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330064,
                        "componentDefId": 23942,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330065,
                        "componentDefId": 23943,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330066,
                        "componentDefId": 23940,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330067,
                        "componentDefId": 23941,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "GALK1A1",
            "description": "Progenity - Galactokinase deficiency ",
            "placeHolderCode": "3610A1P",
            "reportDescriptionIndividual": "<strong>Galactokinase deficiency <\/strong>",
            "reportDescriptionPanel": "<strong>Galactokinase deficiency <\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071555,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071556,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071557,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071558,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071559,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330068,
                        "componentDefId": 23946,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330069,
                        "componentDefId": 23947,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330070,
                        "componentDefId": 23944,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330071,
                        "componentDefId": 23945,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 546
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926060,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 3926059,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926058,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926057,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926056,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256644,
                        "componentDefId": 23944,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256645,
                        "componentDefId": 23946,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256646,
                        "componentDefId": 23947,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256647,
                        "componentDefId": 23945,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 546
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071555,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071556,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071557,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071558,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071559,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330068,
                        "componentDefId": 23946,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330069,
                        "componentDefId": 23947,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330070,
                        "componentDefId": 23944,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330071,
                        "componentDefId": 23945,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 546
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "GALTA1",
            "description": "Progenity - Galactosemia",
            "placeHolderCode": "3611A1P",
            "reportDescriptionIndividual": "<strong>Galactosemia<\/strong>",
            "reportDescriptionPanel": "<strong>Galactosemia<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071560,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071561,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071562,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071563,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071564,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330076,
                        "componentDefId": 23950,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330077,
                        "componentDefId": 23951,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330078,
                        "componentDefId": 23948,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330079,
                        "componentDefId": 23949,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926081,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926082,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926083,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926084,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926085,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256648,
                        "componentDefId": 23951,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256649,
                        "componentDefId": 23950,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256650,
                        "componentDefId": 23948,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256651,
                        "componentDefId": 23949,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071560,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071561,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071562,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071563,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071564,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330076,
                        "componentDefId": 23950,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330077,
                        "componentDefId": 23951,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330078,
                        "componentDefId": 23948,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330079,
                        "componentDefId": 23949,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "GOA1",
            "description": "Progenity - Geroderma osteodysplastica",
            "placeHolderCode": "3612A1P",
            "reportDescriptionIndividual": "<strong>Geroderma osteodysplastica<\/strong>",
            "reportDescriptionPanel": "<strong>Geroderma osteodysplastica<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 4,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071565,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071566,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071567,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071568,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071569,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330080,
                        "componentDefId": 23954,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330081,
                        "componentDefId": 23955,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330082,
                        "componentDefId": 23952,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330083,
                        "componentDefId": 23953,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 111
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926076,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926079,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926080,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 3926077,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926078,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256652,
                        "componentDefId": 23954,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256653,
                        "componentDefId": 23955,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256654,
                        "componentDefId": 23952,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256655,
                        "componentDefId": 23953,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 111
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926076,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926079,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926080,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 3926077,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926078,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256652,
                        "componentDefId": 23954,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256653,
                        "componentDefId": 23955,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256654,
                        "componentDefId": 23952,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256655,
                        "componentDefId": 23953,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 111
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "SLC12A3A1",
            "description": "Progenity - Gitelman syndrome",
            "placeHolderCode": "3613A1P",
            "reportDescriptionIndividual": "<strong>Gitelman syndrome<\/strong>",
            "reportDescriptionPanel": "<strong>Gitelman syndrome<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071570,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071571,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071572,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071573,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 4071574,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330084,
                        "componentDefId": 23958,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330085,
                        "componentDefId": 23959,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330086,
                        "componentDefId": 23956,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330087,
                        "componentDefId": 23957,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926181,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926182,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926183,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926184,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3926185,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256656,
                        "componentDefId": 23958,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256657,
                        "componentDefId": 23959,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256658,
                        "componentDefId": 23956,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256659,
                        "componentDefId": 23957,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926181,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926182,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926183,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926184,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3926185,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256656,
                        "componentDefId": 23958,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256657,
                        "componentDefId": 23959,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256658,
                        "componentDefId": 23956,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256659,
                        "componentDefId": 23957,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "G6PDA1",
            "description": "Progenity - Glucose-6-phosphate dehydrogenase deficiency",
            "placeHolderCode": "3614A1P",
            "reportDescriptionIndividual": "<strong>Glucose-6-phosphate dehydrogenase deficiency<\/strong>",
            "reportDescriptionPanel": "<strong>Glucose-6-phosphate dehydrogenase deficiency<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 46,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071575,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071576,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071577,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071578,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071579,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330088,
                        "componentDefId": 23962,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330089,
                        "componentDefId": 23963,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330090,
                        "componentDefId": 23960,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330091,
                        "componentDefId": 23961,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 146
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926051,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926052,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926053,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926054,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926055,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256660,
                        "componentDefId": 23962,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256661,
                        "componentDefId": 23963,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256662,
                        "componentDefId": 23960,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256663,
                        "componentDefId": 23961,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 104
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926051,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926052,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926053,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926054,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926055,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256660,
                        "componentDefId": 23962,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256661,
                        "componentDefId": 23963,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256662,
                        "componentDefId": 23960,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256663,
                        "componentDefId": 23961,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 104
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "GCDHA1",
            "description": "Progenity - Glutaric acidemia, type I",
            "placeHolderCode": "3615A1P",
            "reportDescriptionIndividual": "<strong>Glutaric acidemia, type I<\/strong>",
            "reportDescriptionPanel": "<strong>Glutaric acidemia, type I<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 8,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071580,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071581,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071582,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071583,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071584,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330092,
                        "componentDefId": 23966,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330093,
                        "componentDefId": 23967,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330094,
                        "componentDefId": 23964,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330095,
                        "componentDefId": 23965,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 3151
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926096,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926097,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926098,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926099,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926100,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256664,
                        "componentDefId": 23966,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256665,
                        "componentDefId": 23967,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256666,
                        "componentDefId": 23964,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256668,
                        "componentDefId": 23965,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 351
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926096,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926097,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926098,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926099,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926100,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256664,
                        "componentDefId": 23966,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256665,
                        "componentDefId": 23967,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256666,
                        "componentDefId": 23964,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256668,
                        "componentDefId": 23965,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 351
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "GCEAA1",
            "description": "Progenity - Glycine encephalopathy, AMT-related",
            "placeHolderCode": "3616A1P",
            "reportDescriptionIndividual": "<strong>Glycine encephalopathy, AMT-related<\/strong>",
            "reportDescriptionPanel": "<strong>Glycine encephalopathy, AMT-related<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071585,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071586,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071587,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071588,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071589,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330096,
                        "componentDefId": 23970,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330097,
                        "componentDefId": 23971,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330098,
                        "componentDefId": 23968,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330099,
                        "componentDefId": 23969,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 139
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926111,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926112,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926113,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926114,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926115,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256667,
                        "componentDefId": 23970,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256669,
                        "componentDefId": 23968,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256670,
                        "componentDefId": 23971,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256671,
                        "componentDefId": 23969,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 139
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926111,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926112,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926113,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926114,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926115,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256667,
                        "componentDefId": 23970,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256669,
                        "componentDefId": 23968,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256670,
                        "componentDefId": 23971,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256671,
                        "componentDefId": 23969,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 139
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "GCEGA1",
            "description": "Progenity - Glycine encephalopathy, GLDC-related",
            "placeHolderCode": "3617A1P",
            "reportDescriptionIndividual": "<strong>Glycine encephalopathy, GLDC-related<\/strong>",
            "reportDescriptionPanel": "<strong>Glycine encephalopathy, GLDC-related<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071590,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071591,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071592,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071593,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071594,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330104,
                        "componentDefId": 23974,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330105,
                        "componentDefId": 23975,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330106,
                        "componentDefId": 23972,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330107,
                        "componentDefId": 23973,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 393
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926151,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926152,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926153,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926154,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926155,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256672,
                        "componentDefId": 23974,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256673,
                        "componentDefId": 23975,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256674,
                        "componentDefId": 23972,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256675,
                        "componentDefId": 23973,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 393
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926151,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926152,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926153,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926154,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926155,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256672,
                        "componentDefId": 23974,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256673,
                        "componentDefId": 23975,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256674,
                        "componentDefId": 23972,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256675,
                        "componentDefId": 23973,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 393
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "GSBIBA1",
            "description": "Progenity - Glycogen storage disease, type IB",
            "placeHolderCode": "3618A1P",
            "reportDescriptionIndividual": "<strong>Glycogen storage disease, type IB<\/strong>",
            "reportDescriptionPanel": "<strong>Glycogen storage disease, type IB<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071595,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071596,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071597,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071598,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071599,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330108,
                        "componentDefId": 23978,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330109,
                        "componentDefId": 23979,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330110,
                        "componentDefId": 23976,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330111,
                        "componentDefId": 23977,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 111
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926121,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926122,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926123,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926124,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926125,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256676,
                        "componentDefId": 23978,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256677,
                        "componentDefId": 23977,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256678,
                        "componentDefId": 23979,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256679,
                        "componentDefId": 23976,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 111
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926121,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926122,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926123,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926124,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926125,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256676,
                        "componentDefId": 23978,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256677,
                        "componentDefId": 23977,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256678,
                        "componentDefId": 23979,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256679,
                        "componentDefId": 23976,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 111
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "GSD2A1",
            "description": "Progenity - Glycogen storage disease, type II",
            "placeHolderCode": "3619A1P",
            "reportDescriptionIndividual": "<strong>Glycogen storage disease, type II<\/strong>",
            "reportDescriptionPanel": "<strong>Glycogen storage disease, type II<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071600,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071601,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071602,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071603,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071604,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330112,
                        "componentDefId": 23982,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330113,
                        "componentDefId": 23983,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330114,
                        "componentDefId": 23980,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330115,
                        "componentDefId": 23981,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 287
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926086,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926087,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926088,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926089,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926090,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256680,
                        "componentDefId": 23983,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256681,
                        "componentDefId": 23982,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256682,
                        "componentDefId": 23980,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256683,
                        "componentDefId": 23981,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 287
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926086,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926087,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926088,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926089,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926090,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256680,
                        "componentDefId": 23983,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256681,
                        "componentDefId": 23982,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256682,
                        "componentDefId": 23980,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256683,
                        "componentDefId": 23981,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 287
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "GSD3A1",
            "description": "Progenity - Glycogen storage disease, type III",
            "placeHolderCode": "3620A1P",
            "reportDescriptionIndividual": "<strong>Glycogen storage disease, type III<\/strong>",
            "reportDescriptionPanel": "<strong>Glycogen storage disease, type III<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071605,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071606,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071607,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071608,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071609,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330116,
                        "componentDefId": 23986,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330117,
                        "componentDefId": 23987,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330118,
                        "componentDefId": 23984,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330119,
                        "componentDefId": 23985,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 431
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926073,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926074,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926075,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 3926072,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926071,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256684,
                        "componentDefId": 23986,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256685,
                        "componentDefId": 23987,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256686,
                        "componentDefId": 23984,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256687,
                        "componentDefId": 23985,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 431
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926073,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926074,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926075,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 3926072,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926071,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256684,
                        "componentDefId": 23986,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256685,
                        "componentDefId": 23987,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256686,
                        "componentDefId": 23984,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256687,
                        "componentDefId": 23985,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 431
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "GSD4A1",
            "description": "Progenity - Glycogen storage disease, type IV",
            "placeHolderCode": "3621A1P",
            "reportDescriptionIndividual": "<strong>Glycogen storage disease, type IV<\/strong>",
            "reportDescriptionPanel": "<strong>Glycogen storage disease, type IV<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071610,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071611,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071612,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071613,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071614,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330120,
                        "componentDefId": 23990,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330121,
                        "componentDefId": 23991,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330122,
                        "componentDefId": 23988,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330123,
                        "componentDefId": 23989,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 786
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926136,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926137,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926138,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926139,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926140,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256688,
                        "componentDefId": 23990,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256689,
                        "componentDefId": 23991,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256690,
                        "componentDefId": 23988,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256691,
                        "componentDefId": 23989,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 786
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071610,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071611,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071612,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071613,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071614,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330120,
                        "componentDefId": 23990,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330121,
                        "componentDefId": 23991,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330122,
                        "componentDefId": 23988,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330123,
                        "componentDefId": 23989,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 786
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "GSD5A1",
            "description": "Progenity - Glycogen storage disease, type V",
            "placeHolderCode": "3622A1P",
            "reportDescriptionIndividual": "<strong>Glycogen storage disease, type V<\/strong>",
            "reportDescriptionPanel": "<strong>Glycogen storage disease, type V<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071615,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071616,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071617,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071618,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071619,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330124,
                        "componentDefId": 23994,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330125,
                        "componentDefId": 23995,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330126,
                        "componentDefId": 23992,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330127,
                        "componentDefId": 23993,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926104,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926105,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 3926101,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926102,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926103,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256692,
                        "componentDefId": 23994,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256693,
                        "componentDefId": 23995,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256694,
                        "componentDefId": 23992,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256695,
                        "componentDefId": 23993,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071615,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071616,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071617,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071618,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071619,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330124,
                        "componentDefId": 23994,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330125,
                        "componentDefId": 23995,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330126,
                        "componentDefId": 23992,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330127,
                        "componentDefId": 23993,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "GSD7A1",
            "description": "Progenity - Glycogen storage disease, type VII",
            "placeHolderCode": "3623A1P",
            "reportDescriptionIndividual": "<strong>Glycogen storage disease, type VII<\/strong>",
            "reportDescriptionPanel": "<strong>Glycogen storage disease, type VII<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071620,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071621,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071622,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071623,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071624,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330128,
                        "componentDefId": 23998,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330129,
                        "componentDefId": 23999,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330130,
                        "componentDefId": 23996,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330131,
                        "componentDefId": 23997,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 249
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926131,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926132,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926133,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926134,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926135,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256696,
                        "componentDefId": 23998,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256697,
                        "componentDefId": 23999,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256698,
                        "componentDefId": 23996,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256699,
                        "componentDefId": 23997,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 249
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071620,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071621,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071622,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071623,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071624,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330128,
                        "componentDefId": 23998,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330129,
                        "componentDefId": 23999,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330130,
                        "componentDefId": 23996,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330131,
                        "componentDefId": 23997,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 249
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "GLB1A1",
            "description": "Progenity - GM1-gangliosidosis",
            "placeHolderCode": "3624A1P",
            "reportDescriptionIndividual": "<strong>GM1-gangliosidosis<\/strong>",
            "reportDescriptionPanel": "<strong>GM1-gangliosidosis<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071625,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071626,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071627,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071628,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071629,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330132,
                        "componentDefId": 24002,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330133,
                        "componentDefId": 24003,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330134,
                        "componentDefId": 24000,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330135,
                        "componentDefId": 24001,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926106,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926107,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926108,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926109,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926110,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256700,
                        "componentDefId": 24002,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256701,
                        "componentDefId": 24003,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256702,
                        "componentDefId": 24000,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256703,
                        "componentDefId": 24001,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071625,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071626,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071627,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071628,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071629,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330132,
                        "componentDefId": 24002,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330133,
                        "componentDefId": 24003,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330134,
                        "componentDefId": 24000,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330135,
                        "componentDefId": 24001,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "GSA1",
            "description": "Progenity - GRACILE syndrome",
            "placeHolderCode": "3625A1P",
            "reportDescriptionIndividual": "<strong>GRACILE syndrome<\/strong>",
            "reportDescriptionPanel": "<strong>GRACILE syndrome<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071630,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071631,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071632,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071633,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 4071634,
                        "description": "GCS V4 Global + Additional Info",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-global-102016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global 102016. Original report is on file and available upon request.<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330136,
                        "componentDefId": 24645,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330137,
                        "componentDefId": 24646,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330138,
                        "componentDefId": 24643,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330139,
                        "componentDefId": 24644,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 652
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926146,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926147,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926148,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926149,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 3926150,
                        "description": "GCS V4 Global + Additional Info",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-global-042016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global 042016. Original report is on file and available upon request.<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256704,
                        "componentDefId": 24645,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256705,
                        "componentDefId": 24646,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256706,
                        "componentDefId": 24643,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256707,
                        "componentDefId": 24644,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 652
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071630,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071631,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071632,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071633,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 4071634,
                        "description": "GCS V4 Global + Additional Info",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-global-102016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global 102016. Original report is on file and available upon request.<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330136,
                        "componentDefId": 24645,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330137,
                        "componentDefId": 24646,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330138,
                        "componentDefId": 24643,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330139,
                        "componentDefId": 24644,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 652
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "GAMTA3",
            "description": "Progenity - Guanidinoacetate methyltransferase deficiency V3",
            "placeHolderCode": "3626A3P",
            "reportDescriptionIndividual": "<strong>Guanidinoacetate methyltransferase deficiency<\/strong>",
            "reportDescriptionPanel": "<strong>Guanidinoacetate methyltransferase deficiency<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 6,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": true,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071635,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071636,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071637,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071638,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071639,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330140,
                        "componentDefId": 24010,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330141,
                        "componentDefId": 24011,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330142,
                        "componentDefId": 24008,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330143,
                        "componentDefId": 24009,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 16901
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926126,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926127,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926128,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926129,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926130,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256708,
                        "componentDefId": 24010,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256709,
                        "componentDefId": 24011,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256710,
                        "componentDefId": 24008,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256711,
                        "componentDefId": 24009,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 49901
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071635,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071636,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071637,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071638,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071639,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330140,
                        "componentDefId": 24010,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330141,
                        "componentDefId": 24011,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330142,
                        "componentDefId": 24008,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330143,
                        "componentDefId": 24009,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 16901
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "HBCA1",
            "description": "Progenity - Hemoglobinopathy, Hb C ",
            "placeHolderCode": "3628A1P",
            "reportDescriptionIndividual": "<strong>Hemoglobinopathy,  Hb C <\/strong>",
            "reportDescriptionPanel": "<strong>Hemoglobinopathy,  Hb C <\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 2,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071640,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071641,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071642,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071643,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071644,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330144,
                        "componentDefId": 24014,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330145,
                        "componentDefId": 24015,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330146,
                        "componentDefId": 24012,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330147,
                        "componentDefId": 24013,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 16901
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926156,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926157,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926158,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926159,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926160,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256712,
                        "componentDefId": 24014,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256713,
                        "componentDefId": 24015,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256714,
                        "componentDefId": 24012,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256715,
                        "componentDefId": 24013,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 49901
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071640,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071641,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071642,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071643,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071644,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330144,
                        "componentDefId": 24014,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330145,
                        "componentDefId": 24015,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330146,
                        "componentDefId": 24012,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330147,
                        "componentDefId": 24013,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 16901
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "HBDA1",
            "description": "Progenity - Hemoglobinopathy, Hb D ",
            "placeHolderCode": "3629A1P",
            "reportDescriptionIndividual": "<strong>Hemoglobinopathy,  Hb D <\/strong>",
            "reportDescriptionPanel": "<strong>Hemoglobinopathy,  Hb D <\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 2,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071645,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071646,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071647,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071648,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071649,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330148,
                        "componentDefId": 24018,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330149,
                        "componentDefId": 24019,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330150,
                        "componentDefId": 24016,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330151,
                        "componentDefId": 24017,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 16901
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926161,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926162,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926163,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926164,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926165,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256716,
                        "componentDefId": 24018,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256717,
                        "componentDefId": 24019,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256718,
                        "componentDefId": 24016,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256719,
                        "componentDefId": 24017,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 49901
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071645,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071646,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071647,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071648,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071649,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330148,
                        "componentDefId": 24018,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330149,
                        "componentDefId": 24019,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330150,
                        "componentDefId": 24016,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330151,
                        "componentDefId": 24017,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 16901
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "HBEA1",
            "description": "Progenity - Hemoglobinopathy, Hb E ",
            "placeHolderCode": "3630A1P",
            "reportDescriptionIndividual": "<strong>Hemoglobinopathy,  Hb E <\/strong>",
            "reportDescriptionPanel": "<strong>Hemoglobinopathy,  Hb E <\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071650,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071651,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071652,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071653,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071654,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330152,
                        "componentDefId": 24022,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330153,
                        "componentDefId": 24023,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330154,
                        "componentDefId": 24020,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330155,
                        "componentDefId": 24021,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 16901
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926176,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926177,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926178,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926179,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926180,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256720,
                        "componentDefId": 24022,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256721,
                        "componentDefId": 24023,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256723,
                        "componentDefId": 24021,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256727,
                        "componentDefId": 24020,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 49901
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071650,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071651,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071652,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071653,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071654,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330152,
                        "componentDefId": 24022,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330153,
                        "componentDefId": 24023,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330154,
                        "componentDefId": 24020,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330155,
                        "componentDefId": 24021,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 16901
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "HBOA1",
            "description": "Progenity - Hemoglobinopathy, Hb O ",
            "placeHolderCode": "3631A1P",
            "reportDescriptionIndividual": "<strong>Hemoglobinopathy,  Hb O <\/strong>",
            "reportDescriptionPanel": "<strong>Hemoglobinopathy,  Hb O <\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071655,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071656,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071657,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071658,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071659,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330156,
                        "componentDefId": 24026,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330157,
                        "componentDefId": 24027,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330158,
                        "componentDefId": 24024,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330159,
                        "componentDefId": 24025,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 62401
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926141,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926142,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926143,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926144,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926145,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256722,
                        "componentDefId": 24027,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256724,
                        "componentDefId": 24024,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256726,
                        "componentDefId": 24025,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256728,
                        "componentDefId": 24026,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 2401
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926141,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926142,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926143,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926144,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926145,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256722,
                        "componentDefId": 24027,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256724,
                        "componentDefId": 24024,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256726,
                        "componentDefId": 24025,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256728,
                        "componentDefId": 24026,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 2401
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "HBSA1",
            "description": "Progenity - Hemoglobinopathy, Sickle cell anemia (HbS)",
            "placeHolderCode": "3632A1P",
            "reportDescriptionIndividual": "<strong>Hemoglobinopathy, Sickle cell anemia (HbS)<\/strong>",
            "reportDescriptionPanel": "<strong>Hemoglobinopathy, Sickle cell anemia (HbS)<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071660,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071661,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071662,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071663,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 4071664,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330160,
                        "componentDefId": 24030,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330161,
                        "componentDefId": 24031,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330162,
                        "componentDefId": 24028,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330163,
                        "componentDefId": 24029,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 2222
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926166,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926167,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926168,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926169,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3926170,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256725,
                        "componentDefId": 24031,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256729,
                        "componentDefId": 24030,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256730,
                        "componentDefId": 24028,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256731,
                        "componentDefId": 24029,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 2222
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926166,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926167,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926168,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926169,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3926170,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256725,
                        "componentDefId": 24031,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256729,
                        "componentDefId": 24030,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256730,
                        "componentDefId": 24028,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256731,
                        "componentDefId": 24029,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 2222
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "HEMAA1",
            "description": "Progenity - Hemophilia A",
            "placeHolderCode": "3633A1P",
            "reportDescriptionIndividual": "<strong>Hemophilia A<\/strong>",
            "reportDescriptionPanel": "<strong>Hemophilia A<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 4,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071665,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071666,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071667,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071668,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 4071669,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330164,
                        "componentDefId": 24034,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330165,
                        "componentDefId": 24035,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330166,
                        "componentDefId": 24032,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330167,
                        "componentDefId": 24033,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 16948
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926171,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926172,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926173,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926174,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3926175,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256732,
                        "componentDefId": 24034,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256733,
                        "componentDefId": 24032,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256734,
                        "componentDefId": 24035,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256736,
                        "componentDefId": 24033,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 16948
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926171,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926172,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926173,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926174,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3926175,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256732,
                        "componentDefId": 24034,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256733,
                        "componentDefId": 24032,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256734,
                        "componentDefId": 24035,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256736,
                        "componentDefId": 24033,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 16948
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "HEMBA1",
            "description": "Progenity - Hemophilia B",
            "placeHolderCode": "3634A1P",
            "reportDescriptionIndividual": "<strong>Hemophilia B<\/strong>",
            "reportDescriptionPanel": "<strong>Hemophilia B<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 7,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071670,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071671,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071672,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071673,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071674,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330168,
                        "componentDefId": 24038,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330169,
                        "componentDefId": 24039,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330170,
                        "componentDefId": 24036,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330171,
                        "componentDefId": 24037,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926186,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926187,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926188,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926189,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926190,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256735,
                        "componentDefId": 24038,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256737,
                        "componentDefId": 24039,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256738,
                        "componentDefId": 24036,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256739,
                        "componentDefId": 24037,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926186,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926187,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926188,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926189,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926190,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256735,
                        "componentDefId": 24038,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256737,
                        "componentDefId": 24039,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256738,
                        "componentDefId": 24036,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256739,
                        "componentDefId": 24037,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "MTDPS6A1",
            "description": "Progenity - Hepatocerebral mitochondrial DNA depletion syndrome, MPV17-related ",
            "placeHolderCode": "3635A1P",
            "reportDescriptionIndividual": "<strong>Hepatocerebral mitochondrial DNA depletion syndrome, MPV17-related <\/strong>",
            "reportDescriptionPanel": "<strong>Hepatocerebral mitochondrial DNA depletion syndrome, MPV17-related <\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071675,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071676,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071677,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071678,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071679,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330172,
                        "componentDefId": 24058,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330173,
                        "componentDefId": 24059,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330174,
                        "componentDefId": 24056,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330175,
                        "componentDefId": 24057,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 961
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926196,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926197,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926198,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926199,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926200,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256740,
                        "componentDefId": 24058,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256741,
                        "componentDefId": 24059,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256742,
                        "componentDefId": 24056,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256743,
                        "componentDefId": 24057,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 961
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926196,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926197,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926198,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926199,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926200,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256740,
                        "componentDefId": 24058,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256741,
                        "componentDefId": 24059,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256742,
                        "componentDefId": 24056,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256743,
                        "componentDefId": 24057,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 961
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "HJEBA1",
            "description": "Progenity - Herlitz junctional epidermolysis bullosa, LAMB3-Related",
            "placeHolderCode": "3641A1P",
            "reportDescriptionIndividual": "<strong>Herlitz junctional epidermolysis bullosa, LAMB3-Related<\/strong>",
            "reportDescriptionPanel": "<strong>Herlitz junctional epidermolysis bullosa, LAMB3-Related<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071680,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071681,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071682,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071683,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071684,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330176,
                        "componentDefId": 24062,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330177,
                        "componentDefId": 24063,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330178,
                        "componentDefId": 24060,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330179,
                        "componentDefId": 24061,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926191,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926192,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926193,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926194,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926195,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256744,
                        "componentDefId": 24062,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256745,
                        "componentDefId": 24063,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256746,
                        "componentDefId": 24060,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256747,
                        "componentDefId": 24061,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926191,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926192,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926193,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926194,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926195,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256744,
                        "componentDefId": 24062,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256745,
                        "componentDefId": 24063,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256746,
                        "componentDefId": 24060,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256747,
                        "componentDefId": 24061,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "HPS3A1",
            "description": "Progenity - Hermansky-Pudlak syndrome, type III",
            "placeHolderCode": "3642A1P",
            "reportDescriptionIndividual": "<strong>Hermansky-Pudlak syndrome, type III<\/strong>",
            "reportDescriptionPanel": "<strong>Hermansky-Pudlak syndrome, type III<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071685,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071686,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071687,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071688,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071689,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330180,
                        "componentDefId": 24066,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330181,
                        "componentDefId": 24067,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330182,
                        "componentDefId": 24064,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330183,
                        "componentDefId": 24065,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 339
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926208,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926209,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926210,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926211,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926212,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256748,
                        "componentDefId": 24066,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256749,
                        "componentDefId": 24064,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256750,
                        "componentDefId": 24067,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256751,
                        "componentDefId": 24065,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 339
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926208,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926209,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926210,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926211,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926212,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256748,
                        "componentDefId": 24066,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256749,
                        "componentDefId": 24064,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256750,
                        "componentDefId": 24067,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256751,
                        "componentDefId": 24065,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 339
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "HLCSA1",
            "description": "Progenity - Holocarboxylase synthetase deficiency",
            "placeHolderCode": "3643A1P",
            "reportDescriptionIndividual": "<strong>Holocarboxylase synthetase deficiency<\/strong>",
            "reportDescriptionPanel": "<strong>Holocarboxylase synthetase deficiency<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071690,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071691,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071692,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071693,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071694,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330184,
                        "componentDefId": 24070,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330185,
                        "componentDefId": 24071,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330186,
                        "componentDefId": 24068,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330187,
                        "componentDefId": 24069,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 334
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926218,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926220,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926222,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926224,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926225,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256752,
                        "componentDefId": 24070,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256753,
                        "componentDefId": 24071,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256754,
                        "componentDefId": 24068,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256755,
                        "componentDefId": 24069,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 334
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926218,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926220,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926222,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926224,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926225,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256752,
                        "componentDefId": 24070,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256753,
                        "componentDefId": 24071,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256754,
                        "componentDefId": 24068,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256755,
                        "componentDefId": 24069,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 334
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "HCCBSA1",
            "description": "Progenity - Homocystinuria, CBS-related",
            "placeHolderCode": "3644A1P",
            "reportDescriptionIndividual": "<strong>Homocystinuria, CBS-related<\/strong>",
            "reportDescriptionPanel": "<strong>Homocystinuria, CBS-related<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071695,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071696,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071697,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071698,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071699,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330188,
                        "componentDefId": 24074,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330189,
                        "componentDefId": 24075,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330190,
                        "componentDefId": 24072,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330191,
                        "componentDefId": 24073,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926213,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926214,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926215,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926216,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926217,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256756,
                        "componentDefId": 24074,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256757,
                        "componentDefId": 24075,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256758,
                        "componentDefId": 24072,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256759,
                        "componentDefId": 24073,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926213,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926214,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926215,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926216,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926217,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256756,
                        "componentDefId": 24074,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256757,
                        "componentDefId": 24075,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256758,
                        "componentDefId": 24072,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256759,
                        "componentDefId": 24073,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "HFTCA1",
            "description": "Progenity - Hyperphosphatemic familial tumoral calcinosis",
            "placeHolderCode": "3645A1P",
            "reportDescriptionIndividual": "<strong>Hyperphosphatemic familial tumoral calcinosis<\/strong>",
            "reportDescriptionPanel": "<strong>Hyperphosphatemic familial tumoral calcinosis<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 5,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071700,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071701,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071702,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071703,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071704,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330192,
                        "componentDefId": 24078,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330193,
                        "componentDefId": 24079,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330194,
                        "componentDefId": 24076,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330195,
                        "componentDefId": 24077,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 176
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926226,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926227,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926228,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926229,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926230,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256760,
                        "componentDefId": 24078,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256761,
                        "componentDefId": 24079,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256762,
                        "componentDefId": 24076,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256763,
                        "componentDefId": 24077,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 176
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926226,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926227,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926228,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926229,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926230,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256760,
                        "componentDefId": 24078,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256761,
                        "componentDefId": 24079,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256762,
                        "componentDefId": 24076,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256763,
                        "componentDefId": 24077,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 176
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "ECTD10BA1",
            "description": "Progenity - Hypohidrotic ectodermal dysplasia",
            "placeHolderCode": "3646A1P",
            "reportDescriptionIndividual": "<strong>Hypohidrotic ectodermal dysplasia<\/strong>",
            "reportDescriptionPanel": "<strong>Hypohidrotic ectodermal dysplasia<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071705,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071706,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071707,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071708,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071709,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330196,
                        "componentDefId": 24082,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330197,
                        "componentDefId": 24083,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330198,
                        "componentDefId": 24080,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330199,
                        "componentDefId": 24081,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 243
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926219,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926221,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926223,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926241,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926242,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256764,
                        "componentDefId": 24082,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256765,
                        "componentDefId": 24083,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256766,
                        "componentDefId": 24080,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256767,
                        "componentDefId": 24081,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 187
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071705,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071706,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071707,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071708,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071709,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330196,
                        "componentDefId": 24082,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330197,
                        "componentDefId": 24083,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330198,
                        "componentDefId": 24080,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330199,
                        "componentDefId": 24081,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 243
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "HPTA1",
            "description": "Progenity - Hypophosphatasia, autosomal recessive",
            "placeHolderCode": "3647A1P",
            "reportDescriptionIndividual": "<strong>Hypophosphatasia, autosomal recessive<\/strong>",
            "reportDescriptionPanel": "<strong>Hypophosphatasia, autosomal recessive<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071710,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071711,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071712,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071713,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071714,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330292,
                        "componentDefId": 24090,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330293,
                        "componentDefId": 24091,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330294,
                        "componentDefId": 24088,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330295,
                        "componentDefId": 24089,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926231,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926232,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926233,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926234,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926235,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256768,
                        "componentDefId": 24090,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256769,
                        "componentDefId": 24091,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256770,
                        "componentDefId": 24088,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256771,
                        "componentDefId": 24089,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071710,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071711,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071712,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071713,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071714,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330292,
                        "componentDefId": 24090,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330293,
                        "componentDefId": 24091,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330294,
                        "componentDefId": 24088,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330295,
                        "componentDefId": 24089,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "IC4P100A1",
            "description": "Progenity - Mitochondrial complex IV deficiency",
            "placeHolderCode": "3649A1P",
            "reportDescriptionIndividual": "<strong>Mitochondrial complex IV deficiency<\/strong>",
            "reportDescriptionPanel": "<strong>Mitochondrial complex IV deficiency<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 3,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071715,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071716,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071717,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071718,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071719,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330200,
                        "componentDefId": 24094,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330201,
                        "componentDefId": 24095,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330202,
                        "componentDefId": 24092,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330203,
                        "componentDefId": 24093,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 471
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926236,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926237,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926238,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926239,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926240,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256772,
                        "componentDefId": 24094,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256773,
                        "componentDefId": 24093,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256774,
                        "componentDefId": 24092,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256775,
                        "componentDefId": 24095,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 471
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071715,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071716,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071717,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071718,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071719,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330200,
                        "componentDefId": 24094,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330201,
                        "componentDefId": 24095,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330202,
                        "componentDefId": 24092,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330203,
                        "componentDefId": 24093,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 471
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "IVAA1",
            "description": "Progenity - Isovaleric acidemia",
            "placeHolderCode": "3650A1P",
            "reportDescriptionIndividual": "<strong>Isovaleric acidemia<\/strong>",
            "reportDescriptionPanel": "<strong>Isovaleric acidemia<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071720,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071721,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071722,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071723,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 4071724,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330208,
                        "componentDefId": 24098,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330209,
                        "componentDefId": 24099,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330210,
                        "componentDefId": 24096,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330211,
                        "componentDefId": 24097,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 9146
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926243,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926244,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926245,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926246,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3926247,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256776,
                        "componentDefId": 24098,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256777,
                        "componentDefId": 24099,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256782,
                        "componentDefId": 24096,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256784,
                        "componentDefId": 24097,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 9146
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071720,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071721,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071722,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071723,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 4071724,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330208,
                        "componentDefId": 24098,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330209,
                        "componentDefId": 24099,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330210,
                        "componentDefId": 24096,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330211,
                        "componentDefId": 24097,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 9146
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "RS1A1",
            "description": "Progenity - Juvenile retinoschisis, X-linked",
            "placeHolderCode": "3651A1P",
            "reportDescriptionIndividual": "<strong>Juvenile retinoschisis, X-linked<\/strong>",
            "reportDescriptionPanel": "<strong>Juvenile retinoschisis, X-linked<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 7,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071725,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071726,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071727,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071728,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071729,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330212,
                        "componentDefId": 24102,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330213,
                        "componentDefId": 24103,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330214,
                        "componentDefId": 24100,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330215,
                        "componentDefId": 24101,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 205
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926263,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926264,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926265,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926266,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926267,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256779,
                        "componentDefId": 24101,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256780,
                        "componentDefId": 24102,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256781,
                        "componentDefId": 24100,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256785,
                        "componentDefId": 24103,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 205
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071725,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071726,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071727,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071728,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071729,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330212,
                        "componentDefId": 24102,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330213,
                        "componentDefId": 24103,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330214,
                        "componentDefId": 24100,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330215,
                        "componentDefId": 24101,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 205
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "GCLA1",
            "description": "Progenity - Krabbe disease",
            "placeHolderCode": "3652A1P",
            "reportDescriptionIndividual": "<strong>Krabbe disease<\/strong>",
            "reportDescriptionPanel": "<strong>Krabbe disease<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071730,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071731,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071732,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071733,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071734,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330216,
                        "componentDefId": 24110,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330217,
                        "componentDefId": 24111,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330218,
                        "componentDefId": 24108,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330219,
                        "componentDefId": 24109,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926323,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926324,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926325,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926326,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926327,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256778,
                        "componentDefId": 24110,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256783,
                        "componentDefId": 24111,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256786,
                        "componentDefId": 24109,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256791,
                        "componentDefId": 24108,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071730,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071731,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071732,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071733,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071734,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330216,
                        "componentDefId": 24110,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330217,
                        "componentDefId": 24111,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330218,
                        "componentDefId": 24108,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330219,
                        "componentDefId": 24109,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "LCA5A1",
            "description": "Progenity - Leber congenital amaurosis, LCA5-related",
            "placeHolderCode": "3654A1P",
            "reportDescriptionIndividual": "<strong>Leber congenital amaurosis, LCA5-related<\/strong>",
            "reportDescriptionPanel": "<strong>Leber congenital amaurosis, LCA5-related<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071735,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071736,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071737,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071738,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071739,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330224,
                        "componentDefId": 24114,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330225,
                        "componentDefId": 24115,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330226,
                        "componentDefId": 24112,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330227,
                        "componentDefId": 24113,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926248,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926249,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926250,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926251,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926252,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256787,
                        "componentDefId": 24114,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256788,
                        "componentDefId": 24113,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256789,
                        "componentDefId": 24112,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256790,
                        "componentDefId": 24115,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071735,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071736,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071737,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071738,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071739,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330224,
                        "componentDefId": 24114,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330225,
                        "componentDefId": 24115,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330226,
                        "componentDefId": 24112,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330227,
                        "componentDefId": 24113,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "LRPPRCA1",
            "description": "Progenity - Leigh syndrome, French Canadian",
            "placeHolderCode": "3655A1P",
            "reportDescriptionIndividual": "<strong>Leigh syndrome, French Canadian<\/strong>",
            "reportDescriptionPanel": "<strong>Leigh syndrome, French Canadian<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 3,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071740,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071741,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071742,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071743,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071744,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330240,
                        "componentDefId": 24696,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330241,
                        "componentDefId": 24697,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330242,
                        "componentDefId": 24694,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330243,
                        "componentDefId": 24695,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 243
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926268,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926269,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926270,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926271,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926272,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2243292,
                        "componentDefId": 24697,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2243293,
                        "componentDefId": 24695,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2243295,
                        "componentDefId": 24696,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 2,
                        "amended": false
                    },
                    {
                        "componentResultId": 2243299,
                        "componentDefId": 24694,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 243
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071740,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071741,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071742,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071743,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071744,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330240,
                        "componentDefId": 24696,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330241,
                        "componentDefId": 24697,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330242,
                        "componentDefId": 24694,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330243,
                        "componentDefId": 24695,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 243
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "LGMD2IA2",
            "description": "Progenity - Limb-girdle muscular dystrophy, type 2I",
            "placeHolderCode": "3656A2P",
            "reportDescriptionIndividual": "<strong>Limb-girdle muscular dystrophy, type 2I<\/strong>",
            "reportDescriptionPanel": "<strong>Limb-girdle muscular dystrophy, type 2I<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 7,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-07-11T00:00:00",
            "assayTypeId": 1,
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071745,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071746,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071747,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071748,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071749,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330228,
                        "componentDefId": 24122,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330229,
                        "componentDefId": 24123,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330230,
                        "componentDefId": 24120,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330231,
                        "componentDefId": 24121,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 469
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926273,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926274,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926275,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926276,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926277,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256792,
                        "componentDefId": 24122,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256793,
                        "componentDefId": 24123,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256794,
                        "componentDefId": 24120,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256795,
                        "componentDefId": 24121,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 178
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926273,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926274,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926275,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926276,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926277,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256792,
                        "componentDefId": 24122,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256793,
                        "componentDefId": 24123,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256794,
                        "componentDefId": 24120,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256795,
                        "componentDefId": 24121,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 178
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "LGMD2AA1",
            "description": "Progenity - Limb-girdle muscular dystrophy, type 2A",
            "placeHolderCode": "3657A1P",
            "reportDescriptionIndividual": "<strong>Limb-girdle muscular dystrophy, type 2A<\/strong>",
            "reportDescriptionPanel": "<strong>Limb-girdle muscular dystrophy, type 2A<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 2,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071750,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071751,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071752,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071753,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071754,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330232,
                        "componentDefId": 24130,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330233,
                        "componentDefId": 24131,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330234,
                        "componentDefId": 24128,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330235,
                        "componentDefId": 24129,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 735
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926253,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926254,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926255,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926256,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926257,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256796,
                        "componentDefId": 24130,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256797,
                        "componentDefId": 24131,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256798,
                        "componentDefId": 24128,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256800,
                        "componentDefId": 24129,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 735
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926253,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926254,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926255,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926256,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926257,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256796,
                        "componentDefId": 24130,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256797,
                        "componentDefId": 24131,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256798,
                        "componentDefId": 24128,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256800,
                        "componentDefId": 24129,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 735
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "LGMD2DA1",
            "description": "Progenity - Limb-girdle muscular dystrophy, type 2D",
            "placeHolderCode": "3659A1P",
            "reportDescriptionIndividual": "<strong>Limb-girdle muscular dystrophy, type 2D<\/strong>",
            "reportDescriptionPanel": "<strong>Limb-girdle muscular dystrophy, type 2D<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 3,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071755,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071756,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071757,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071758,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071759,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330236,
                        "componentDefId": 24134,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330237,
                        "componentDefId": 24135,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330238,
                        "componentDefId": 24132,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330239,
                        "componentDefId": 24133,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 666
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926258,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926259,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926260,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926261,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926262,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256799,
                        "componentDefId": 24134,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256801,
                        "componentDefId": 24132,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256802,
                        "componentDefId": 24135,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256803,
                        "componentDefId": 24133,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 666
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926258,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926259,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926260,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926261,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926262,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256799,
                        "componentDefId": 24134,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256801,
                        "componentDefId": 24132,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256802,
                        "componentDefId": 24135,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256803,
                        "componentDefId": 24133,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 666
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "LGMD2EA1",
            "description": "Progenity - Limb-girdle muscular dystrophy, type 2E",
            "placeHolderCode": "3660A1P",
            "reportDescriptionIndividual": "<strong>Limb-girdle muscular dystrophy, type 2E<\/strong>",
            "reportDescriptionPanel": "<strong>Limb-girdle muscular dystrophy, type 2E<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 2,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071760,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071761,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071762,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071763,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071764,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330244,
                        "componentDefId": 24138,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330245,
                        "componentDefId": 24139,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330246,
                        "componentDefId": 24136,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330247,
                        "componentDefId": 24137,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 658
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926278,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926279,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926280,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926281,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926282,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256804,
                        "componentDefId": 24138,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256805,
                        "componentDefId": 24139,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256806,
                        "componentDefId": 24136,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256807,
                        "componentDefId": 24137,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 658
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926278,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926279,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926280,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926281,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926282,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256804,
                        "componentDefId": 24138,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256805,
                        "componentDefId": 24139,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256806,
                        "componentDefId": 24136,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256807,
                        "componentDefId": 24137,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 658
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "LPLDA1",
            "description": "Progenity - Lipoprotein lipase deficiency",
            "placeHolderCode": "3661A1P",
            "reportDescriptionIndividual": "<strong>Lipoprotein lipase deficiency<\/strong>",
            "reportDescriptionPanel": "<strong>Lipoprotein lipase deficiency<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071765,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071766,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071767,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071768,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071769,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330248,
                        "componentDefId": 24142,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330249,
                        "componentDefId": 24143,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330250,
                        "componentDefId": 24140,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330251,
                        "componentDefId": 24141,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 1916
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926313,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926314,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926315,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926316,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926317,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256808,
                        "componentDefId": 24142,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256809,
                        "componentDefId": 24143,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256810,
                        "componentDefId": 24140,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256812,
                        "componentDefId": 24141,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 1916
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926313,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926314,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926315,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926316,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926317,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256808,
                        "componentDefId": 24142,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256809,
                        "componentDefId": 24143,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256810,
                        "componentDefId": 24140,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256812,
                        "componentDefId": 24141,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 1916
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "LCHADA1",
            "description": "Progenity - Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency",
            "placeHolderCode": "3662A1P",
            "reportDescriptionIndividual": "<strong>Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency<\/strong>",
            "reportDescriptionPanel": "<strong>Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 4,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071770,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071771,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071772,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071773,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071774,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330252,
                        "componentDefId": 24146,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330253,
                        "componentDefId": 24147,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330254,
                        "componentDefId": 24144,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330255,
                        "componentDefId": 24145,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926333,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926334,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926335,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926336,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926337,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256811,
                        "componentDefId": 24146,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256813,
                        "componentDefId": 24147,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256814,
                        "componentDefId": 24145,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256815,
                        "componentDefId": 24144,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926333,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926334,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926335,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926336,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926337,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256811,
                        "componentDefId": 24146,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256813,
                        "componentDefId": 24147,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256814,
                        "componentDefId": 24145,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256815,
                        "componentDefId": 24144,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "LHCGRA1",
            "description": "Progenity - Luteinizing hormone resistance",
            "placeHolderCode": "3663A1P",
            "reportDescriptionIndividual": "<strong>Luteinizing hormone resistance<\/strong>",
            "reportDescriptionPanel": "<strong>Luteinizing hormone resistance<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071775,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071776,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071777,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071778,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071779,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330260,
                        "componentDefId": 24150,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330261,
                        "componentDefId": 24151,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330262,
                        "componentDefId": 24148,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330263,
                        "componentDefId": 24149,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 267
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926423,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926424,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926425,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926426,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926427,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256816,
                        "componentDefId": 24150,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256817,
                        "componentDefId": 24151,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256818,
                        "componentDefId": 24148,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256819,
                        "componentDefId": 24149,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 267
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926423,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926424,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926425,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926426,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926427,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256816,
                        "componentDefId": 24150,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256817,
                        "componentDefId": 24151,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256818,
                        "componentDefId": 24148,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256819,
                        "componentDefId": 24149,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 267
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "MSUDIBA1",
            "description": "Progenity - Maple syrup urine disease,type Ib",
            "placeHolderCode": "3664A1P",
            "reportDescriptionIndividual": "<strong>Maple syrup urine disease,\r\ntype Ib<\/strong>",
            "reportDescriptionPanel": "<strong>Maple syrup urine disease,\r\ntype Ib<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071780,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071781,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071782,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071783,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071784,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330264,
                        "componentDefId": 24154,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330265,
                        "componentDefId": 24155,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330266,
                        "componentDefId": 24152,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330267,
                        "componentDefId": 24153,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 245
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926293,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926294,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926295,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926296,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926297,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256820,
                        "componentDefId": 24154,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256821,
                        "componentDefId": 24155,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256822,
                        "componentDefId": 24152,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256823,
                        "componentDefId": 24153,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 68
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926293,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926294,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926295,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926296,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926297,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256820,
                        "componentDefId": 24154,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256821,
                        "componentDefId": 24155,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256822,
                        "componentDefId": 24152,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256823,
                        "componentDefId": 24153,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 68
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "ACADMDA1",
            "description": "Progenity - Medium-chain acyl-CoA dehydrogenase deficiency",
            "placeHolderCode": "3665A1P",
            "reportDescriptionIndividual": "<strong>Medium-chain acyl-CoA dehydrogenase deficiency<\/strong>",
            "reportDescriptionPanel": "<strong>Medium-chain acyl-CoA dehydrogenase deficiency<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 2,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071785,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071786,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071787,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071788,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071789,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330268,
                        "componentDefId": 24158,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330269,
                        "componentDefId": 24159,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330270,
                        "componentDefId": 24156,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330271,
                        "componentDefId": 24157,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926408,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926409,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926410,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926411,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926412,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256824,
                        "componentDefId": 24158,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256825,
                        "componentDefId": 24159,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256837,
                        "componentDefId": 24156,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256838,
                        "componentDefId": 24157,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926408,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926409,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926410,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926411,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926412,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256824,
                        "componentDefId": 24158,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256825,
                        "componentDefId": 24159,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256837,
                        "componentDefId": 24156,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256838,
                        "componentDefId": 24157,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "MEDNIKA1",
            "description": "Progenity - MEDNIK syndrome",
            "placeHolderCode": "3666A1P",
            "reportDescriptionIndividual": "<strong>MEDNIK syndrome<\/strong>",
            "reportDescriptionPanel": "<strong>MEDNIK syndrome<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071790,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071791,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071792,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071793,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071794,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330272,
                        "componentDefId": 24162,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330273,
                        "componentDefId": 24163,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330274,
                        "componentDefId": 24160,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330275,
                        "componentDefId": 24161,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 232
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926418,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926419,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926420,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926421,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926422,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256827,
                        "componentDefId": 24162,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256828,
                        "componentDefId": 24160,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256831,
                        "componentDefId": 24163,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256840,
                        "componentDefId": 24161,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 111
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926418,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926419,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926420,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926421,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926422,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256827,
                        "componentDefId": 24162,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256828,
                        "componentDefId": 24160,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256831,
                        "componentDefId": 24163,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256840,
                        "componentDefId": 24161,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 111
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "ARSAA1",
            "description": "Progenity - Metachromatic leukodystrophy",
            "placeHolderCode": "3667A1P",
            "reportDescriptionIndividual": "<strong>Metachromatic leukodystrophy<\/strong>",
            "reportDescriptionPanel": "<strong>Metachromatic leukodystrophy<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 2,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071795,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071796,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071797,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071798,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071799,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330276,
                        "componentDefId": 24166,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330277,
                        "componentDefId": 24167,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330278,
                        "componentDefId": 24164,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330279,
                        "componentDefId": 24165,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 604
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926403,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926404,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926405,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926406,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926407,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256826,
                        "componentDefId": 24164,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256829,
                        "componentDefId": 24166,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256830,
                        "componentDefId": 24167,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256834,
                        "componentDefId": 24165,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 604
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071795,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071796,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071797,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071798,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071799,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330276,
                        "componentDefId": 24166,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330277,
                        "componentDefId": 24167,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330278,
                        "componentDefId": 24164,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330279,
                        "componentDefId": 24165,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 604
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "MMAAA1",
            "description": "Progenity - Methylmalonic aciduria, cblA type",
            "placeHolderCode": "3668A1P",
            "reportDescriptionIndividual": "<strong>Methylmalonic aciduria, cblA type<\/strong>",
            "reportDescriptionPanel": "<strong>Methylmalonic aciduria, cblA type<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071800,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071801,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071802,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071803,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071804,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330280,
                        "componentDefId": 24170,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330281,
                        "componentDefId": 24171,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330282,
                        "componentDefId": 24168,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330283,
                        "componentDefId": 24169,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 1007
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926298,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926299,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926300,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926301,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926302,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256832,
                        "componentDefId": 24169,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256833,
                        "componentDefId": 24171,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256835,
                        "componentDefId": 24170,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256836,
                        "componentDefId": 24168,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 1007
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071800,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071801,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071802,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071803,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071804,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330280,
                        "componentDefId": 24170,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330281,
                        "componentDefId": 24171,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330282,
                        "componentDefId": 24168,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330283,
                        "componentDefId": 24169,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 1007
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "MMABA1",
            "description": "Progenity - Methylmalonic aciduria, cblB type",
            "placeHolderCode": "3669A1P",
            "reportDescriptionIndividual": "<strong>Methylmalonic aciduria, cblB type<\/strong>",
            "reportDescriptionPanel": "<strong>Methylmalonic aciduria, cblB type<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071805,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071806,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071807,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071808,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071809,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330284,
                        "componentDefId": 24174,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330285,
                        "componentDefId": 24175,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330286,
                        "componentDefId": 24172,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330287,
                        "componentDefId": 24173,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 336
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926303,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926304,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926305,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926306,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926307,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256839,
                        "componentDefId": 24174,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256841,
                        "componentDefId": 24172,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256842,
                        "componentDefId": 24173,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256844,
                        "componentDefId": 24175,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 336
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071805,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071806,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071807,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071808,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071809,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330284,
                        "componentDefId": 24174,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330285,
                        "componentDefId": 24175,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330286,
                        "componentDefId": 24172,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330287,
                        "componentDefId": 24173,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 336
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "MMACA1",
            "description": "Progenity - Methylmalonic aciduria, cblC type",
            "placeHolderCode": "3670A1P",
            "reportDescriptionIndividual": "<strong>Methylmalonic aciduria, cblC type<\/strong>",
            "reportDescriptionPanel": "<strong>Methylmalonic aciduria, cblC type<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 2,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071810,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071811,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071812,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071813,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071814,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330288,
                        "componentDefId": 24178,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330289,
                        "componentDefId": 24179,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330290,
                        "componentDefId": 24176,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330291,
                        "componentDefId": 24177,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 169
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926283,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926284,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926285,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926286,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926287,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256843,
                        "componentDefId": 24178,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256845,
                        "componentDefId": 24179,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256846,
                        "componentDefId": 24177,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256847,
                        "componentDefId": 24176,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 161
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071810,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071811,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071812,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071813,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071814,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330288,
                        "componentDefId": 24178,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330289,
                        "componentDefId": 24179,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330290,
                        "componentDefId": 24176,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330291,
                        "componentDefId": 24177,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 169
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "MMAMA1",
            "description": "Progenity - Methylmalonic aciduria, MUT-related",
            "placeHolderCode": "3671A1P",
            "reportDescriptionIndividual": "<strong>Methylmalonic aciduria, MUT-related<\/strong>",
            "reportDescriptionPanel": "<strong>Methylmalonic aciduria, MUT-related<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 2,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071815,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071816,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071817,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071818,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071819,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330412,
                        "componentDefId": 24182,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330413,
                        "componentDefId": 24183,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330414,
                        "componentDefId": 24180,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330415,
                        "componentDefId": 24181,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926363,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926364,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926365,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926366,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926367,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256848,
                        "componentDefId": 24182,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256849,
                        "componentDefId": 24183,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256850,
                        "componentDefId": 24180,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256851,
                        "componentDefId": 24181,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071815,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071816,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071817,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071818,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071819,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330412,
                        "componentDefId": 24182,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330413,
                        "componentDefId": 24183,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330414,
                        "componentDefId": 24180,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330415,
                        "componentDefId": 24181,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "PCH1AA1",
            "description": "Progenity - Pontocerebellar hypoplasia, type IA",
            "placeHolderCode": "3672A1P",
            "reportDescriptionIndividual": "<strong>Pontocerebellar hypoplasia, type IA<\/strong>",
            "reportDescriptionPanel": "<strong>Pontocerebellar hypoplasia, type IA<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071820,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071821,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071822,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071823,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071824,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330300,
                        "componentDefId": 24186,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330301,
                        "componentDefId": 24187,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330302,
                        "componentDefId": 24184,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330303,
                        "componentDefId": 24185,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926393,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926394,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926395,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926396,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926397,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256852,
                        "componentDefId": 24186,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256853,
                        "componentDefId": 24187,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256854,
                        "componentDefId": 24184,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256855,
                        "componentDefId": 24185,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071820,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071821,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071822,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071823,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071824,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330300,
                        "componentDefId": 24186,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330301,
                        "componentDefId": 24187,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330302,
                        "componentDefId": 24184,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330303,
                        "componentDefId": 24185,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "MLASA1A1",
            "description": "Progenity - Mitochondrial myopathy and sideroblastic anemia 1",
            "placeHolderCode": "3673A1P",
            "reportDescriptionIndividual": "<strong>Mitochondrial myopathy and sideroblastic anemia 1<\/strong>",
            "reportDescriptionPanel": "<strong>Mitochondrial myopathy and sideroblastic anemia 1<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071825,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071826,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071827,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071828,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071829,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330296,
                        "componentDefId": 24190,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330297,
                        "componentDefId": 24191,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330298,
                        "componentDefId": 24188,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330299,
                        "componentDefId": 24189,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 210
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926318,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926319,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926320,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926321,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926322,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256856,
                        "componentDefId": 24190,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256857,
                        "componentDefId": 24191,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256858,
                        "componentDefId": 24189,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256859,
                        "componentDefId": 24188,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 210
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071825,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071826,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071827,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071828,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071829,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330296,
                        "componentDefId": 24190,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330297,
                        "componentDefId": 24191,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330298,
                        "componentDefId": 24188,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330299,
                        "componentDefId": 24189,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 210
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "MLA1",
            "description": "Progenity - Mucolipidosis, type II/III alpha/beta",
            "placeHolderCode": "3674A1P",
            "reportDescriptionIndividual": "<strong>Mucolipidosis, type II/III alpha/beta<\/strong>",
            "reportDescriptionPanel": "<strong>Mucolipidosis, type II/III alpha/beta<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071830,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071831,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071832,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071833,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 4071834,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330312,
                        "componentDefId": 24194,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330313,
                        "componentDefId": 24195,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330314,
                        "componentDefId": 24192,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330315,
                        "componentDefId": 24193,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 231214
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926308,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926309,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926310,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926311,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3926312,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256860,
                        "componentDefId": 24194,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256861,
                        "componentDefId": 24195,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256862,
                        "componentDefId": 24192,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256863,
                        "componentDefId": 24193,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 231214
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926308,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926309,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926310,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926311,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3926312,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256860,
                        "componentDefId": 24194,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256861,
                        "componentDefId": 24195,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256862,
                        "componentDefId": 24192,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256863,
                        "componentDefId": 24193,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 231214
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "MPS2A1",
            "description": "Progenity - Mucopolysaccharidosis, type II (Hunter syndrome)",
            "placeHolderCode": "3675A1P",
            "reportDescriptionIndividual": "<strong>Mucopolysaccharidosis, type II (Hunter syndrome)<\/strong>",
            "reportDescriptionPanel": "<strong>Mucopolysaccharidosis, type II (Hunter syndrome)<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 10,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071835,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071836,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071837,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071838,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071839,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330316,
                        "componentDefId": 24198,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330317,
                        "componentDefId": 24199,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330318,
                        "componentDefId": 24196,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330319,
                        "componentDefId": 24197,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926288,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926289,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926290,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926291,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926292,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256864,
                        "componentDefId": 24198,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256865,
                        "componentDefId": 24199,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256866,
                        "componentDefId": 24196,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256867,
                        "componentDefId": 24197,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926288,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926289,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926290,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926291,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926292,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256864,
                        "componentDefId": 24198,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256865,
                        "componentDefId": 24199,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256866,
                        "componentDefId": 24196,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256867,
                        "componentDefId": 24197,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "MPS3CA1",
            "description": "Progenity - Mucopolysaccharidosis, type IIIC",
            "placeHolderCode": "3676A1P",
            "reportDescriptionIndividual": "<strong>Mucopolysaccharidosis, type\nIIIC<\/strong>",
            "reportDescriptionPanel": "<strong>Mucopolysaccharidosis, type\nIIIC<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 17,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071840,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071841,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071842,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071843,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071844,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330320,
                        "componentDefId": 24202,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330321,
                        "componentDefId": 24203,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330322,
                        "componentDefId": 24200,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330323,
                        "componentDefId": 24201,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 291
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926358,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926359,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926360,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926361,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926362,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256868,
                        "componentDefId": 24202,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256869,
                        "componentDefId": 24203,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256870,
                        "componentDefId": 24200,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256871,
                        "componentDefId": 24201,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 291
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926358,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926359,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926360,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926361,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926362,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256868,
                        "componentDefId": 24202,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256869,
                        "componentDefId": 24203,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256870,
                        "componentDefId": 24200,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256871,
                        "componentDefId": 24201,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 291
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "MPS6A1",
            "description": "Progenity - Mucopolysaccharidosis, type VI",
            "placeHolderCode": "3677A1P",
            "reportDescriptionIndividual": "<strong>Mucopolysaccharidosis, type VI<\/strong>",
            "reportDescriptionPanel": "<strong>Mucopolysaccharidosis, type VI<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 23,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071845,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071846,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071847,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071848,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071849,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330308,
                        "componentDefId": 24206,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330309,
                        "componentDefId": 24207,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330310,
                        "componentDefId": 24204,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330311,
                        "componentDefId": 24205,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 176
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926413,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926414,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926415,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926416,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926417,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256872,
                        "componentDefId": 24206,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256873,
                        "componentDefId": 24207,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256874,
                        "componentDefId": 24204,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256875,
                        "componentDefId": 24205,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 176
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926413,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926414,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926415,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926416,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926417,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256872,
                        "componentDefId": 24206,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256873,
                        "componentDefId": 24207,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256874,
                        "componentDefId": 24204,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256875,
                        "componentDefId": 24205,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 176
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "MPSIHA1",
            "description": "Progenity - Mucopolysaccharidosis, type I (Hurler syndrome)",
            "placeHolderCode": "3678A1P",
            "reportDescriptionIndividual": "<strong>Mucopolysaccharidosis, type I (Hurler syndrome)<\/strong>",
            "reportDescriptionPanel": "<strong>Mucopolysaccharidosis, type I (Hurler syndrome)<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 13,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071850,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071851,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071852,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071853,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071854,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330324,
                        "componentDefId": 24210,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330325,
                        "componentDefId": 24211,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330326,
                        "componentDefId": 24208,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330327,
                        "componentDefId": 24209,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926398,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926399,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926400,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926401,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926402,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256876,
                        "componentDefId": 24210,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256877,
                        "componentDefId": 24211,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256878,
                        "componentDefId": 24208,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256880,
                        "componentDefId": 24209,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926398,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926399,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926400,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926401,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926402,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256876,
                        "componentDefId": 24210,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256877,
                        "componentDefId": 24211,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256878,
                        "componentDefId": 24208,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256880,
                        "componentDefId": 24209,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "MLBEA1",
            "description": "Progenity - Mulibrey nanism",
            "placeHolderCode": "3679A1P",
            "reportDescriptionIndividual": "<strong>Mulibrey nanism<\/strong>",
            "reportDescriptionPanel": "<strong>Mulibrey nanism<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071855,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071856,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071857,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071858,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071859,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330328,
                        "componentDefId": 24214,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330329,
                        "componentDefId": 24215,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330330,
                        "componentDefId": 24212,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330331,
                        "componentDefId": 24213,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926378,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926379,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926380,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926381,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926382,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256879,
                        "componentDefId": 24214,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256882,
                        "componentDefId": 24212,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256883,
                        "componentDefId": 24213,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256885,
                        "componentDefId": 24215,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926378,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926379,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926380,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926381,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926382,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256879,
                        "componentDefId": 24214,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256882,
                        "componentDefId": 24212,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256883,
                        "componentDefId": 24213,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256885,
                        "componentDefId": 24215,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "MSDA1",
            "description": "Progenity - Multiple sulfatase deficiency",
            "placeHolderCode": "3680A1P",
            "reportDescriptionIndividual": "<strong>Multiple sulfatase deficiency<\/strong>",
            "reportDescriptionPanel": "<strong>Multiple sulfatase deficiency<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 2,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071860,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071861,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071862,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071863,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071864,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330332,
                        "componentDefId": 24218,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330333,
                        "componentDefId": 24219,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330334,
                        "componentDefId": 24216,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330335,
                        "componentDefId": 24217,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926328,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926329,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926330,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926331,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926332,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256881,
                        "componentDefId": 24218,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256884,
                        "componentDefId": 24219,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256886,
                        "componentDefId": 24217,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256891,
                        "componentDefId": 24216,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926328,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926329,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926330,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926331,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926332,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256881,
                        "componentDefId": 24218,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256884,
                        "componentDefId": 24219,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256886,
                        "componentDefId": 24217,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256891,
                        "componentDefId": 24216,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "MDDGA1A1",
            "description": "Progenity - Muscle-eye-brain disease",
            "placeHolderCode": "3681A1P",
            "reportDescriptionIndividual": "<strong>Muscle-eye-brain disease<\/strong>",
            "reportDescriptionPanel": "<strong>Muscle-eye-brain disease<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071865,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071866,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071867,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071868,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 4071869,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330336,
                        "componentDefId": 24222,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330337,
                        "componentDefId": 24223,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330338,
                        "componentDefId": 24220,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330339,
                        "componentDefId": 24221,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 33333
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926434,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926435,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926438,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926441,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3926442,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256887,
                        "componentDefId": 24222,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256889,
                        "componentDefId": 24220,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256890,
                        "componentDefId": 24223,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256892,
                        "componentDefId": 24221,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 33333
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071865,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071866,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071867,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071868,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 4071869,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330336,
                        "componentDefId": 24222,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330337,
                        "componentDefId": 24223,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330338,
                        "componentDefId": 24220,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330339,
                        "componentDefId": 24221,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 33333
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "XLMTMA1",
            "description": "Progenity - Myotubular myopathy, MTM1-related",
            "placeHolderCode": "3682A1P",
            "reportDescriptionIndividual": "<strong>Myotubular myopathy, MTM1-related<\/strong>",
            "reportDescriptionPanel": "<strong>Myotubular myopathy, MTM1-related<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 3,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071870,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071871,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071872,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071873,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071874,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330344,
                        "componentDefId": 24226,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330345,
                        "componentDefId": 24227,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330346,
                        "componentDefId": 24224,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330347,
                        "componentDefId": 24225,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926428,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926436,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926437,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926439,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926440,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256888,
                        "componentDefId": 24226,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256893,
                        "componentDefId": 24227,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256894,
                        "componentDefId": 24224,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256895,
                        "componentDefId": 24225,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071870,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071871,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071872,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071873,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071874,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330344,
                        "componentDefId": 24226,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330345,
                        "componentDefId": 24227,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330346,
                        "componentDefId": 24224,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330347,
                        "componentDefId": 24225,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "NPHS1A1",
            "description": "Progenity - Nephrotic syndrome, type I",
            "placeHolderCode": "3683A1P",
            "reportDescriptionIndividual": "<strong>Nephrotic syndrome, type I<\/strong>",
            "reportDescriptionPanel": "<strong>Nephrotic syndrome, type I<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071875,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071876,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071877,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071878,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071879,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330348,
                        "componentDefId": 24230,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330349,
                        "componentDefId": 24231,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330350,
                        "componentDefId": 24228,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330351,
                        "componentDefId": 24229,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 176
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926388,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926389,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926390,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926391,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926392,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256896,
                        "componentDefId": 24230,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256897,
                        "componentDefId": 24231,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256898,
                        "componentDefId": 24228,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256899,
                        "componentDefId": 24229,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 176
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071875,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071876,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071877,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071878,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071879,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330348,
                        "componentDefId": 24230,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330349,
                        "componentDefId": 24231,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330350,
                        "componentDefId": 24228,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330351,
                        "componentDefId": 24229,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 176
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "CLN5A1",
            "description": "Progenity - Neuronal ceroid lipofuscinosis, CLN5-related",
            "placeHolderCode": "3684A1P",
            "reportDescriptionIndividual": "<strong>Neuronal ceroid lipofuscinosis, CLN5-related<\/strong>",
            "reportDescriptionPanel": "<strong>Neuronal ceroid lipofuscinosis, CLN5-related<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071880,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071881,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071882,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071883,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071884,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330352,
                        "componentDefId": 24234,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330353,
                        "componentDefId": 24235,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330354,
                        "componentDefId": 24232,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330355,
                        "componentDefId": 24233,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 176
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926353,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926354,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926355,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926356,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926357,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256900,
                        "componentDefId": 24234,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256901,
                        "componentDefId": 24235,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256902,
                        "componentDefId": 24233,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256903,
                        "componentDefId": 24232,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 176
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071880,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071881,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071882,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071883,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071884,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330352,
                        "componentDefId": 24234,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330353,
                        "componentDefId": 24235,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330354,
                        "componentDefId": 24232,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330355,
                        "componentDefId": 24233,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 176
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "CLN6A1",
            "description": "Progenity - Neuronal ceroid lipofuscinosis, CLN6-related",
            "placeHolderCode": "3685A1P",
            "reportDescriptionIndividual": "<strong>Neuronal ceroid lipofuscinosis, CLN6-related<\/strong>",
            "reportDescriptionPanel": "<strong>Neuronal ceroid lipofuscinosis, CLN6-related<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071885,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071886,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071887,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071888,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071889,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330356,
                        "componentDefId": 24238,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330357,
                        "componentDefId": 24239,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330358,
                        "componentDefId": 24236,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330359,
                        "componentDefId": 24237,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 176
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926338,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926339,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926340,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926341,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926342,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256904,
                        "componentDefId": 24238,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256905,
                        "componentDefId": 24239,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256906,
                        "componentDefId": 24236,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256907,
                        "componentDefId": 24237,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 176
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071885,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071886,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071887,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071888,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071889,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330356,
                        "componentDefId": 24238,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330357,
                        "componentDefId": 24239,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330358,
                        "componentDefId": 24236,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330359,
                        "componentDefId": 24237,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 176
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "CLN8A1",
            "description": "Progenity - Neuronal ceroid lipofuscinosis, CLN8-related",
            "placeHolderCode": "3686A1P",
            "reportDescriptionIndividual": "<strong>Neuronal ceroid lipofuscinosis, CLN8-related<\/strong>",
            "reportDescriptionPanel": "<strong>Neuronal ceroid lipofuscinosis, CLN8-related<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071890,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071891,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071892,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071893,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071894,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330360,
                        "componentDefId": 24242,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330361,
                        "componentDefId": 24243,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330362,
                        "componentDefId": 24240,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330363,
                        "componentDefId": 24241,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 437
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926348,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926349,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926350,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926351,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926352,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256908,
                        "componentDefId": 24242,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256909,
                        "componentDefId": 24243,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256910,
                        "componentDefId": 24240,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256911,
                        "componentDefId": 24241,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 437
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071890,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071891,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071892,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071893,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071894,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330360,
                        "componentDefId": 24242,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330361,
                        "componentDefId": 24243,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330362,
                        "componentDefId": 24240,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330363,
                        "componentDefId": 24241,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 437
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "CLN1A1",
            "description": "Progenity - Neuronal ceroid lipofuscinosis, PPT1-related",
            "placeHolderCode": "3687A1P",
            "reportDescriptionIndividual": "<strong>Neuronal ceroid lipofuscinosis, PPT1-related<\/strong>",
            "reportDescriptionPanel": "<strong>Neuronal ceroid lipofuscinosis, PPT1-related<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071895,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071896,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071897,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071898,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071899,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330364,
                        "componentDefId": 24246,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330365,
                        "componentDefId": 24247,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330366,
                        "componentDefId": 24244,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330367,
                        "componentDefId": 24245,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 335
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926373,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926374,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926375,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926376,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926377,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256912,
                        "componentDefId": 24246,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256913,
                        "componentDefId": 24247,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256914,
                        "componentDefId": 24244,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256915,
                        "componentDefId": 24245,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 335
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071895,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071896,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071897,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071898,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071899,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330364,
                        "componentDefId": 24246,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330365,
                        "componentDefId": 24247,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330366,
                        "componentDefId": 24244,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330367,
                        "componentDefId": 24245,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 335
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "CLN2A1",
            "description": "Progenity - Neuronal ceroid lipofuscinosis, TPP1-related",
            "placeHolderCode": "3688A1P",
            "reportDescriptionIndividual": "<strong>Neuronal ceroid lipofuscinosis, TPP1-related<\/strong>",
            "reportDescriptionPanel": "<strong>Neuronal ceroid lipofuscinosis, TPP1-related<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071900,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071901,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071902,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071903,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071904,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330368,
                        "componentDefId": 24250,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330369,
                        "componentDefId": 24251,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330370,
                        "componentDefId": 24248,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330371,
                        "componentDefId": 24249,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 176
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926343,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926344,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926345,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926346,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926347,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256916,
                        "componentDefId": 24250,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256917,
                        "componentDefId": 24251,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256918,
                        "componentDefId": 24248,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256919,
                        "componentDefId": 24249,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 176
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071900,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071901,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071902,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071903,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071904,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330368,
                        "componentDefId": 24250,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330369,
                        "componentDefId": 24251,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330370,
                        "componentDefId": 24248,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330371,
                        "componentDefId": 24249,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 176
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "CLN7A1",
            "description": "Progenity - Neuronal ceroid-lipofuscinosis, MFSD8-related",
            "placeHolderCode": "3689A1P",
            "reportDescriptionIndividual": "<strong>Neuronal ceroid-lipofuscinosis, MFSD8-related<\/strong>",
            "reportDescriptionPanel": "<strong>Neuronal ceroid-lipofuscinosis, MFSD8-related<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071905,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071906,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071907,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071908,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071909,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330380,
                        "componentDefId": 24254,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330381,
                        "componentDefId": 24255,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330382,
                        "componentDefId": 24252,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330383,
                        "componentDefId": 24253,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926383,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926384,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926385,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926386,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926387,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256920,
                        "componentDefId": 24254,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256921,
                        "componentDefId": 24255,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256922,
                        "componentDefId": 24252,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256923,
                        "componentDefId": 24253,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926383,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926384,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926385,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926386,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926387,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256920,
                        "componentDefId": 24254,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256921,
                        "componentDefId": 24255,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256922,
                        "componentDefId": 24252,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256923,
                        "componentDefId": 24253,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "NPC2A1",
            "description": "Progenity - Niemann-Pick disease, type CII",
            "placeHolderCode": "3690A1P",
            "reportDescriptionIndividual": "<strong>Niemann-Pick disease, type CII<\/strong>",
            "reportDescriptionPanel": "<strong>Niemann-Pick disease, type CII<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071910,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071911,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071912,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071913,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071914,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330376,
                        "componentDefId": 24258,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330377,
                        "componentDefId": 24259,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330378,
                        "componentDefId": 24256,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330379,
                        "componentDefId": 24257,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 249
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926368,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926369,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926370,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926371,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926372,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256924,
                        "componentDefId": 24258,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256925,
                        "componentDefId": 24259,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256926,
                        "componentDefId": 24256,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256927,
                        "componentDefId": 24257,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 249
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926368,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926369,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926370,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926371,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926372,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256924,
                        "componentDefId": 24258,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256925,
                        "componentDefId": 24259,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256926,
                        "componentDefId": 24256,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256927,
                        "componentDefId": 24257,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 249
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "NPC1A1",
            "description": "Progenity - Niemann-Pick disease, type C1",
            "placeHolderCode": "3691A1P",
            "reportDescriptionIndividual": "<strong>Niemann-Pick disease, type C1<\/strong>",
            "reportDescriptionPanel": "<strong>Niemann-Pick disease, type C1<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 2,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071915,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071916,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071917,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071918,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071919,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330384,
                        "componentDefId": 24262,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330385,
                        "componentDefId": 24263,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330386,
                        "componentDefId": 24260,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330387,
                        "componentDefId": 24261,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 524
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926429,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926430,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926431,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926432,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926433,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256928,
                        "componentDefId": 24262,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256929,
                        "componentDefId": 24263,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256930,
                        "componentDefId": 24260,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256931,
                        "componentDefId": 24261,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 524
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926429,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926430,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926431,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926432,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926433,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256928,
                        "componentDefId": 24262,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256929,
                        "componentDefId": 24263,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256930,
                        "componentDefId": 24260,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256931,
                        "componentDefId": 24261,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 524
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "NBSA1",
            "description": "Progenity - Nijmegen breakage syndrome",
            "placeHolderCode": "3692A1P",
            "reportDescriptionIndividual": "<strong>Nijmegen breakage syndrome<\/strong>",
            "reportDescriptionPanel": "<strong>Nijmegen breakage syndrome<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071920,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071921,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071922,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071923,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071924,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330388,
                        "componentDefId": 24266,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330389,
                        "componentDefId": 24267,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330390,
                        "componentDefId": 24264,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330391,
                        "componentDefId": 24265,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 147
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926453,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926454,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926455,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926456,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926457,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256932,
                        "componentDefId": 24266,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256933,
                        "componentDefId": 24267,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256934,
                        "componentDefId": 24264,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256935,
                        "componentDefId": 24265,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 47
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926453,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926454,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926455,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926456,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926457,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256932,
                        "componentDefId": 24266,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256933,
                        "componentDefId": 24267,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256934,
                        "componentDefId": 24264,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256935,
                        "componentDefId": 24265,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 47
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "DFNB1AA1",
            "description": "Progenity - Nonsyndromic hearing loss, GJB2-related ",
            "placeHolderCode": "3693A1P",
            "reportDescriptionIndividual": "<strong>Nonsyndromic hearing loss, GJB2-related <\/strong>",
            "reportDescriptionPanel": "<strong>Nonsyndromic hearing loss, GJB2-related <\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071925,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071926,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071927,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071928,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071929,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330392,
                        "componentDefId": 24270,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330393,
                        "componentDefId": 24271,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330394,
                        "componentDefId": 24268,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330395,
                        "componentDefId": 24269,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926443,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926444,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926445,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926446,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926447,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256936,
                        "componentDefId": 24270,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256937,
                        "componentDefId": 24271,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256938,
                        "componentDefId": 24268,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256939,
                        "componentDefId": 24269,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926443,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926444,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926445,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926446,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926447,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256936,
                        "componentDefId": 24270,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256937,
                        "componentDefId": 24271,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256938,
                        "componentDefId": 24268,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256939,
                        "componentDefId": 24269,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "DCLRE1CA1",
            "description": "Progenity - Omenn syndrome ",
            "placeHolderCode": "3694A1P",
            "reportDescriptionIndividual": "<strong>Omenn syndrome <\/strong>",
            "reportDescriptionPanel": "<strong>Omenn syndrome <\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071930,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071931,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071932,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071933,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 4071934,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330396,
                        "componentDefId": 24274,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330397,
                        "componentDefId": 24275,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330398,
                        "componentDefId": 24272,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330399,
                        "componentDefId": 24273,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 44444
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926448,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926449,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926450,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926451,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3926452,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256940,
                        "componentDefId": 24275,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256941,
                        "componentDefId": 24274,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256942,
                        "componentDefId": 24272,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256943,
                        "componentDefId": 24273,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 44444
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926448,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926449,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926450,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926451,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3926452,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256940,
                        "componentDefId": 24275,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256941,
                        "componentDefId": 24274,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256942,
                        "componentDefId": 24272,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256943,
                        "componentDefId": 24273,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 44444
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "OTCA1",
            "description": "Progenity - Ornithine transcarbamylase deficiency",
            "placeHolderCode": "3695A1P",
            "reportDescriptionIndividual": "<strong>Ornithine transcarbamylase\ndeficiency<\/strong>",
            "reportDescriptionPanel": "<strong>Ornithine transcarbamylase\ndeficiency<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 15,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071935,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071936,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071937,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071938,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071939,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330400,
                        "componentDefId": 24278,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330401,
                        "componentDefId": 24279,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330402,
                        "componentDefId": 24276,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330403,
                        "componentDefId": 24277,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926474,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926475,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926476,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926477,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926478,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256944,
                        "componentDefId": 24278,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256945,
                        "componentDefId": 24276,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256946,
                        "componentDefId": 24279,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256949,
                        "componentDefId": 24277,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071935,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071936,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071937,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071938,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071939,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330400,
                        "componentDefId": 24278,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330401,
                        "componentDefId": 24279,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330402,
                        "componentDefId": 24276,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330403,
                        "componentDefId": 24277,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "HHHA1",
            "description": "Progenity - Ornithine translocase deficiency",
            "placeHolderCode": "3696A1P",
            "reportDescriptionIndividual": "<strong>Ornithine translocase deficiency<\/strong>",
            "reportDescriptionPanel": "<strong>Ornithine translocase deficiency<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071940,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071941,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071942,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071943,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071944,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330404,
                        "componentDefId": 24282,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330405,
                        "componentDefId": 24283,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330406,
                        "componentDefId": 24280,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330407,
                        "componentDefId": 24281,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 999
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926479,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926480,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926481,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926482,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926483,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256947,
                        "componentDefId": 24282,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256948,
                        "componentDefId": 24283,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256950,
                        "componentDefId": 24280,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256951,
                        "componentDefId": 24281,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071940,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071941,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071942,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071943,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071944,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330404,
                        "componentDefId": 24282,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330405,
                        "componentDefId": 24283,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330406,
                        "componentDefId": 24280,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330407,
                        "componentDefId": 24281,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 999
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "PDSA1",
            "description": "Progenity - Pendred syndrome ",
            "placeHolderCode": "3697A1P",
            "reportDescriptionIndividual": "<strong>Pendred syndrome <\/strong>",
            "reportDescriptionPanel": "<strong>Pendred syndrome <\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071212,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071213,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071214,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071215,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071216,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329835,
                        "componentDefId": 24290,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329836,
                        "componentDefId": 24291,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329837,
                        "componentDefId": 24288,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329838,
                        "componentDefId": 24289,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 86
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926494,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926495,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926496,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926497,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926498,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256956,
                        "componentDefId": 24290,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256957,
                        "componentDefId": 24288,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256958,
                        "componentDefId": 24291,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256959,
                        "componentDefId": 24289,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 86
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071212,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071213,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071214,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071215,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071216,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329835,
                        "componentDefId": 24290,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329836,
                        "componentDefId": 24291,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329837,
                        "componentDefId": 24288,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329838,
                        "componentDefId": 24289,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 86
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "PCKDA1",
            "description": "Progenity - Autosomal recessive polycystic kidney disease",
            "placeHolderCode": "3699A1P",
            "reportDescriptionIndividual": "<strong>Autosomal recessive polycystic kidney disease<\/strong>",
            "reportDescriptionPanel": "<strong>Autosomal recessive polycystic kidney disease<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 3,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071217,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071218,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071219,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071220,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071221,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329831,
                        "componentDefId": 24294,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329832,
                        "componentDefId": 24295,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329833,
                        "componentDefId": 24292,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329834,
                        "componentDefId": 24293,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 1783
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926484,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926485,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926486,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926487,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926488,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256960,
                        "componentDefId": 24294,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256961,
                        "componentDefId": 24295,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256962,
                        "componentDefId": 24292,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256963,
                        "componentDefId": 24293,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 1783
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071217,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071218,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071219,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071220,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071221,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329831,
                        "componentDefId": 24294,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329832,
                        "componentDefId": 24295,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329833,
                        "componentDefId": 24292,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329834,
                        "componentDefId": 24293,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 1783
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "PAS1A1",
            "description": "Progenity - Autoimmune polyglandular syndrome, type 1",
            "placeHolderCode": "3700A1P",
            "reportDescriptionIndividual": "<strong>Autoimmune polyglandular syndrome, type 1 <\/strong>",
            "reportDescriptionPanel": "<strong>Autoimmune polyglandular syndrome, type 1 <\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 3,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071950,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071951,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071952,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071953,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071954,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330416,
                        "componentDefId": 24298,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330417,
                        "componentDefId": 24299,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330418,
                        "componentDefId": 24296,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330419,
                        "componentDefId": 24297,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 40
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926499,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926500,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926501,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926502,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926503,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256964,
                        "componentDefId": 24298,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256965,
                        "componentDefId": 24299,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256966,
                        "componentDefId": 24296,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256967,
                        "componentDefId": 24297,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 40
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071950,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071951,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071952,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071953,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071954,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330416,
                        "componentDefId": 24298,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330417,
                        "componentDefId": 24299,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330418,
                        "componentDefId": 24296,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330419,
                        "componentDefId": 24297,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 40
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "GLC3AA1",
            "description": "Progenity - Primary congenital glaucoma",
            "placeHolderCode": "3701A1P",
            "reportDescriptionIndividual": "<strong>Primary congenital glaucoma<\/strong>",
            "reportDescriptionPanel": "<strong>Primary congenital glaucoma<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071955,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071956,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071957,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071958,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071959,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330420,
                        "componentDefId": 24302,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330421,
                        "componentDefId": 24303,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330422,
                        "componentDefId": 24300,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330423,
                        "componentDefId": 24301,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 191
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926504,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926505,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926506,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926507,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926508,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256968,
                        "componentDefId": 24302,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256969,
                        "componentDefId": 24303,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256970,
                        "componentDefId": 24300,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256971,
                        "componentDefId": 24301,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 191
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071955,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071956,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071957,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071958,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071959,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330420,
                        "componentDefId": 24302,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330421,
                        "componentDefId": 24303,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330422,
                        "componentDefId": 24300,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330423,
                        "componentDefId": 24301,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 191
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "HP1A1",
            "description": "Progenity - Primary hyperoxaluria, type I",
            "placeHolderCode": "3702A1P",
            "reportDescriptionIndividual": "<strong>Primary hyperoxaluria, type I<\/strong>",
            "reportDescriptionPanel": "<strong>Primary hyperoxaluria, type I<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 2,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071960,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071961,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071962,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071963,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071964,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330424,
                        "componentDefId": 24306,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330425,
                        "componentDefId": 24307,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330426,
                        "componentDefId": 24304,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330427,
                        "componentDefId": 24305,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 793
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926489,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926490,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926491,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926492,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926493,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256972,
                        "componentDefId": 24306,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256973,
                        "componentDefId": 24307,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256974,
                        "componentDefId": 24304,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256975,
                        "componentDefId": 24305,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071960,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071961,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071962,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071963,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071964,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330424,
                        "componentDefId": 24306,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330425,
                        "componentDefId": 24307,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330426,
                        "componentDefId": 24304,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330427,
                        "componentDefId": 24305,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 793
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "HP2A1",
            "description": "Progenity - Primary hyperoxaluria, type II",
            "placeHolderCode": "3703A1P",
            "reportDescriptionIndividual": "<strong>Primary hyperoxaluria, type II<\/strong>",
            "reportDescriptionPanel": "<strong>Primary hyperoxaluria, type II<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 2,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071965,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071966,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071967,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071968,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071969,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330428,
                        "componentDefId": 24310,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330429,
                        "componentDefId": 24311,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330430,
                        "componentDefId": 24308,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330431,
                        "componentDefId": 24309,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 176
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926514,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926515,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926516,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926517,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926518,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256976,
                        "componentDefId": 24311,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256977,
                        "componentDefId": 24310,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256978,
                        "componentDefId": 24308,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256981,
                        "componentDefId": 24309,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 176
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926514,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926515,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926516,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926517,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926518,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256976,
                        "componentDefId": 24311,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256977,
                        "componentDefId": 24310,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256978,
                        "componentDefId": 24308,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256981,
                        "componentDefId": 24309,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 176
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "PFIC2A1",
            "description": "Progenity - Progressive familial intrahepatic cholestasis, type II",
            "placeHolderCode": "3704A1P",
            "reportDescriptionIndividual": "<strong>Progressive familial intrahepatic cholestasis, type II<\/strong>",
            "reportDescriptionPanel": "<strong>Progressive familial intrahepatic cholestasis, type II<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071970,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071971,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071972,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071973,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071974,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330432,
                        "componentDefId": 24314,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330433,
                        "componentDefId": 24315,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330434,
                        "componentDefId": 24312,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330435,
                        "componentDefId": 24313,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926519,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926520,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926521,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926522,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926523,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256979,
                        "componentDefId": 24314,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256980,
                        "componentDefId": 24315,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256982,
                        "componentDefId": 24312,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256983,
                        "componentDefId": 24313,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926519,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926520,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926521,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926522,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926523,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256979,
                        "componentDefId": 24314,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256980,
                        "componentDefId": 24315,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256982,
                        "componentDefId": 24312,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256983,
                        "componentDefId": 24313,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "PEPDA1",
            "description": "Progenity - Prolidase deficiency",
            "placeHolderCode": "3705A1P",
            "reportDescriptionIndividual": "<strong>Prolidase deficiency<\/strong>",
            "reportDescriptionPanel": "<strong>Prolidase deficiency<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 6,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071975,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071976,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071977,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071978,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071979,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330436,
                        "componentDefId": 24318,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330437,
                        "componentDefId": 24319,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330438,
                        "componentDefId": 24316,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330439,
                        "componentDefId": 24317,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 124
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926524,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926525,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926526,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926527,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926528,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256984,
                        "componentDefId": 24318,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256985,
                        "componentDefId": 24319,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256986,
                        "componentDefId": 24316,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256987,
                        "componentDefId": 24317,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 124
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926524,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926525,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926526,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926527,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926528,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256984,
                        "componentDefId": 24318,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256985,
                        "componentDefId": 24319,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256986,
                        "componentDefId": 24316,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256987,
                        "componentDefId": 24317,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 124
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "PCCAA1",
            "description": "Progenity - Propionic acidemia, PCCA-related",
            "placeHolderCode": "3706A1P",
            "reportDescriptionIndividual": "<strong>Propionic acidemia, PCCA-related<\/strong>",
            "reportDescriptionPanel": "<strong>Propionic acidemia, PCCA-related<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071980,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071981,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071982,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071983,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071984,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330440,
                        "componentDefId": 24322,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330441,
                        "componentDefId": 24323,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330442,
                        "componentDefId": 24320,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330443,
                        "componentDefId": 24321,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 160
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926509,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926510,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926511,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926512,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926513,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256988,
                        "componentDefId": 24322,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256989,
                        "componentDefId": 24323,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256990,
                        "componentDefId": 24320,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256991,
                        "componentDefId": 24321,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 124
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926509,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926510,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926511,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926512,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926513,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256988,
                        "componentDefId": 24322,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256989,
                        "componentDefId": 24323,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256990,
                        "componentDefId": 24320,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256991,
                        "componentDefId": 24321,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 124
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "PCCBA1",
            "description": "Progenity - Propionic acidemia, PCCB-related",
            "placeHolderCode": "3707A1P",
            "reportDescriptionIndividual": "<strong>Propionic acidemia, PCCB-related<\/strong>",
            "reportDescriptionPanel": "<strong>Propionic acidemia, PCCB-related<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071985,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071986,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071987,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071988,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071989,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330444,
                        "componentDefId": 24330,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330445,
                        "componentDefId": 24331,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330446,
                        "componentDefId": 24328,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330447,
                        "componentDefId": 24329,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 166
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926559,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926560,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926561,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926562,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926563,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256992,
                        "componentDefId": 24330,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256993,
                        "componentDefId": 24331,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256994,
                        "componentDefId": 24328,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256996,
                        "componentDefId": 24329,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 166
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926559,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926560,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926561,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926562,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926563,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256992,
                        "componentDefId": 24330,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256993,
                        "componentDefId": 24331,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256994,
                        "componentDefId": 24328,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256996,
                        "componentDefId": 24329,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 166
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "PXEA1",
            "description": "Progenity - Pseudoxanthoma elasticum",
            "placeHolderCode": "3709A1P",
            "reportDescriptionIndividual": "<strong>Pseudoxanthoma elasticum<\/strong>",
            "reportDescriptionPanel": "<strong>Pseudoxanthoma elasticum<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071990,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071991,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071992,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071993,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071994,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330448,
                        "componentDefId": 24334,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330449,
                        "componentDefId": 24335,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330450,
                        "componentDefId": 24332,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330451,
                        "componentDefId": 24333,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926549,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926550,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926551,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926552,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926553,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257002,
                        "componentDefId": 24333,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257003,
                        "componentDefId": 24334,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257004,
                        "componentDefId": 24335,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257007,
                        "componentDefId": 24332,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926549,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926550,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926551,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926552,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926553,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257002,
                        "componentDefId": 24333,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257003,
                        "componentDefId": 24334,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257004,
                        "componentDefId": 24335,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257007,
                        "componentDefId": 24332,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "PKNDA1",
            "description": "Progenity - Pycnodysostosis",
            "placeHolderCode": "3710A1P",
            "reportDescriptionIndividual": "<strong>Pycnodysostosis<\/strong>",
            "reportDescriptionPanel": "<strong>Pycnodysostosis<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071995,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071996,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071997,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071998,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071999,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330452,
                        "componentDefId": 24338,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330453,
                        "componentDefId": 24339,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330454,
                        "componentDefId": 24336,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330455,
                        "componentDefId": 24337,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 861
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926554,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926555,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926556,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926557,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926558,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256997,
                        "componentDefId": 24336,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256999,
                        "componentDefId": 24338,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257000,
                        "componentDefId": 24337,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257005,
                        "componentDefId": 24339,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 861
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926554,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926555,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926556,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926557,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926558,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256997,
                        "componentDefId": 24336,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256999,
                        "componentDefId": 24338,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257000,
                        "componentDefId": 24337,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257005,
                        "componentDefId": 24339,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 861
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "PDHBA1",
            "description": "Progenity - Pyruvate dehydrogenase deficiency, autosomal recessive",
            "placeHolderCode": "3711A1P",
            "reportDescriptionIndividual": "<strong>Pyruvate dehydrogenase deficiency, autosomal recessive<\/strong>",
            "reportDescriptionPanel": "<strong>Pyruvate dehydrogenase deficiency, autosomal recessive<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072000,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072001,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072002,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072003,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 4072004,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330456,
                        "componentDefId": 24342,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330457,
                        "componentDefId": 24343,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330458,
                        "componentDefId": 24340,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330459,
                        "componentDefId": 24341,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 581
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926529,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926530,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926531,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926532,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3926533,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256995,
                        "componentDefId": 24343,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256998,
                        "componentDefId": 24340,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257006,
                        "componentDefId": 24342,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257008,
                        "componentDefId": 24341,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 581
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926529,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926530,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926531,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926532,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3926533,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256995,
                        "componentDefId": 24343,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256998,
                        "componentDefId": 24340,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257006,
                        "componentDefId": 24342,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257008,
                        "componentDefId": 24341,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 581
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "PDHA1A1",
            "description": "Progenity - Pyruvate dehydrogenase deficiency, X-Linked",
            "placeHolderCode": "3712A1P",
            "reportDescriptionIndividual": "<strong>Pyruvate dehydrogenase deficiency, X-Linked<\/strong>",
            "reportDescriptionPanel": "<strong>Pyruvate dehydrogenase deficiency, X-Linked<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 13,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072005,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072006,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072007,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072008,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072009,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330460,
                        "componentDefId": 24346,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330461,
                        "componentDefId": 24347,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330462,
                        "componentDefId": 24344,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330463,
                        "componentDefId": 24345,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926539,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926540,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926541,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926542,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926543,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257001,
                        "componentDefId": 24347,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257009,
                        "componentDefId": 24346,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257010,
                        "componentDefId": 24344,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257011,
                        "componentDefId": 24345,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072005,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072006,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072007,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072008,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072009,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330460,
                        "componentDefId": 24346,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330461,
                        "componentDefId": 24347,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330462,
                        "componentDefId": 24344,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330463,
                        "componentDefId": 24345,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "RP59A1",
            "description": "Progenity - Retinitis pigmentosa 59",
            "placeHolderCode": "3713A1P",
            "reportDescriptionIndividual": "<strong>Retinitis pigmentosa 59<\/strong>",
            "reportDescriptionPanel": "<strong>Retinitis pigmentosa 59<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072010,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072011,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072012,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072013,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072014,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330464,
                        "componentDefId": 24350,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330465,
                        "componentDefId": 24351,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330466,
                        "componentDefId": 24348,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330467,
                        "componentDefId": 24349,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 305
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926544,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926545,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926546,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926547,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926548,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257012,
                        "componentDefId": 24351,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257013,
                        "componentDefId": 24350,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257014,
                        "componentDefId": 24348,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257015,
                        "componentDefId": 24349,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 167
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072010,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072011,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072012,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072013,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072014,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330464,
                        "componentDefId": 24350,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330465,
                        "componentDefId": 24351,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330466,
                        "componentDefId": 24348,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330467,
                        "componentDefId": 24349,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 305
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "RCDP1A1",
            "description": "Progenity - Rhizomelic chondrodysplasia punctata, type I",
            "placeHolderCode": "3714A1P",
            "reportDescriptionIndividual": "<strong>Rhizomelic chondrodysplasia punctata, type I<\/strong>",
            "reportDescriptionPanel": "<strong>Rhizomelic chondrodysplasia punctata, type I<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072015,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072016,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072017,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072018,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072019,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330468,
                        "componentDefId": 24354,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330469,
                        "componentDefId": 24355,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330470,
                        "componentDefId": 24352,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330471,
                        "componentDefId": 24353,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926534,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926535,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926536,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926537,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926538,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257016,
                        "componentDefId": 24354,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257017,
                        "componentDefId": 24355,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257018,
                        "componentDefId": 24352,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257020,
                        "componentDefId": 24353,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072015,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072016,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072017,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072018,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072019,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330468,
                        "componentDefId": 24354,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330469,
                        "componentDefId": 24355,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330470,
                        "componentDefId": 24352,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330471,
                        "componentDefId": 24353,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "SDA1",
            "description": "Progenity - Salla disease",
            "placeHolderCode": "3715A1P",
            "reportDescriptionIndividual": "<strong>Salla disease<\/strong>",
            "reportDescriptionPanel": "<strong>Salla disease<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072020,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072021,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072022,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072023,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072024,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330472,
                        "componentDefId": 24358,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330473,
                        "componentDefId": 24359,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330474,
                        "componentDefId": 24356,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330475,
                        "componentDefId": 24357,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 253
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926654,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926655,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926656,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926657,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926658,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257019,
                        "componentDefId": 24358,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257021,
                        "componentDefId": 24356,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257022,
                        "componentDefId": 24359,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257023,
                        "componentDefId": 24357,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072020,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072021,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072022,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072023,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072024,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330472,
                        "componentDefId": 24358,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330473,
                        "componentDefId": 24359,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330474,
                        "componentDefId": 24356,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330475,
                        "componentDefId": 24357,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 253
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "HEXBA1",
            "description": "Progenity - Sandhoff disease",
            "placeHolderCode": "3716A1P",
            "reportDescriptionIndividual": "<strong>Sandhoff disease<\/strong>",
            "reportDescriptionPanel": "<strong>Sandhoff disease<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072025,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072026,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072027,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072028,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072029,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330476,
                        "componentDefId": 24362,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330477,
                        "componentDefId": 24363,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330478,
                        "componentDefId": 24360,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330479,
                        "componentDefId": 24361,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 1022
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926574,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926575,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926576,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926577,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926578,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257024,
                        "componentDefId": 24362,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257025,
                        "componentDefId": 24363,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257026,
                        "componentDefId": 24360,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257028,
                        "componentDefId": 24361,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 1022
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072025,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072026,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072027,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072028,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072029,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330476,
                        "componentDefId": 24362,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330477,
                        "componentDefId": 24363,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330478,
                        "componentDefId": 24360,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330479,
                        "componentDefId": 24361,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 1022
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "RAG1A1",
            "description": "Progenity - Severe combined immunodeficiency, RAG1-related",
            "placeHolderCode": "3718A1P",
            "reportDescriptionIndividual": "<strong>Severe combined immunodeficiency, RAG1-related<\/strong>",
            "reportDescriptionPanel": "<strong>Severe combined immunodeficiency, RAG1-related<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072030,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072031,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072032,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072033,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 4072034,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330480,
                        "componentDefId": 24366,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330481,
                        "componentDefId": 24367,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330482,
                        "componentDefId": 24364,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330483,
                        "componentDefId": 24365,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 28248
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926564,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926565,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926566,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926567,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3926568,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257027,
                        "componentDefId": 24366,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257029,
                        "componentDefId": 24367,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257030,
                        "componentDefId": 24364,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257031,
                        "componentDefId": 24365,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 28248
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926564,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926565,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926566,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926567,
                        "description": "Inheritance X-Linked",
                        "longText": "X-Linked"
                    },
                    {
                        "globalTextId": 3926568,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257027,
                        "componentDefId": 24366,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257029,
                        "componentDefId": 24367,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257030,
                        "componentDefId": 24364,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257031,
                        "componentDefId": 24365,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 28248
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "SCIDX1A1",
            "description": "Progenity - Severe combinedimmunodeficiency, X-linked",
            "placeHolderCode": "3719A1P",
            "reportDescriptionIndividual": "<strong>Severe combined immunodeficiency, X-linked<\/strong>",
            "reportDescriptionPanel": "<strong>Severe combined immunodeficiency, X-linked<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 5,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072035,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072036,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072037,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072038,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072039,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330484,
                        "componentDefId": 24370,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330485,
                        "componentDefId": 24371,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330486,
                        "componentDefId": 24368,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330487,
                        "componentDefId": 24369,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 104
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926694,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926695,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926696,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926697,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926698,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257032,
                        "componentDefId": 24370,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257033,
                        "componentDefId": 24371,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257034,
                        "componentDefId": 24368,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257035,
                        "componentDefId": 24369,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 104
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926694,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926695,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926696,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926697,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926698,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257032,
                        "componentDefId": 24370,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257033,
                        "componentDefId": 24371,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257034,
                        "componentDefId": 24368,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257035,
                        "componentDefId": 24369,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 104
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "SCADA1",
            "description": "Progenity - Short-chain acyl-CoA dehydrogenase deficiency ",
            "placeHolderCode": "3720A1P",
            "reportDescriptionIndividual": "<strong>Short-chain acyl-CoA dehydrogenase deficiency <\/strong>",
            "reportDescriptionPanel": "<strong>Short-chain acyl-CoA dehydrogenase deficiency <\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 3,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072040,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072041,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072042,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072043,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072044,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330488,
                        "componentDefId": 24374,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330489,
                        "componentDefId": 24375,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330490,
                        "componentDefId": 24372,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330491,
                        "componentDefId": 24373,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 199
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926649,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926650,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926651,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926652,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926653,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257036,
                        "componentDefId": 24374,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257037,
                        "componentDefId": 24375,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257038,
                        "componentDefId": 24372,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257039,
                        "componentDefId": 24373,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 199
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926649,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926650,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926651,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926652,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926653,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257036,
                        "componentDefId": 24374,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257037,
                        "componentDefId": 24375,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257038,
                        "componentDefId": 24372,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257039,
                        "componentDefId": 24373,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 199
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "SDSA1",
            "description": "Progenity - Shwachman-Diamond syndrome ",
            "placeHolderCode": "3721A1P",
            "reportDescriptionIndividual": "<strong>Shwachman-Diamond syndrome <\/strong>",
            "reportDescriptionPanel": "<strong>Shwachman-Diamond syndrome <\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072045,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072046,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072047,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072048,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072049,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330492,
                        "componentDefId": 24378,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330493,
                        "componentDefId": 24379,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330494,
                        "componentDefId": 24376,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330495,
                        "componentDefId": 24377,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 781
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926569,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926570,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926571,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926572,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926573,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257040,
                        "componentDefId": 24378,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257041,
                        "componentDefId": 24379,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257042,
                        "componentDefId": 24377,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257044,
                        "componentDefId": 24376,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926569,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926570,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926571,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926572,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926573,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257040,
                        "componentDefId": 24378,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257041,
                        "componentDefId": 24379,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257042,
                        "componentDefId": 24377,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257044,
                        "componentDefId": 24376,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "SLSA1",
            "description": "Progenity - Sjgren-Larsson syndrome ",
            "placeHolderCode": "3722A1P",
            "reportDescriptionIndividual": "<strong>Sjgren-Larsson syndrome <\/strong>",
            "reportDescriptionPanel": "<strong>Sjgren-Larsson syndrome <\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072050,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072051,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072052,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072053,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 4072054,
                        "description": "GCS V4 Global + Additional Info",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-global-102016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global 102016. Original report is on file and available upon request.<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330496,
                        "componentDefId": 24649,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330497,
                        "componentDefId": 24650,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330498,
                        "componentDefId": 24647,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330499,
                        "componentDefId": 24648,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 120
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926594,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926595,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926596,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926597,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 3926598,
                        "description": "GCS V4 Global + Additional Info",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-global-042016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global 042016. Original report is on file and available upon request.<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257043,
                        "componentDefId": 24649,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257045,
                        "componentDefId": 24650,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257047,
                        "componentDefId": 24648,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257048,
                        "componentDefId": 24647,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 120
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926594,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926595,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926596,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926597,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 3926598,
                        "description": "GCS V4 Global + Additional Info",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-global-042016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global 042016. Original report is on file and available upon request.<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257043,
                        "componentDefId": 24649,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257045,
                        "componentDefId": 24650,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257047,
                        "componentDefId": 24648,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257048,
                        "componentDefId": 24647,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 120
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "SLOSA3",
            "description": "Progenity - Smith-Lemli-Opitz syndrome V3",
            "placeHolderCode": "3723A3P",
            "reportDescriptionIndividual": "<strong>Smith-Lemli-Opitz syndrome <\/strong>",
            "reportDescriptionPanel": "<strong>Smith-Lemli-Opitz syndrome <\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 4,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": true,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072055,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072056,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072057,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072058,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072059,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330500,
                        "componentDefId": 24386,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330501,
                        "componentDefId": 24387,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330502,
                        "componentDefId": 24384,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330503,
                        "componentDefId": 24385,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926584,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926585,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926586,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926587,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926588,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257046,
                        "componentDefId": 24386,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257049,
                        "componentDefId": 24387,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257050,
                        "componentDefId": 24385,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257052,
                        "componentDefId": 24384,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926584,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926585,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926586,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926587,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926588,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257046,
                        "componentDefId": 24386,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257049,
                        "componentDefId": 24387,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257050,
                        "componentDefId": 24385,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257052,
                        "componentDefId": 24384,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "SACSA1",
            "description": "Progenity - Spastic ataxia of Charlevoix-Saguenay, autosomal recessive",
            "placeHolderCode": "3724A1P",
            "reportDescriptionIndividual": "<strong>Spastic ataxia of Charlevoix-Saguenay, autosomal recessive<\/strong>",
            "reportDescriptionPanel": "<strong>Spastic ataxia of Charlevoix-Saguenay, autosomal recessive<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072060,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072061,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072062,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072063,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072064,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330220,
                        "componentDefId": 24390,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330221,
                        "componentDefId": 24391,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330222,
                        "componentDefId": 24388,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330223,
                        "componentDefId": 24389,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 694
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926664,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926665,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926666,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926667,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926668,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257051,
                        "componentDefId": 24390,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257053,
                        "componentDefId": 24391,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257054,
                        "componentDefId": 24388,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257055,
                        "componentDefId": 24389,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 694
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072060,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072061,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072062,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072063,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072064,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330220,
                        "componentDefId": 24390,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330221,
                        "componentDefId": 24391,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330222,
                        "componentDefId": 24388,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330223,
                        "componentDefId": 24389,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 694
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "RDH12A1",
            "description": "Progenity - Leber congenital amaurosis, RDH12 related",
            "placeHolderCode": "3725A1P",
            "reportDescriptionIndividual": "<strong>Leber congenital amaurosis, RDH12 related<\/strong>",
            "reportDescriptionPanel": "<strong>Leber congenital amaurosis, RDH12 related<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 3,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072065,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072066,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072067,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072068,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072069,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330506,
                        "componentDefId": 24398,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330507,
                        "componentDefId": 24399,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330508,
                        "componentDefId": 24396,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330509,
                        "componentDefId": 24397,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 908
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926624,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926625,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926626,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926627,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926628,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257056,
                        "componentDefId": 24398,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257057,
                        "componentDefId": 24399,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257058,
                        "componentDefId": 24396,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257059,
                        "componentDefId": 24397,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 908
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072065,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072066,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072067,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072068,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072069,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330506,
                        "componentDefId": 24398,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330507,
                        "componentDefId": 24399,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330508,
                        "componentDefId": 24396,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330509,
                        "componentDefId": 24397,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 908
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "NPHS2A1",
            "description": "Progenity - Steroid-resistant nephrotic syndrome",
            "placeHolderCode": "3727A1P",
            "reportDescriptionIndividual": "<strong>Steroid-resistant nephrotic syndrome<\/strong>",
            "reportDescriptionPanel": "<strong>Steroid-resistant nephrotic syndrome<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 8,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072070,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072071,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072072,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072073,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072074,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330510,
                        "componentDefId": 24402,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330511,
                        "componentDefId": 24403,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330512,
                        "componentDefId": 24400,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330513,
                        "componentDefId": 24401,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926634,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926635,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926636,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926637,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926638,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257060,
                        "componentDefId": 24402,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257061,
                        "componentDefId": 24403,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257062,
                        "componentDefId": 24400,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257063,
                        "componentDefId": 24401,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072070,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072071,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072072,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072073,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072074,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330510,
                        "componentDefId": 24402,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330511,
                        "componentDefId": 24403,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330512,
                        "componentDefId": 24400,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330513,
                        "componentDefId": 24401,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "SWSA1",
            "description": "Progenity - Stuve-Wiedemann syndrome",
            "placeHolderCode": "3728A1P",
            "reportDescriptionIndividual": "<strong>Stuve-Wiedemann syndrome<\/strong>",
            "reportDescriptionPanel": "<strong>Stuve-Wiedemann syndrome<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072075,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072076,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072077,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072078,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072079,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330514,
                        "componentDefId": 24406,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330515,
                        "componentDefId": 24407,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330516,
                        "componentDefId": 24404,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330517,
                        "componentDefId": 24405,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 331
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926684,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926685,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926686,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926692,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926693,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257064,
                        "componentDefId": 24406,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257065,
                        "componentDefId": 24407,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257066,
                        "componentDefId": 24404,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257067,
                        "componentDefId": 24405,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 331
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072075,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072076,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072077,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072078,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072079,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330514,
                        "componentDefId": 24406,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330515,
                        "componentDefId": 24407,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330516,
                        "componentDefId": 24404,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330517,
                        "componentDefId": 24405,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 331
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "STROCA1",
            "description": "Progenity - Sulfate transporter-related osteochondrodysplasia",
            "placeHolderCode": "3729A1P",
            "reportDescriptionIndividual": "<strong>Sulfate transporter-related osteochondrodysplasia<\/strong>",
            "reportDescriptionPanel": "<strong>Sulfate transporter-related osteochondrodysplasia<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072080,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072081,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072082,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072083,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072084,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330537,
                        "componentDefId": 24410,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330538,
                        "componentDefId": 24411,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330539,
                        "componentDefId": 24408,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330540,
                        "componentDefId": 24409,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 135
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926579,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926580,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926581,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926582,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926583,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257068,
                        "componentDefId": 24410,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257069,
                        "componentDefId": 24411,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257070,
                        "componentDefId": 24408,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257071,
                        "componentDefId": 24409,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 135
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072080,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072081,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072082,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072083,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072084,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330537,
                        "componentDefId": 24410,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330538,
                        "componentDefId": 24411,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330539,
                        "componentDefId": 24408,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330540,
                        "componentDefId": 24409,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 135
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "TYRSN1A1",
            "description": "Progenity - Tyrosinemia, type I",
            "placeHolderCode": "3730A1P",
            "reportDescriptionIndividual": "<strong>Tyrosinemia, type I<\/strong>",
            "reportDescriptionPanel": "<strong>Tyrosinemia, type I<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072085,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072086,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072087,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072088,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072089,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330541,
                        "componentDefId": 24414,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330542,
                        "componentDefId": 24415,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330543,
                        "componentDefId": 24412,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330544,
                        "componentDefId": 24413,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 189
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926639,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926640,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926641,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926642,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926643,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257072,
                        "componentDefId": 24414,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257073,
                        "componentDefId": 24413,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257075,
                        "componentDefId": 24412,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257076,
                        "componentDefId": 24415,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 189
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072085,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072086,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072087,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072088,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072089,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330541,
                        "componentDefId": 24414,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330542,
                        "componentDefId": 24415,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330543,
                        "componentDefId": 24412,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330544,
                        "componentDefId": 24413,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 189
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "USH1BA1",
            "description": "Progenity - Usher syndrome, type IB",
            "placeHolderCode": "3731A1P",
            "reportDescriptionIndividual": "<strong>Usher syndrome, type IB<\/strong>",
            "reportDescriptionPanel": "<strong>Usher syndrome, type IB<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072090,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072091,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072092,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072093,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072094,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330545,
                        "componentDefId": 24418,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330546,
                        "componentDefId": 24419,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330547,
                        "componentDefId": 24416,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330548,
                        "componentDefId": 24417,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 444
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926589,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926590,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926591,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926592,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926593,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257074,
                        "componentDefId": 24418,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257077,
                        "componentDefId": 24419,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257078,
                        "componentDefId": 24416,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257079,
                        "componentDefId": 24417,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 444
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926589,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926590,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926591,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926592,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926593,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257074,
                        "componentDefId": 24418,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257077,
                        "componentDefId": 24419,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257078,
                        "componentDefId": 24416,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257079,
                        "componentDefId": 24417,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 444
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "USH1CA1",
            "description": "Progenity - Usher syndrome, type IC ",
            "placeHolderCode": "3732A1P",
            "reportDescriptionIndividual": "<strong>Usher syndrome, type IC <\/strong>",
            "reportDescriptionPanel": "<strong>Usher syndrome, type IC <\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072095,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072096,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072097,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072098,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072099,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330549,
                        "componentDefId": 24422,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330550,
                        "componentDefId": 24423,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330551,
                        "componentDefId": 24420,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330552,
                        "componentDefId": 24421,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 278
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926679,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926680,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926681,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926682,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926683,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257080,
                        "componentDefId": 24422,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257081,
                        "componentDefId": 24423,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257082,
                        "componentDefId": 24420,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257083,
                        "componentDefId": 24421,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 278
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926679,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926680,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926681,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926682,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926683,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257080,
                        "componentDefId": 24422,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257081,
                        "componentDefId": 24423,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257082,
                        "componentDefId": 24420,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257083,
                        "componentDefId": 24421,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 278
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "USH1DA1",
            "description": "Progenity - Usher syndrome, type ID",
            "placeHolderCode": "3733A1P",
            "reportDescriptionIndividual": "<strong>Usher syndrome, type ID<\/strong>",
            "reportDescriptionPanel": "<strong>Usher syndrome, type ID<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072100,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072101,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072102,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072103,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072104,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330561,
                        "componentDefId": 24426,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330562,
                        "componentDefId": 24427,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330563,
                        "componentDefId": 24424,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330564,
                        "componentDefId": 24425,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 97
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926604,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926605,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926606,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926607,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926608,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257084,
                        "componentDefId": 24426,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257085,
                        "componentDefId": 24427,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257086,
                        "componentDefId": 24425,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257087,
                        "componentDefId": 24424,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 97
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926604,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926605,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926606,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926607,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926608,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257084,
                        "componentDefId": 24426,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257085,
                        "componentDefId": 24427,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257086,
                        "componentDefId": 24425,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257087,
                        "componentDefId": 24424,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 97
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "ACADVLDA1",
            "description": "Progenity - Very long-chain acyl-CoA dehydrogenase deficiency",
            "placeHolderCode": "3734A1P",
            "reportDescriptionIndividual": "<strong>Very long-chain acyl-CoA dehydrogenase deficiency<\/strong>",
            "reportDescriptionPanel": "<strong>Very long-chain acyl-CoA dehydrogenase deficiency<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 4,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072105,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072106,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072107,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072108,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072109,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330565,
                        "componentDefId": 24430,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330566,
                        "componentDefId": 24431,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330567,
                        "componentDefId": 24428,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330568,
                        "componentDefId": 24429,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 55
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926699,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926700,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926701,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926702,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926703,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257088,
                        "componentDefId": 24430,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257091,
                        "componentDefId": 24428,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257094,
                        "componentDefId": 24431,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257098,
                        "componentDefId": 24429,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 55
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926699,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926700,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926701,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926702,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926703,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257088,
                        "componentDefId": 24430,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257091,
                        "componentDefId": 24428,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257094,
                        "componentDefId": 24431,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257098,
                        "componentDefId": 24429,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 55
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "VDDR1AA1",
            "description": "Progenity - Vitamin D-dependent rickets, type I",
            "placeHolderCode": "3735A1P",
            "reportDescriptionIndividual": "<strong>Vitamin D-dependent rickets, type I<\/strong>",
            "reportDescriptionPanel": "<strong>Vitamin D-dependent rickets, type I<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 1,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072110,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072111,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072112,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072113,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072114,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330573,
                        "componentDefId": 24434,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330574,
                        "componentDefId": 24435,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330575,
                        "componentDefId": 24432,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330576,
                        "componentDefId": 24433,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 149
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926709,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926710,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926711,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926712,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926713,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257089,
                        "componentDefId": 24434,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257090,
                        "componentDefId": 24432,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257093,
                        "componentDefId": 24433,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257095,
                        "componentDefId": 24435,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 149
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926709,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926710,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926711,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3926712,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926713,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257089,
                        "componentDefId": 24434,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257090,
                        "componentDefId": 24432,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257093,
                        "componentDefId": 24433,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257095,
                        "componentDefId": 24435,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 149
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "WDA1",
            "description": "Progenity - Wilson disease",
            "placeHolderCode": "3736A1P",
            "reportDescriptionIndividual": "<strong>Wilson disease<\/strong>",
            "reportDescriptionPanel": "<strong>Wilson disease<\/strong>",
            "isPanel": false,
            "externalReport": false,
            "active": true,
            "concurrencyId": 0,
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072115,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072116,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072117,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072118,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 4072119,
                        "description": "GCS V4 Global + Additional Info",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-global-102016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global 102016. Original report is on file and available upon request.<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330577,
                        "componentDefId": 24653,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330578,
                        "componentDefId": 24654,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330579,
                        "componentDefId": 24651,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330580,
                        "componentDefId": 24652,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 333
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3926613,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3926615,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926617,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926619,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 3926621,
                        "description": "GCS V4 Global + Additional Info",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-global-042016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global 042016. Original report is on file and available upon request.<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2257092,
                        "componentDefId": 24654,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257096,
                        "componentDefId": 24651,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257099,
                        "componentDefId": 24652,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2257100,
                        "componentDefId": 24653,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 333
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072115,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4072116,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072117,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072118,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 4072119,
                        "description": "GCS V4 Global + Additional Info",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-global-102016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global 102016. Original report is on file and available upon request.<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330577,
                        "componentDefId": 24653,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330578,
                        "componentDefId": 24654,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330579,
                        "componentDefId": 24651,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330580,
                        "componentDefId": 24652,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 333
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "PBD1AA2",
            "description": "Progenity - Zellweger syndrome spectrum, PEX6-related",
            "placeHolderCode": "3739A2P",
            "reportDescriptionIndividual": "<strong>Zellweger syndrome spectrum, PEX6-related<\/strong>",
            "reportDescriptionPanel": "<strong>Zellweger syndrome spectrum, PEX6-related<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 5,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071227,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071228,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071229,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071230,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071231,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329871,
                        "componentDefId": 24483,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329872,
                        "componentDefId": 24500,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329873,
                        "componentDefId": 24449,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329874,
                        "componentDefId": 24466,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925562,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925563,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925564,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925565,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925566,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256263,
                        "componentDefId": 24500,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256265,
                        "componentDefId": 24483,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256266,
                        "componentDefId": 24449,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256268,
                        "componentDefId": 24466,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071227,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071228,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071229,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071230,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071231,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329871,
                        "componentDefId": 24483,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329872,
                        "componentDefId": 24500,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329873,
                        "componentDefId": 24449,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329874,
                        "componentDefId": 24466,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "BLMA3",
            "description": "Progenity - Bloom syndrome",
            "placeHolderCode": "2101A3P",
            "reportDescriptionIndividual": "<strong>Bloom syndrome<\/strong>",
            "reportDescriptionPanel": "<strong>Bloom syndrome<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 2,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071232,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071233,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071234,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071235,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071236,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329875,
                        "componentDefId": 24484,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329876,
                        "componentDefId": 24501,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329877,
                        "componentDefId": 24450,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329878,
                        "componentDefId": 24467,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 328
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925551,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 3925550,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925544,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925543,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925542,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256267,
                        "componentDefId": 24484,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256269,
                        "componentDefId": 24501,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256270,
                        "componentDefId": 24450,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256271,
                        "componentDefId": 24467,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 328
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071232,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071233,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071234,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071235,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071236,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329875,
                        "componentDefId": 24484,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329876,
                        "componentDefId": 24501,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329877,
                        "componentDefId": 24450,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329878,
                        "componentDefId": 24467,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 328
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "ASPAA3",
            "description": "Progenity - Canavan disease",
            "placeHolderCode": "2102A3P",
            "reportDescriptionIndividual": "<strong>Canavan disease<\/strong>",
            "reportDescriptionPanel": "<strong>Canavan disease<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 3,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071237,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071238,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071239,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071240,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071241,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330072,
                        "componentDefId": 24485,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330073,
                        "componentDefId": 24502,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330074,
                        "componentDefId": 24451,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330075,
                        "componentDefId": 24468,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 279
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925600,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925601,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925602,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925603,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925604,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256272,
                        "componentDefId": 24485,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256273,
                        "componentDefId": 24502,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256274,
                        "componentDefId": 24451,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256275,
                        "componentDefId": 24468,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 279
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071237,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071238,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071239,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071240,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071241,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330072,
                        "componentDefId": 24485,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330073,
                        "componentDefId": 24502,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330074,
                        "componentDefId": 24451,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330075,
                        "componentDefId": 24468,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 279
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "GBAA3",
            "description": "Progenity - Gaucher disease",
            "placeHolderCode": "2103A3P",
            "reportDescriptionIndividual": "<strong>Gaucher disease<\/strong>",
            "reportDescriptionPanel": "<strong>Gaucher disease<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 7,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071242,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071243,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071244,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071245,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071246,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330027,
                        "componentDefId": 24486,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330028,
                        "componentDefId": 24503,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330029,
                        "componentDefId": 24452,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330030,
                        "componentDefId": 24469,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925549,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 3925548,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925547,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925546,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925545,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256276,
                        "componentDefId": 24486,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256277,
                        "componentDefId": 24503,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256278,
                        "componentDefId": 24452,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256279,
                        "componentDefId": 24469,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071242,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071243,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071244,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071245,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071246,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330027,
                        "componentDefId": 24486,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330028,
                        "componentDefId": 24503,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330029,
                        "componentDefId": 24452,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330030,
                        "componentDefId": 24469,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "IKAPA3",
            "description": "Progenity - Familial dysautonomia",
            "placeHolderCode": "2104A3P",
            "reportDescriptionIndividual": "<strong>Familial dysautonomia\n<\/strong>",
            "reportDescriptionPanel": "<strong>Familial dysautonomia\n<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 4,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071247,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071248,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071249,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071250,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071251,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330043,
                        "componentDefId": 24487,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330044,
                        "componentDefId": 24504,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330045,
                        "componentDefId": 24453,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330046,
                        "componentDefId": 24470,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 878
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925556,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 3925555,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925554,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925553,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925552,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256280,
                        "componentDefId": 24487,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256281,
                        "componentDefId": 24504,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256282,
                        "componentDefId": 24453,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256283,
                        "componentDefId": 24470,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 878
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071247,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071248,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071249,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071250,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071251,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330043,
                        "componentDefId": 24487,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330044,
                        "componentDefId": 24504,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330045,
                        "componentDefId": 24453,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330046,
                        "componentDefId": 24470,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 878
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "FANCCA3",
            "description": "Progenity - Fanconi anemia type C",
            "placeHolderCode": "2105A3P",
            "reportDescriptionIndividual": "<strong>Fanconi anemia type C<\/strong>",
            "reportDescriptionPanel": "<strong>Fanconi anemia type C<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 5,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071252,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071253,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071254,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071255,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071256,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330304,
                        "componentDefId": 24488,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330305,
                        "componentDefId": 24505,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330306,
                        "componentDefId": 24454,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330307,
                        "componentDefId": 24471,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925582,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925583,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925584,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925585,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925586,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256284,
                        "componentDefId": 24488,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256285,
                        "componentDefId": 24505,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256286,
                        "componentDefId": 24454,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256287,
                        "componentDefId": 24471,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925582,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925583,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925584,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925585,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925586,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256284,
                        "componentDefId": 24488,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256285,
                        "componentDefId": 24505,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256286,
                        "componentDefId": 24454,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256287,
                        "componentDefId": 24471,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "MLP4A3",
            "description": "Progenity - Mucolipidosis type IV",
            "placeHolderCode": "2106A3P",
            "reportDescriptionIndividual": "<strong>Mucolipidosis type IV<\/strong>",
            "reportDescriptionPanel": "<strong>Mucolipidosis type IV<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 3,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071257,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071258,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071259,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071260,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071261,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330372,
                        "componentDefId": 24489,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330373,
                        "componentDefId": 24506,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330374,
                        "componentDefId": 24455,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330375,
                        "componentDefId": 24472,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 312
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925567,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925568,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925569,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925570,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925571,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256288,
                        "componentDefId": 24489,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256289,
                        "componentDefId": 24506,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256290,
                        "componentDefId": 24455,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256295,
                        "componentDefId": 24472,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925567,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925568,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925569,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925570,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925571,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256288,
                        "componentDefId": 24489,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256289,
                        "componentDefId": 24506,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256290,
                        "componentDefId": 24455,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256295,
                        "componentDefId": 24472,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "NPABA3",
            "description": "Progenity - Niemann-Pick disease, type A and B",
            "placeHolderCode": "2107A3P",
            "reportDescriptionIndividual": "<strong>Niemann-Pick disease, type A and B<\/strong>",
            "reportDescriptionPanel": "<strong>Niemann-Pick disease, type A and B<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 3,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071262,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071263,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071264,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071265,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071266,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330518,
                        "componentDefId": 24490,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330519,
                        "componentDefId": 24507,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330520,
                        "componentDefId": 24456,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330521,
                        "componentDefId": 24473,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 730
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925560,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925561,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 3925559,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925558,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925557,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256291,
                        "componentDefId": 24507,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256292,
                        "componentDefId": 24490,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256293,
                        "componentDefId": 24456,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256296,
                        "componentDefId": 24473,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 730
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925560,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925561,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 3925559,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925558,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925557,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256291,
                        "componentDefId": 24507,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256292,
                        "componentDefId": 24490,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256293,
                        "componentDefId": 24456,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256296,
                        "componentDefId": 24473,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 730
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "TSDA3",
            "description": "Progenity - Tay-Sachs disease (DNA)",
            "placeHolderCode": "2108A3P",
            "reportDescriptionIndividual": "<strong>Tay-Sachs disease (DNA)<\/strong>",
            "reportDescriptionPanel": "<strong>Tay-Sachs disease (DNA)<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 16,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071267,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071268,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071269,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071270,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071271,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329979,
                        "componentDefId": 24491,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329980,
                        "componentDefId": 24508,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329981,
                        "componentDefId": 24457,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329982,
                        "componentDefId": 24474,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925595,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925596,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925597,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925598,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925599,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256294,
                        "componentDefId": 24508,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256297,
                        "componentDefId": 24491,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256298,
                        "componentDefId": 24457,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256299,
                        "componentDefId": 24474,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925595,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925596,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925597,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925598,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925599,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256294,
                        "componentDefId": 24508,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256297,
                        "componentDefId": 24491,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256298,
                        "componentDefId": 24457,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256299,
                        "componentDefId": 24474,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "DLDA3",
            "description": "Progenity - Dihydrolipoamide dehydrogenase deficiency ",
            "placeHolderCode": "2202A3P",
            "reportDescriptionIndividual": "<strong>Dihydrolipoamide dehydrogenase deficiency <\/strong>",
            "reportDescriptionPanel": "<strong>Dihydrolipoamide dehydrogenase deficiency <\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 2,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071272,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071273,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071274,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071275,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071276,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330031,
                        "componentDefId": 24492,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330032,
                        "componentDefId": 24509,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330033,
                        "componentDefId": 24458,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330034,
                        "componentDefId": 24475,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 184
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925616,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925617,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925618,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925619,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 3925615,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256300,
                        "componentDefId": 24492,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256301,
                        "componentDefId": 24509,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256302,
                        "componentDefId": 24458,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256303,
                        "componentDefId": 24475,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 184
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925616,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925617,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925618,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925619,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 3925615,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256300,
                        "componentDefId": 24492,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256301,
                        "componentDefId": 24509,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256302,
                        "componentDefId": 24458,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256303,
                        "componentDefId": 24475,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 184
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "ABCC8A3",
            "description": "Progenity - Familial hyperinsulinism",
            "placeHolderCode": "2203A3P",
            "reportDescriptionIndividual": "<strong>Familial hyperinsulinism, ABCC8-related<\/strong>",
            "reportDescriptionPanel": "<strong>Familial hyperinsulinism, ABCC8-related<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 3,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071277,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071278,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071279,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071280,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071281,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330100,
                        "componentDefId": 24493,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330101,
                        "componentDefId": 24510,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330102,
                        "componentDefId": 24459,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330103,
                        "componentDefId": 24476,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 321
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925647,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925648,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925649,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925650,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925651,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256304,
                        "componentDefId": 24493,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256305,
                        "componentDefId": 24510,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256306,
                        "componentDefId": 24476,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256307,
                        "componentDefId": 24459,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 321
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071277,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071278,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071279,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071280,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071281,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330100,
                        "componentDefId": 24493,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330101,
                        "componentDefId": 24510,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330102,
                        "componentDefId": 24459,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330103,
                        "componentDefId": 24476,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 321
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "GSD1AA3",
            "description": "Progenity - Glycogen storage disease,type IA",
            "placeHolderCode": "2204A3P",
            "reportDescriptionIndividual": "<strong>Glycogen storage disease,\r\ntype IA<\/strong>",
            "reportDescriptionPanel": "<strong>Glycogen storage disease,\r\ntype IA<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 3,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071282,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071283,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071284,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071285,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071286,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330256,
                        "componentDefId": 24494,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330257,
                        "componentDefId": 24511,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330258,
                        "componentDefId": 24460,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330259,
                        "componentDefId": 24477,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 267
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925587,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925588,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925589,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925590,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925591,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256308,
                        "componentDefId": 24494,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256309,
                        "componentDefId": 24511,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256310,
                        "componentDefId": 24460,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256311,
                        "componentDefId": 24477,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 267
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071282,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071283,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071284,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071285,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071286,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330256,
                        "componentDefId": 24494,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330257,
                        "componentDefId": 24511,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330258,
                        "componentDefId": 24460,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330259,
                        "componentDefId": 24477,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 267
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "MSUDIAA3",
            "description": "Progenity - Maple syrup urine disease,type Ia ",
            "placeHolderCode": "2205A3P",
            "reportDescriptionIndividual": "<strong>Maple syrup urine disease,\r\ntype Ia <\/strong>",
            "reportDescriptionPanel": "<strong>Maple syrup urine disease,\r\ntype Ia <\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 4,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071287,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071288,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071289,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071290,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071291,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330340,
                        "componentDefId": 24495,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330341,
                        "componentDefId": 24512,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330342,
                        "componentDefId": 24461,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330343,
                        "componentDefId": 24478,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925682,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925683,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925684,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925685,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925686,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256312,
                        "componentDefId": 24495,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256313,
                        "componentDefId": 24512,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256314,
                        "componentDefId": 24461,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256315,
                        "componentDefId": 24478,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071287,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071288,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071289,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071290,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071291,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330340,
                        "componentDefId": 24495,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330341,
                        "componentDefId": 24512,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330342,
                        "componentDefId": 24461,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330343,
                        "componentDefId": 24478,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "NEM2A3",
            "description": "Progenity - Nemaline myopathy 2",
            "placeHolderCode": "2206A3P",
            "reportDescriptionIndividual": "<strong>Nemaline myopathy 2<\/strong>",
            "reportDescriptionPanel": "<strong>Nemaline myopathy 2<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 4,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071292,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071293,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071294,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071295,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071296,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330553,
                        "componentDefId": 24496,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330554,
                        "componentDefId": 24513,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330555,
                        "componentDefId": 24462,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330556,
                        "componentDefId": 24479,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 439
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925610,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925611,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925612,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925613,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925614,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256316,
                        "componentDefId": 24496,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256317,
                        "componentDefId": 24513,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256318,
                        "componentDefId": 24462,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256319,
                        "componentDefId": 24479,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 439
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071292,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071293,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071294,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071295,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071296,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330553,
                        "componentDefId": 24496,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330554,
                        "componentDefId": 24513,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330555,
                        "componentDefId": 24462,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330556,
                        "componentDefId": 24479,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 439
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "USH1FA3",
            "description": "Progenity - Usher syndrome, type IF",
            "placeHolderCode": "2207A3P",
            "reportDescriptionIndividual": "<strong>Usher syndrome, type IF<\/strong>",
            "reportDescriptionPanel": "<strong>Usher syndrome, type IF<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 3,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071297,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071298,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071299,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071300,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071301,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330557,
                        "componentDefId": 24497,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330558,
                        "componentDefId": 24514,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330559,
                        "componentDefId": 24463,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330560,
                        "componentDefId": 24480,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925652,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925653,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925654,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925655,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925656,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256320,
                        "componentDefId": 24514,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256321,
                        "componentDefId": 24497,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256322,
                        "componentDefId": 24463,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256323,
                        "componentDefId": 24480,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071297,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071298,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071299,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071300,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071301,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330557,
                        "componentDefId": 24497,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330558,
                        "componentDefId": 24514,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330559,
                        "componentDefId": 24463,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330560,
                        "componentDefId": 24480,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "USH3AA3",
            "description": "Progenity - Usher syndrome, type III",
            "placeHolderCode": "2208A3P",
            "reportDescriptionIndividual": "<strong>Usher syndrome, type III<\/strong>",
            "reportDescriptionPanel": "<strong>Usher syndrome, type III<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 3,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071302,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071303,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071304,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071305,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071306,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330569,
                        "componentDefId": 24498,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330570,
                        "componentDefId": 24515,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330571,
                        "componentDefId": 24464,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330572,
                        "componentDefId": 24481,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925677,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925678,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925679,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925680,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925681,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256324,
                        "componentDefId": 24498,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256325,
                        "componentDefId": 24464,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256326,
                        "componentDefId": 24515,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256327,
                        "componentDefId": 24481,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071302,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071303,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071304,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071305,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071306,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330569,
                        "componentDefId": 24498,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330570,
                        "componentDefId": 24515,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330571,
                        "componentDefId": 24464,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330572,
                        "componentDefId": 24481,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "MDDGA4A4",
            "description": "Progenity - Walker-Warburg syndrome ",
            "placeHolderCode": "2209A4P",
            "reportDescriptionIndividual": "<strong>Walker-Warburg syndrome <\/strong>",
            "reportDescriptionPanel": "<strong>Walker-Warburg syndrome <\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 3,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071222,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071223,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071224,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071225,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 4071226,
                        "description": "CF 600 Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-CF600-052015<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Preparent&trade; CF 600 052015. Original report is on file and available upon request.<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2329959,
                        "componentDefId": 24519,
                        "result": "1",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329960,
                        "componentDefId": 24520,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329961,
                        "componentDefId": 24523,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329962,
                        "componentDefId": 24524,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329963,
                        "componentDefId": 24517,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329964,
                        "componentDefId": 24518,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329965,
                        "componentDefId": 24521,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2329966,
                        "componentDefId": 24522,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925605,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925606,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925607,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925608,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 3925609,
                        "description": "CF 600 Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-CF600-052015<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Preparent&trade; CF 600 052015. Original report is on file and available upon request.<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256256,
                        "componentDefId": 24524,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256257,
                        "componentDefId": 24520,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256258,
                        "componentDefId": 24523,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256259,
                        "componentDefId": 24518,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256260,
                        "componentDefId": 24519,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256261,
                        "componentDefId": 24517,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256262,
                        "componentDefId": 24521,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256264,
                        "componentDefId": 24522,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925605,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925606,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925607,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925608,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 3925609,
                        "description": "CF 600 Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-CF600-052015<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Preparent&trade; CF 600 052015. Original report is on file and available upon request.<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256256,
                        "componentDefId": 24524,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256257,
                        "componentDefId": 24520,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256258,
                        "componentDefId": 24523,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256259,
                        "componentDefId": 24518,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256260,
                        "componentDefId": 24519,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256261,
                        "componentDefId": 24517,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256262,
                        "componentDefId": 24521,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256264,
                        "componentDefId": 24522,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "CF600A2",
            "description": "PREPARENT CARRIER SCREEN \u2013 Cystic fibrosis 600",
            "placeHolderCode": "2004A2P",
            "reportDescriptionIndividual": "<strong>PREPARENT&trade; CARRIER SCREEN &ndash; Cystic fibrosis 600<\/strong>",
            "reportDescriptionPanel": "<strong>Cystic fibrosis (600 mutations)<\/strong>",
            "isPanel": false,
            "methLimText": "<p><strong><span style=\"font-size: 10pt; font-family: 'Arial Narrow', sans-serif;\">METHODOLOGY<\/span><\/strong><\/p>\n<p><span style=\"font-size: 10pt; font-family: 'Arial Narrow', sans-serif;\">This assay uses purified genomic DNA, nanofluidic multiplex PCR-based amplification of target regions, sample dilution, and PCR barcoding/indexing, followed by massively parallel sequencing.<\/span><\/p>\n<p><span style=\"font-size: 10pt; font-family: 'Arial Narrow', sans-serif;\"><\/span><\/p>\n<p><strong><span style=\"font-size: 10pt; font-family: 'Arial Narrow', sans-serif;\">LIMITATIONS<\/span><\/strong><\/p>\n<p><span style=\"font-size: 10pt; font-family: 'Arial Narrow', sans-serif;\">This interpretation is based on the clinical information provided and the current understanding of the molecular genetics of this condition. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Although DNA-based testing provides highly accurate results, rare diagnostic errors may occur. Examples include misinterpretation because of rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens.<\/span><\/p>\n<p><span style=\"font-size: 10pt; font-family: 'Arial Narrow', sans-serif;\"><\/span><\/p>\n<p><strong><span style=\"font-size: 10pt; font-family: 'Arial Narrow', sans-serif;\">ADDITIONAL INFORMATION<\/span><\/strong><\/p>\n<p><span style=\"font-size: 10pt; font-family: 'Arial Narrow', sans-serif;\">A list of all variants tested is available at: progenity.com/mutations/cf600-082014<br />\n<\/span><\/p>\n<p><span style=\"font-size: 10pt; font-family: 'Arial Narrow', sans-serif;\">To receive a hard copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: CFnxt 600 082014. For references, please visit: progenity.com/references. Original report is on file and available upon request. <\/span><\/p>",
            "fdaStatement": "<p><span style=\"font-size: 8pt; font-family: 'Arial Narrow', sans-serif;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only.<\/span><\/p>\n<p><span style=\"font-size: 8pt; font-family: 'Arial Narrow', sans-serif;\">&nbsp;<\/span><\/p>\n<p><span style=\"font-size: 8pt; font-family: 'Arial Narrow', sans-serif;\">Report Interpretation Reviewed By: John Tazelaar, MD or designee<\/span><\/p>",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 102,
            "residualRiskTable": "<p>&nbsp;<\/p>",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 30
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4071307,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 4071308,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071309,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071310,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071311,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330204,
                        "componentDefId": 24499,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330205,
                        "componentDefId": 24516,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330206,
                        "componentDefId": 24465,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330207,
                        "componentDefId": 24482,
                        "result": "Negative",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "male": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925697,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925698,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925699,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925700,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925701,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256328,
                        "componentDefId": 24499,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256329,
                        "componentDefId": 24516,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256330,
                        "componentDefId": 24465,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256331,
                        "componentDefId": 24482,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 3925697,
                        "description": "GCS Individual Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
                    },
                    {
                        "globalTextId": 3925698,
                        "description": "GCS Individual Limitations",
                        "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925699,
                        "description": "GCS Individual Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925700,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925701,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2256328,
                        "componentDefId": 24499,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256329,
                        "componentDefId": 24516,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256330,
                        "componentDefId": 24465,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2256331,
                        "componentDefId": 24482,
                        "result": "Negative",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 555
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "JBTS2A3",
            "description": "Progenity - Joubert syndrome 2",
            "placeHolderCode": "2210A3P",
            "reportDescriptionIndividual": "<strong>Joubert syndrome 2<\/strong>",
            "reportDescriptionPanel": "<strong>Joubert syndrome 2<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 5,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Normal",
                "globos": [
                    {
                        "globalTextId": 4071312,
                        "description": "SMA Extra Limitations",
                        "longText": "<p><strong>SMA:<\/strong> This analysis cannot identify carrier status due to a 2+0 genotype (2 copies of <em>SMN1<\/em> on one chromosome and zero copies on the other chromosome) or point mutation. It is important to note that 2% of individuals affected with SMA have one de novo mutation. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071313,
                        "description": "SMA Panel Negative Result",
                        "longText": "<p><strong>Spinal Muscular Atrophy (SMA): Normal<\/strong><\/p>\r\n<p><em>SMN1<\/em>: 2 copies, <em>SMN2<\/em>: 2 copies<\/p>"
                    },
                    {
                        "globalTextId": 4071314,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071315,
                        "description": "SMA Panel Negative Interpretation",
                        "longText": "<p>This analysis identified at least two copies of the <em>SMN1<\/em> gene (NORMAL).<\/p>\r\n<p>&nbsp;<\/p>\r\n<p>This result reduces but does not eliminate the risk of SMA carrier status. See the table below for residual risk. These risk calculations assume that the individual is clinically unaffected and has no family history of SMA. Detection rates for patients of other, mixed or unknown ethnicity cannot be calculated. If ethnicity is other, mixed or unknown, use the highest residual risk estimate.<\/p>"
                    },
                    {
                        "globalTextId": 4071316,
                        "description": "SMA Interpretation",
                        "longText": "<p>This analysis identified at least two copies of the <em>SMN1<\/em> gene (NORMAL).<\/p>\r\n<p>&nbsp;<\/p>\r\n<p>This result reduces but does not eliminate the risk of SMA carrier status. See the table below for residual risk. These risk calculations assume that the individual is clinically unaffected and has no family history of SMA. Detection rates for patients of other, mixed or unknown ethnicity cannot be calculated. If ethnicity is other, mixed or unknown, use the highest residual risk estimate.<\/p>"
                    },
                    {
                        "globalTextId": 4071317,
                        "description": "SMA Limitations",
                        "longText": "<p>This analysis cannot identify carrier status due to a 2+0 genotype (2 copies of <em>SMN1<\/em> on one chromosome and zero copies on the other chromosome) or point mutation. It is important to note that 2% of individuals affected with SMA have one de novo mutation. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071318,
                        "description": "SMA Extra Methodology (Progenity)",
                        "longText": "<p><strong>SMA:<\/strong> Direct testing of <em>SMN1<\/em> and <em>SMN2<\/em> copy number was performed by quantitative dosage analysis of genomic DNA using targeted molecular capture probes and massively parallel sequencing. The quantitative dosage analysis examines exon 7 of each <em>SMN1<\/em> and <em>SMN2<\/em> gene as well as &gt;100 control loci throughout the genome. The accuracy of this dosage analysis is greater than 99%.<\/p>"
                    },
                    {
                        "globalTextId": 4071319,
                        "description": "SMA Methodology (Progenity)",
                        "longText": "<p>Direct testing of <em>SMN1<\/em> and <em>SMN2<\/em> copy number was performed by quantitative dosage analysis of genomic DNA using targeted molecular capture probes and massively parallel sequencing. The quantitative dosage analysis examines exon 7 of each <em>SMN1<\/em> and <em>SMN2<\/em> gene as well as &gt;100 control loci throughout the genome. The accuracy of this dosage analysis is greater than 99%.<\/p>"
                    },
                    {
                        "globalTextId": 4071320,
                        "description": "SMA FDA Statement (Progenity)",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. Performing Laboratory: Progenity, Inc., 5230 S. State Road, Ann Arbor, MI 48108<\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330504,
                        "componentDefId": 24525,
                        "result": "2 copies",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330505,
                        "componentDefId": 24526,
                        "result": "2 copies",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 632
            },
            "male": {
                "resultFlag": "Normal",
                "globos": [
                    {
                        "globalTextId": 3925628,
                        "description": "SMA Extra Limitations",
                        "longText": "<p><strong>SMA:<\/strong> This analysis cannot identify carrier status due to a 2+0 genotype (2 copies of <em>SMN1<\/em> on one chromosome and zero copies on the other chromosome) or point mutation. It is important to note that 2% of individuals affected with SMA have one de novo mutation. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925629,
                        "description": "SMA Panel Negative Result",
                        "longText": "<p><strong>Spinal Muscular Atrophy (SMA): Normal<\/strong><\/p>\r\n<p><em>SMN1<\/em>: 2 copies, <em>SMN2<\/em>: 2 copies<\/p>"
                    },
                    {
                        "globalTextId": 3925630,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925631,
                        "description": "SMA Panel Negative Interpretation",
                        "longText": "<p>This analysis identified at least two copies of the <em>SMN1<\/em> gene (NORMAL).<\/p>\r\n<p>&nbsp;<\/p>\r\n<p>This result reduces but does not eliminate the risk of SMA carrier status. See the table below for residual risk. These risk calculations assume that the individual is clinically unaffected and has no family history of SMA. Detection rates for patients of other, mixed or unknown ethnicity cannot be calculated. If ethnicity is other, mixed or unknown, use the highest residual risk estimate.<\/p>"
                    },
                    {
                        "globalTextId": 3925632,
                        "description": "SMA Interpretation",
                        "longText": "<p>This analysis identified at least two copies of the <em>SMN1<\/em> gene (NORMAL).<\/p>\r\n<p>&nbsp;<\/p>\r\n<p>This result reduces but does not eliminate the risk of SMA carrier status. See the table below for residual risk. These risk calculations assume that the individual is clinically unaffected and has no family history of SMA. Detection rates for patients of other, mixed or unknown ethnicity cannot be calculated. If ethnicity is other, mixed or unknown, use the highest residual risk estimate.<\/p>"
                    },
                    {
                        "globalTextId": 3925633,
                        "description": "SMA Limitations",
                        "longText": "<p>This analysis cannot identify carrier status due to a 2+0 genotype (2 copies of <em>SMN1<\/em> on one chromosome and zero copies on the other chromosome) or point mutation. It is important to note that 2% of individuals affected with SMA have one de novo mutation. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925634,
                        "description": "SMA Extra Methodology (Progenity)",
                        "longText": "<p><strong>SMA:<\/strong> Direct testing of <em>SMN1<\/em> and <em>SMN2<\/em> copy number was performed by quantitative dosage analysis of genomic DNA using targeted molecular capture probes and massively parallel sequencing. The quantitative dosage analysis examines exon 7 of each <em>SMN1<\/em> and <em>SMN2<\/em> gene as well as &gt;100 control loci throughout the genome. The accuracy of this dosage analysis is greater than 99%.<\/p>"
                    },
                    {
                        "globalTextId": 3925635,
                        "description": "SMA Methodology (Progenity)",
                        "longText": "<p>Direct testing of <em>SMN1<\/em> and <em>SMN2<\/em> copy number was performed by quantitative dosage analysis of genomic DNA using targeted molecular capture probes and massively parallel sequencing. The quantitative dosage analysis examines exon 7 of each <em>SMN1<\/em> and <em>SMN2<\/em> gene as well as &gt;100 control loci throughout the genome. The accuracy of this dosage analysis is greater than 99%.<\/p>"
                    },
                    {
                        "globalTextId": 3925636,
                        "description": "SMA FDA Statement (Progenity)",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. Performing Laboratory: Progenity, Inc., 5230 S. State Road, Ann Arbor, MI 48108<\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2243284,
                        "componentDefId": 24525,
                        "result": "2 copies",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2243285,
                        "componentDefId": 24526,
                        "result": "2 copies",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "partner": {
                "resultFlag": "Normal",
                "globos": [
                    {
                        "globalTextId": 3925628,
                        "description": "SMA Extra Limitations",
                        "longText": "<p><strong>SMA:<\/strong> This analysis cannot identify carrier status due to a 2+0 genotype (2 copies of <em>SMN1<\/em> on one chromosome and zero copies on the other chromosome) or point mutation. It is important to note that 2% of individuals affected with SMA have one de novo mutation. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925629,
                        "description": "SMA Panel Negative Result",
                        "longText": "<p><strong>Spinal Muscular Atrophy (SMA): Normal<\/strong><\/p>\r\n<p><em>SMN1<\/em>: 2 copies, <em>SMN2<\/em>: 2 copies<\/p>"
                    },
                    {
                        "globalTextId": 3925630,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925631,
                        "description": "SMA Panel Negative Interpretation",
                        "longText": "<p>This analysis identified at least two copies of the <em>SMN1<\/em> gene (NORMAL).<\/p>\r\n<p>&nbsp;<\/p>\r\n<p>This result reduces but does not eliminate the risk of SMA carrier status. See the table below for residual risk. These risk calculations assume that the individual is clinically unaffected and has no family history of SMA. Detection rates for patients of other, mixed or unknown ethnicity cannot be calculated. If ethnicity is other, mixed or unknown, use the highest residual risk estimate.<\/p>"
                    },
                    {
                        "globalTextId": 3925632,
                        "description": "SMA Interpretation",
                        "longText": "<p>This analysis identified at least two copies of the <em>SMN1<\/em> gene (NORMAL).<\/p>\r\n<p>&nbsp;<\/p>\r\n<p>This result reduces but does not eliminate the risk of SMA carrier status. See the table below for residual risk. These risk calculations assume that the individual is clinically unaffected and has no family history of SMA. Detection rates for patients of other, mixed or unknown ethnicity cannot be calculated. If ethnicity is other, mixed or unknown, use the highest residual risk estimate.<\/p>"
                    },
                    {
                        "globalTextId": 3925633,
                        "description": "SMA Limitations",
                        "longText": "<p>This analysis cannot identify carrier status due to a 2+0 genotype (2 copies of <em>SMN1<\/em> on one chromosome and zero copies on the other chromosome) or point mutation. It is important to note that 2% of individuals affected with SMA have one de novo mutation. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925634,
                        "description": "SMA Extra Methodology (Progenity)",
                        "longText": "<p><strong>SMA:<\/strong> Direct testing of <em>SMN1<\/em> and <em>SMN2<\/em> copy number was performed by quantitative dosage analysis of genomic DNA using targeted molecular capture probes and massively parallel sequencing. The quantitative dosage analysis examines exon 7 of each <em>SMN1<\/em> and <em>SMN2<\/em> gene as well as &gt;100 control loci throughout the genome. The accuracy of this dosage analysis is greater than 99%.<\/p>"
                    },
                    {
                        "globalTextId": 3925635,
                        "description": "SMA Methodology (Progenity)",
                        "longText": "<p>Direct testing of <em>SMN1<\/em> and <em>SMN2<\/em> copy number was performed by quantitative dosage analysis of genomic DNA using targeted molecular capture probes and massively parallel sequencing. The quantitative dosage analysis examines exon 7 of each <em>SMN1<\/em> and <em>SMN2<\/em> gene as well as &gt;100 control loci throughout the genome. The accuracy of this dosage analysis is greater than 99%.<\/p>"
                    },
                    {
                        "globalTextId": 3925636,
                        "description": "SMA FDA Statement (Progenity)",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. Performing Laboratory: Progenity, Inc., 5230 S. State Road, Ann Arbor, MI 48108<\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2243284,
                        "componentDefId": 24525,
                        "result": "2 copies",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2243285,
                        "componentDefId": 24526,
                        "result": "2 copies",
                        "resultsDateTime": "2016-07-15T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "SMAA1",
            "description": "PREPARENT CARRIER SCREEN - SMA",
            "placeHolderCode": "2400A1P",
            "reportDescriptionIndividual": "<strong>PREPARENT&trade; CARRIER SCREEN - Spinal Muscular Atrophy<\/strong>",
            "reportDescriptionPanel": "<strong>Spinal Muscular Atrophy<\/strong>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 47,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": true,
            "showInCRMSubChoice": true,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 35
        },
        {
            "female": {
                "resultFlag": "Normal",
                "globos": [
                    {
                        "globalTextId": 4071321,
                        "description": "FX Extra Methodology",
                        "longText": "<p><strong>Fragile X:<\/strong> A single-tube CGG repeat primed PCR based assay using two gene-specific primers that flank the triplet repeat along with a third primer that is complementary to the (CGG)n repeat was used to determine genotypes for CGG allele sizes within the Fragile X gene (<em>FMR1<\/em>). This assay will identify alleles of all sizes but cannot determine methylation status of expanded alleles. In &gt;99% of cases, Fragile X syndrome is caused by an expansion of CGG repeat sequences in the <em>FMR1<\/em> gene; non-expansion type mutations are not detected by this assay. This test detects full mutation expansions up to at least 1200 CGG repeats, and accurately sizes products with &le; 200 CGG repeats. The accuracy of this methodology is +/- 1 for 0-54 CGG repeats, +/- 2 for 55-70 CGG repeats, +/- 3 for 71-120 CGG repeats, and +/- 5 for 121-200 CGG repeats.<\/p>"
                    },
                    {
                        "globalTextId": 4071322,
                        "description": "FX Extra Limitations",
                        "longText": "<p><strong>Fragile X:<\/strong> In &gt;99% of cases, Fragile X syndrome is caused by an expansion of CGG repeat sequences in the <em>FMR1<\/em> gene; non-expansion type mutations are not detected by this assay. This interpretation is based on the clinical information provided and the current understanding of the molecular genetics of this condition. This assay cannot determine the number of <em>FMR1 <\/em>alleles or the number of X chromosomes. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4071323,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4071324,
                        "description": "FX Normal Panel Interpretation",
                        "longText": "<p>This result indicates the patient is not a carrier of a fragile X expansion mutation.<\/p>\r\n<br />\r\n<table cellspacing=\"0\" cellpadding=\"0\" border=\"1\" style=\"border: medium none currentcolor;\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-width: 1pt; border-style: solid; padding: 0in 5.4pt; width: 3.75in; background-image: url('http://10.1.27.103/PRWQA/Maintenance/e'); background-attachment: scroll; background-size: auto auto; background-origin: padding-box; background-clip: border-box; background-position: 0% 0%; background-repeat: repeat;\" colspan=\"2\">\r\n            <p><strong><span style=\"font-size: 8pt;\">Reference Range: CGG Repeats<\/span><\/strong><\/p>\r\n            <\/td>\r\n        <\/tr>\r\n        <tr>\r\n            <td valign=\"top\" style=\"border-width: 0px 1pt 1pt; border-style: none solid solid; padding: 0in 5.4pt; width: 135pt; text-align: left; border-top: 0px none #000000; background-color: transparent;\">\r\n            <p><span style=\"font-size: 8pt;\">Normal<\/span><\/p>\r\n            <\/td>\r\n            <td valign=\"top\" style=\"border-width: 0px 1pt 1pt 0px; border-style: none solid solid none; padding: 0in 5.4pt; width: 135pt; text-align: left; border-top: 0px none #000000; border-left: 0px none #000000; background-color: transparent;\">\r\n            <p><span style=\"font-size: 8pt;\">&lt;45<\/span><\/p>\r\n            <\/td>\r\n        <\/tr>\r\n        <tr>\r\n            <td valign=\"top\" style=\"border-width: 0px 1pt 1pt; border-style: none solid solid; padding: 0in 5.4pt; width: 135pt; text-align: left; border-top: 0px none #000000; background-color: transparent;\">\r\n            <p><span style=\"font-size: 8pt;\">Gray Zone (Intermediate)<\/span><\/p>\r\n            <\/td>\r\n            <td valign=\"top\" style=\"border-width: 0px 1pt 1pt 0px; border-style: none solid solid none; padding: 0in 5.4pt; width: 135pt; text-align: left; border-top: 0px none #000000; border-left: 0px none #000000; background-color: transparent;\">\r\n            <p><span style=\"font-size: 8pt;\">45&ndash;54<\/span><\/p>\r\n            <\/td>\r\n        <\/tr>\r\n        <tr>\r\n            <td valign=\"top\" style=\"border-width: 0px 1pt 1pt; border-style: none solid solid; padding: 0in 5.4pt; width: 135pt; text-align: left; border-top: 0px none #000000; background-color: transparent;\">\r\n            <p><span style=\"font-size: 8pt;\">Premutation Carrier<\/span><\/p>\r\n            <\/td>\r\n            <td valign=\"top\" style=\"border-width: 0px 1pt 1pt 0px; border-style: none solid solid none; padding: 0in 5.4pt; width: 135pt; text-align: left; border-top: 0px none #000000; border-left: 0px none #000000; background-color: transparent;\">\r\n            <p><span style=\"font-size: 8pt;\">55&ndash;200<\/span><\/p>\r\n            <\/td>\r\n        <\/tr>\r\n        <tr>\r\n            <td valign=\"top\" style=\"border-width: 0px 1pt 1pt; border-style: none solid solid; padding: 0in 5.4pt; width: 135pt; text-align: left; border-top: 0px none #000000; background-color: transparent;\">\r\n            <p><span style=\"font-size: 8pt;\">Full Mutation<\/span><\/p>\r\n            <\/td>\r\n            <td valign=\"top\" style=\"border-width: 0px 1pt 1pt 0px; border-style: none solid solid none; padding: 0in 5.4pt; width: 135pt; text-align: left; border-top: 0px none #000000; border-left: 0px none #000000; background-color: transparent;\">\r\n            <p><span style=\"font-size: 8pt;\">&gt;200<\/span><\/p>\r\n            <\/td>\r\n        <\/tr>\r\n    <\/tbody>\r\n<\/table>"
                    },
                    {
                        "globalTextId": 4071325,
                        "description": "FX Normal Heterozygote Female Result",
                        "longText": "<p><strong>Fragile X Syndrome<\/strong><\/p>\r\n<p>This patient has normal CGG repeats of 35 and 10.<\/p>"
                    },
                    {
                        "globalTextId": 4071326,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 4071327,
                        "description": "FX Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-fragileX-052015<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Preparent&trade; Fragile X 052015. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4071328,
                        "description": "FX Methodology",
                        "longText": "<p>A single-tube CGG repeat primed PCR based assay using two gene-specific primers that flank the triplet repeat along with a third primer that is complementary to the (CGG)n repeat was used to determine genotypes for CGG allele sizes within the fragile X gene (<em>FMR1<\/em>). This assay will identify alleles of all sizes but cannot determine methylation status of expanded alleles. In &gt;99% of cases, fragile X syndrome is caused by an expansion of CGG repeat sequences in the <em>FMR1<\/em> gene; non-expansion type mutations are not detected by this assay. This test detects full mutation expansions up to at least 1200 CGG repeats, and accurately sizes products with &le; 200 CGG repeats. The accuracy of this methodology is +/- 1 for 0-54 CGG repeats, +/- 2 for 55-70 CGG repeats, +/- 3 for 71-120 CGG repeats, and +/- 5 for 121-200 CGG repeats.<\/p>"
                    },
                    {
                        "globalTextId": 4071329,
                        "description": "FX Limitations",
                        "longText": "<p>In &gt;99% of cases, Fragile X syndrome is caused by an expansion of CGG repeat sequences in the <em>FMR1<\/em> gene; non-expansion type mutations are not detected by this assay. This interpretation is based on the clinical information provided and the current understanding of the molecular genetics of this condition. This assay cannot determine the number of <em>FMR1<\/em> alleles or the number of X chromosomes. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330055,
                        "componentDefId": 24537,
                        "result": "35",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330056,
                        "componentDefId": 24538,
                        "result": "10",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330057,
                        "componentDefId": 24539,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330058,
                        "componentDefId": 24540,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330059,
                        "componentDefId": 24541,
                        "result": "0",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "male": {
                "resultFlag": "Normal",
                "globos": [
                    {
                        "globalTextId": 3925702,
                        "description": "FX Extra Methodology",
                        "longText": "<p><strong>Fragile X:<\/strong> A single-tube CGG repeat primed PCR based assay using two gene-specific primers that flank the triplet repeat along with a third primer that is complementary to the (CGG)n repeat was used to determine genotypes for CGG allele sizes within the Fragile X gene (<em>FMR1<\/em>). This assay will identify alleles of all sizes but cannot determine methylation status of expanded alleles. In &gt;99% of cases, Fragile X syndrome is caused by an expansion of CGG repeat sequences in the <em>FMR1<\/em> gene; non-expansion type mutations are not detected by this assay. This test detects full mutation expansions up to at least 1200 CGG repeats, and accurately sizes products with &le; 200 CGG repeats. The accuracy of this methodology is +/- 1 for 0-54 CGG repeats, +/- 2 for 55-70 CGG repeats, +/- 3 for 71-120 CGG repeats, and +/- 5 for 121-200 CGG repeats.<\/p>"
                    },
                    {
                        "globalTextId": 3925703,
                        "description": "FX Extra Limitations",
                        "longText": "<p><strong>Fragile X:<\/strong> In &gt;99% of cases, Fragile X syndrome is caused by an expansion of CGG repeat sequences in the <em>FMR1<\/em> gene; non-expansion type mutations are not detected by this assay. This interpretation is based on the clinical information provided and the current understanding of the molecular genetics of this condition. This assay cannot determine the number of <em>FMR1 <\/em>alleles or the number of X chromosomes. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925704,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925705,
                        "description": "FX Normal Male Negative Result",
                        "longText": "<p><strong>Fragile X Syndrome<\/strong><\/p>\r\n<p>This patient has a normal CGG repeat of 30.<\/p>"
                    },
                    {
                        "globalTextId": 3925706,
                        "description": "FX Normal Panel Interpretation",
                        "longText": "<p>This result indicates the patient is not a carrier of a fragile X expansion mutation.<\/p>\r\n<br />\r\n<table cellspacing=\"0\" cellpadding=\"0\" border=\"1\" style=\"border: medium none currentcolor;\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-width: 1pt; border-style: solid; padding: 0in 5.4pt; width: 3.75in; background-image: url('http://10.1.27.103/PRWQA/Maintenance/e'); background-attachment: scroll; background-size: auto auto; background-origin: padding-box; background-clip: border-box; background-position: 0% 0%; background-repeat: repeat;\" colspan=\"2\">\r\n            <p><strong><span style=\"font-size: 8pt;\">Reference Range: CGG Repeats<\/span><\/strong><\/p>\r\n            <\/td>\r\n        <\/tr>\r\n        <tr>\r\n            <td valign=\"top\" style=\"border-width: 0px 1pt 1pt; border-style: none solid solid; padding: 0in 5.4pt; width: 135pt; text-align: left; border-top: 0px none #000000; background-color: transparent;\">\r\n            <p><span style=\"font-size: 8pt;\">Normal<\/span><\/p>\r\n            <\/td>\r\n            <td valign=\"top\" style=\"border-width: 0px 1pt 1pt 0px; border-style: none solid solid none; padding: 0in 5.4pt; width: 135pt; text-align: left; border-top: 0px none #000000; border-left: 0px none #000000; background-color: transparent;\">\r\n            <p><span style=\"font-size: 8pt;\">&lt;45<\/span><\/p>\r\n            <\/td>\r\n        <\/tr>\r\n        <tr>\r\n            <td valign=\"top\" style=\"border-width: 0px 1pt 1pt; border-style: none solid solid; padding: 0in 5.4pt; width: 135pt; text-align: left; border-top: 0px none #000000; background-color: transparent;\">\r\n            <p><span style=\"font-size: 8pt;\">Gray Zone (Intermediate)<\/span><\/p>\r\n            <\/td>\r\n            <td valign=\"top\" style=\"border-width: 0px 1pt 1pt 0px; border-style: none solid solid none; padding: 0in 5.4pt; width: 135pt; text-align: left; border-top: 0px none #000000; border-left: 0px none #000000; background-color: transparent;\">\r\n            <p><span style=\"font-size: 8pt;\">45&ndash;54<\/span><\/p>\r\n            <\/td>\r\n        <\/tr>\r\n        <tr>\r\n            <td valign=\"top\" style=\"border-width: 0px 1pt 1pt; border-style: none solid solid; padding: 0in 5.4pt; width: 135pt; text-align: left; border-top: 0px none #000000; background-color: transparent;\">\r\n            <p><span style=\"font-size: 8pt;\">Premutation Carrier<\/span><\/p>\r\n            <\/td>\r\n            <td valign=\"top\" style=\"border-width: 0px 1pt 1pt 0px; border-style: none solid solid none; padding: 0in 5.4pt; width: 135pt; text-align: left; border-top: 0px none #000000; border-left: 0px none #000000; background-color: transparent;\">\r\n            <p><span style=\"font-size: 8pt;\">55&ndash;200<\/span><\/p>\r\n            <\/td>\r\n        <\/tr>\r\n        <tr>\r\n            <td valign=\"top\" style=\"border-width: 0px 1pt 1pt; border-style: none solid solid; padding: 0in 5.4pt; width: 135pt; text-align: left; border-top: 0px none #000000; background-color: transparent;\">\r\n            <p><span style=\"font-size: 8pt;\">Full Mutation<\/span><\/p>\r\n            <\/td>\r\n            <td valign=\"top\" style=\"border-width: 0px 1pt 1pt 0px; border-style: none solid solid none; padding: 0in 5.4pt; width: 135pt; text-align: left; border-top: 0px none #000000; border-left: 0px none #000000; background-color: transparent;\">\r\n            <p><span style=\"font-size: 8pt;\">&gt;200<\/span><\/p>\r\n            <\/td>\r\n        <\/tr>\r\n    <\/tbody>\r\n<\/table>"
                    },
                    {
                        "globalTextId": 3925707,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 3925708,
                        "description": "FX Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-fragileX-052015<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Preparent&trade; Fragile X 052015. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925709,
                        "description": "FX Methodology",
                        "longText": "<p>A single-tube CGG repeat primed PCR based assay using two gene-specific primers that flank the triplet repeat along with a third primer that is complementary to the (CGG)n repeat was used to determine genotypes for CGG allele sizes within the fragile X gene (<em>FMR1<\/em>). This assay will identify alleles of all sizes but cannot determine methylation status of expanded alleles. In &gt;99% of cases, fragile X syndrome is caused by an expansion of CGG repeat sequences in the <em>FMR1<\/em> gene; non-expansion type mutations are not detected by this assay. This test detects full mutation expansions up to at least 1200 CGG repeats, and accurately sizes products with &le; 200 CGG repeats. The accuracy of this methodology is +/- 1 for 0-54 CGG repeats, +/- 2 for 55-70 CGG repeats, +/- 3 for 71-120 CGG repeats, and +/- 5 for 121-200 CGG repeats.<\/p>"
                    },
                    {
                        "globalTextId": 3925710,
                        "description": "FX Limitations",
                        "longText": "<p>In &gt;99% of cases, Fragile X syndrome is caused by an expansion of CGG repeat sequences in the <em>FMR1<\/em> gene; non-expansion type mutations are not detected by this assay. This interpretation is based on the clinical information provided and the current understanding of the molecular genetics of this condition. This assay cannot determine the number of <em>FMR1<\/em> alleles or the number of X chromosomes. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2211644,
                        "componentDefId": 24537,
                        "result": "30",
                        "resultsDateTime": "2016-07-15T15:29:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2211645,
                        "componentDefId": 24538,
                        "result": "0",
                        "resultsDateTime": "2016-07-15T15:29:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2211646,
                        "componentDefId": 24539,
                        "result": "0",
                        "resultsDateTime": "2016-07-15T15:29:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2211647,
                        "componentDefId": 24540,
                        "result": "0",
                        "resultsDateTime": "2016-07-15T15:29:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2211648,
                        "componentDefId": 24541,
                        "result": "0",
                        "resultsDateTime": "2016-07-15T15:29:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "partner": {
                "resultFlag": "Normal",
                "globos": [
                    {
                        "globalTextId": 3925702,
                        "description": "FX Extra Methodology",
                        "longText": "<p><strong>Fragile X:<\/strong> A single-tube CGG repeat primed PCR based assay using two gene-specific primers that flank the triplet repeat along with a third primer that is complementary to the (CGG)n repeat was used to determine genotypes for CGG allele sizes within the Fragile X gene (<em>FMR1<\/em>). This assay will identify alleles of all sizes but cannot determine methylation status of expanded alleles. In &gt;99% of cases, Fragile X syndrome is caused by an expansion of CGG repeat sequences in the <em>FMR1<\/em> gene; non-expansion type mutations are not detected by this assay. This test detects full mutation expansions up to at least 1200 CGG repeats, and accurately sizes products with &le; 200 CGG repeats. The accuracy of this methodology is +/- 1 for 0-54 CGG repeats, +/- 2 for 55-70 CGG repeats, +/- 3 for 71-120 CGG repeats, and +/- 5 for 121-200 CGG repeats.<\/p>"
                    },
                    {
                        "globalTextId": 3925703,
                        "description": "FX Extra Limitations",
                        "longText": "<p><strong>Fragile X:<\/strong> In &gt;99% of cases, Fragile X syndrome is caused by an expansion of CGG repeat sequences in the <em>FMR1<\/em> gene; non-expansion type mutations are not detected by this assay. This interpretation is based on the clinical information provided and the current understanding of the molecular genetics of this condition. This assay cannot determine the number of <em>FMR1 <\/em>alleles or the number of X chromosomes. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3925704,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3925705,
                        "description": "FX Normal Male Negative Result",
                        "longText": "<p><strong>Fragile X Syndrome<\/strong><\/p>\r\n<p>This patient has a normal CGG repeat of 30.<\/p>"
                    },
                    {
                        "globalTextId": 3925706,
                        "description": "FX Normal Panel Interpretation",
                        "longText": "<p>This result indicates the patient is not a carrier of a fragile X expansion mutation.<\/p>\r\n<br />\r\n<table cellspacing=\"0\" cellpadding=\"0\" border=\"1\" style=\"border: medium none currentcolor;\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"border-width: 1pt; border-style: solid; padding: 0in 5.4pt; width: 3.75in; background-image: url('http://10.1.27.103/PRWQA/Maintenance/e'); background-attachment: scroll; background-size: auto auto; background-origin: padding-box; background-clip: border-box; background-position: 0% 0%; background-repeat: repeat;\" colspan=\"2\">\r\n            <p><strong><span style=\"font-size: 8pt;\">Reference Range: CGG Repeats<\/span><\/strong><\/p>\r\n            <\/td>\r\n        <\/tr>\r\n        <tr>\r\n            <td valign=\"top\" style=\"border-width: 0px 1pt 1pt; border-style: none solid solid; padding: 0in 5.4pt; width: 135pt; text-align: left; border-top: 0px none #000000; background-color: transparent;\">\r\n            <p><span style=\"font-size: 8pt;\">Normal<\/span><\/p>\r\n            <\/td>\r\n            <td valign=\"top\" style=\"border-width: 0px 1pt 1pt 0px; border-style: none solid solid none; padding: 0in 5.4pt; width: 135pt; text-align: left; border-top: 0px none #000000; border-left: 0px none #000000; background-color: transparent;\">\r\n            <p><span style=\"font-size: 8pt;\">&lt;45<\/span><\/p>\r\n            <\/td>\r\n        <\/tr>\r\n        <tr>\r\n            <td valign=\"top\" style=\"border-width: 0px 1pt 1pt; border-style: none solid solid; padding: 0in 5.4pt; width: 135pt; text-align: left; border-top: 0px none #000000; background-color: transparent;\">\r\n            <p><span style=\"font-size: 8pt;\">Gray Zone (Intermediate)<\/span><\/p>\r\n            <\/td>\r\n            <td valign=\"top\" style=\"border-width: 0px 1pt 1pt 0px; border-style: none solid solid none; padding: 0in 5.4pt; width: 135pt; text-align: left; border-top: 0px none #000000; border-left: 0px none #000000; background-color: transparent;\">\r\n            <p><span style=\"font-size: 8pt;\">45&ndash;54<\/span><\/p>\r\n            <\/td>\r\n        <\/tr>\r\n        <tr>\r\n            <td valign=\"top\" style=\"border-width: 0px 1pt 1pt; border-style: none solid solid; padding: 0in 5.4pt; width: 135pt; text-align: left; border-top: 0px none #000000; background-color: transparent;\">\r\n            <p><span style=\"font-size: 8pt;\">Premutation Carrier<\/span><\/p>\r\n            <\/td>\r\n            <td valign=\"top\" style=\"border-width: 0px 1pt 1pt 0px; border-style: none solid solid none; padding: 0in 5.4pt; width: 135pt; text-align: left; border-top: 0px none #000000; border-left: 0px none #000000; background-color: transparent;\">\r\n            <p><span style=\"font-size: 8pt;\">55&ndash;200<\/span><\/p>\r\n            <\/td>\r\n        <\/tr>\r\n        <tr>\r\n            <td valign=\"top\" style=\"border-width: 0px 1pt 1pt; border-style: none solid solid; padding: 0in 5.4pt; width: 135pt; text-align: left; border-top: 0px none #000000; background-color: transparent;\">\r\n            <p><span style=\"font-size: 8pt;\">Full Mutation<\/span><\/p>\r\n            <\/td>\r\n            <td valign=\"top\" style=\"border-width: 0px 1pt 1pt 0px; border-style: none solid solid none; padding: 0in 5.4pt; width: 135pt; text-align: left; border-top: 0px none #000000; border-left: 0px none #000000; background-color: transparent;\">\r\n            <p><span style=\"font-size: 8pt;\">&gt;200<\/span><\/p>\r\n            <\/td>\r\n        <\/tr>\r\n    <\/tbody>\r\n<\/table>"
                    },
                    {
                        "globalTextId": 3925707,
                        "description": "GCS Individual FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
                    },
                    {
                        "globalTextId": 3925708,
                        "description": "FX Additional Information",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-fragileX-052015<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Preparent&trade; Fragile X 052015. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3925709,
                        "description": "FX Methodology",
                        "longText": "<p>A single-tube CGG repeat primed PCR based assay using two gene-specific primers that flank the triplet repeat along with a third primer that is complementary to the (CGG)n repeat was used to determine genotypes for CGG allele sizes within the fragile X gene (<em>FMR1<\/em>). This assay will identify alleles of all sizes but cannot determine methylation status of expanded alleles. In &gt;99% of cases, fragile X syndrome is caused by an expansion of CGG repeat sequences in the <em>FMR1<\/em> gene; non-expansion type mutations are not detected by this assay. This test detects full mutation expansions up to at least 1200 CGG repeats, and accurately sizes products with &le; 200 CGG repeats. The accuracy of this methodology is +/- 1 for 0-54 CGG repeats, +/- 2 for 55-70 CGG repeats, +/- 3 for 71-120 CGG repeats, and +/- 5 for 121-200 CGG repeats.<\/p>"
                    },
                    {
                        "globalTextId": 3925710,
                        "description": "FX Limitations",
                        "longText": "<p>In &gt;99% of cases, Fragile X syndrome is caused by an expansion of CGG repeat sequences in the <em>FMR1<\/em> gene; non-expansion type mutations are not detected by this assay. This interpretation is based on the clinical information provided and the current understanding of the molecular genetics of this condition. This assay cannot determine the number of <em>FMR1<\/em> alleles or the number of X chromosomes. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2211644,
                        "componentDefId": 24537,
                        "result": "30",
                        "resultsDateTime": "2016-07-15T15:29:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2211645,
                        "componentDefId": 24538,
                        "result": "0",
                        "resultsDateTime": "2016-07-15T15:29:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2211646,
                        "componentDefId": 24539,
                        "result": "0",
                        "resultsDateTime": "2016-07-15T15:29:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2211647,
                        "componentDefId": 24540,
                        "result": "0",
                        "resultsDateTime": "2016-07-15T15:29:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2211648,
                        "componentDefId": 24541,
                        "result": "0",
                        "resultsDateTime": "2016-07-15T15:29:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ]
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "FXA4",
            "description": "PREPARENT CARRIER SCREEN \u2013 Fragile X",
            "placeHolderCode": "2500A4P",
            "reportDescriptionIndividual": "<strong>PREPARENT&trade; CARRIER SCREEN &ndash; Fragile X<\/strong>",
            "reportDescriptionPanel": "<strong>Fragile X Syndrome<\/strong>",
            "isPanel": false,
            "methLimText": "<p><strong><span style=\"font-size: 10pt; font-family: 'Arial Narrow', sans-serif;\">METHODOLOGY<\/span><\/strong><\/p>\n<p><span style=\"font-size: 10pt; font-family: 'Arial Narrow', sans-serif;\">A single-tube CGG repeat primed PCR based assay using two gene-specific primers that flank the triplet repeat along with a third primer that is complementary to the (CGG)n repeat was used to determine genotypes for CGG allele sizes within the fragile X gene (FMR1). This assay will identify alleles of all sizes but cannot determine methylation status of expanded alleles.<\/span><\/p>\n<p><span style=\"font-size: 10pt; font-family: 'Arial Narrow', sans-serif;\"><\/span>&nbsp;<\/p>\n<p><strong><span style=\"font-size: 10pt; font-family: 'Arial Narrow', sans-serif;\">LIMITATIONS<\/span><\/strong><\/p>\n<p><span style=\"font-size: 10pt; font-family: 'Arial Narrow', sans-serif;\">In &gt;99% of cases, fragile X syndrome is caused by an expansion of CGG repeat sequences in the FMR1 gene; non-expansion type mutations are not detected by this assay. This interpretation is based on the clinical information provided and the current understanding of the molecular genetics of this condition. Although DNA-based testing provides highly accurate results, rare diagnostic errors may occur. Examples include misinterpretation because of polymorphisms or rare genetic variants, blood transfusion, mislabeled specimens. Bone marrow transplants from allogenic donors will interfere with testing. This test detects full mutation expansions up to at least 1200 CGG repeats, and accurately sizes products with &le; 200 CGG repeats.&nbsp; The accuracy of this methodology is +/- 1 for 0-54 CGG repeats, +/- 2 for 55-70 CGG repeats, +/- 3 for 71-120 CGG repeats, and +/- 5 for 121-200 CGG repeats. &nbsp;<\/span><\/p>\n<p><span style=\"font-size: 10pt; font-family: 'Arial Narrow', sans-serif;\"><\/span>&nbsp;<\/p>\n<p><strong><span style=\"font-size: 10pt; font-family: 'Arial Narrow', sans-serif;\">ADDITIONAL INFORMATION<\/span><\/strong><\/p>\n<p><span style=\"font-size: 10pt; font-family: 'Arial Narrow', sans-serif;\">For references, please visit: progenity.com/references. Original report is on file and available upon request. <\/span><\/p>",
            "fdaStatement": "<p><span style=\"font-family: 'Arial Narrow', sans-serif; font-size: 13px;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. Performing Laboratory: Progenity, Inc., 5230 S. State Road, Ann Arbor, MI 48108<\/span><\/p>\n<p>&nbsp;<\/p>\n<p>Report Interpretation Reviewed By: John Tazelaar, MD or designee<\/p>",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 93,
            "residualRiskTable": "<p>&nbsp;<\/p>",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 32
        },
        {
            "female": {
                "resultFlag": "Normal",
                "globos": [
                    {
                        "globalTextId": 4072139,
                        "description": "Hemoglobinopathy Details Sentence",
                        "longText": "<p>For details of the Hemoglobinopathy Evaluation, please see separate report.<\/p>"
                    },
                    {
                        "globalTextId": 4072140,
                        "description": "Hemoglobinopathy Extra Methodology",
                        "longText": "<p><strong>Hemoglobinopathy Evaluation:<\/strong> High Performance Liquid Chromatography (HPLC) followed by, if necessary, alkaline and acid Hemoglobin Electrophoresis on agarose gel.<\/p>"
                    },
                    {
                        "globalTextId": 4072141,
                        "description": "Hemoglobinopathy Extra FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\"><strong>Hemoglobinopathy Evaluation:<\/strong> Performing Laboratory: Quest Diagnostics-Wood Dale, 1355 Mittel Blvd, Wood Dale, IL 60191-1024 Laboratory Director: Anthony V Thomas, M.D.<\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [{
                    "componentResultId": 2330581,
                    "componentDefId": 24567,
                    "result": "Normal hemoglobin distribution",
                    "resultsDateTime": "2016-11-30T00:00:00",
                    "concurrencyId": 1,
                    "amended": false
                }]
            },
            "male": {
                "resultFlag": "Normal",
                "globos": [
                    {
                        "globalTextId": 3926742,
                        "description": "Hemoglobinopathy Details Sentence",
                        "longText": "<p>For details of the Hemoglobinopathy Evaluation, please see separate report.<\/p>"
                    },
                    {
                        "globalTextId": 3926743,
                        "description": "Hemoglobinopathy Extra Methodology",
                        "longText": "<p><strong>Hemoglobinopathy Evaluation:<\/strong> High Performance Liquid Chromatography (HPLC) followed by, if necessary, alkaline and acid Hemoglobin Electrophoresis on agarose gel.<\/p>"
                    },
                    {
                        "globalTextId": 3926744,
                        "description": "Hemoglobinopathy Extra FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\"><strong>Hemoglobinopathy Evaluation:<\/strong> Performing Laboratory: Quest Diagnostics-Wood Dale, 1355 Mittel Blvd, Wood Dale, IL 60191-1024 Laboratory Director: Anthony V Thomas, M.D.<\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [{
                    "componentResultId": 2211661,
                    "componentDefId": 24567,
                    "result": "Normal hemoglobin distribution.",
                    "resultsDateTime": "2016-07-15T15:29:00",
                    "concurrencyId": 1,
                    "amended": false
                }]
            },
            "partner": {
                "resultFlag": "Normal",
                "globos": [
                    {
                        "globalTextId": 3926742,
                        "description": "Hemoglobinopathy Details Sentence",
                        "longText": "<p>For details of the Hemoglobinopathy Evaluation, please see separate report.<\/p>"
                    },
                    {
                        "globalTextId": 3926743,
                        "description": "Hemoglobinopathy Extra Methodology",
                        "longText": "<p><strong>Hemoglobinopathy Evaluation:<\/strong> High Performance Liquid Chromatography (HPLC) followed by, if necessary, alkaline and acid Hemoglobin Electrophoresis on agarose gel.<\/p>"
                    },
                    {
                        "globalTextId": 3926744,
                        "description": "Hemoglobinopathy Extra FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\"><strong>Hemoglobinopathy Evaluation:<\/strong> Performing Laboratory: Quest Diagnostics-Wood Dale, 1355 Mittel Blvd, Wood Dale, IL 60191-1024 Laboratory Director: Anthony V Thomas, M.D.<\/span><\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [{
                    "componentResultId": 2211661,
                    "componentDefId": 24567,
                    "result": "Normal hemoglobin distribution.",
                    "resultsDateTime": "2016-07-15T15:29:00",
                    "concurrencyId": 1,
                    "amended": false
                }]
            },
            "perfLabId": "104",
            "componentDefs": [],
            "rules": [],
            "name": "HGBELINTERP2",
            "description": "GCS Hemoglobin Electrophoresis Interpretation",
            "placeHolderCode": "3302Q2P",
            "reportDescriptionIndividual": "<strong>Hemoglobin Electrophoresis Interpretation<\/strong>",
            "reportDescriptionPanel": "<p><strong>Hemoglobin Electrophoresis Interpretation<\/strong><\/p>",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 14,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": true,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": true,
            "doNotBillSubChoice": true,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "requiredInterpretation": false,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 36
        },
        {
            "female": {
                "resultFlag": "Normal",
                "globos": [
                    {
                        "globalTextId": 4072120,
                        "description": "HEXA Extra Methodology",
                        "longText": "<p><strong>Hexosaminidase A:<\/strong> This enzyme assay determines total hexosaminidase and hexosaminidase A activities in leukocytes. The hexosaminidase activities are measured before and after heat inactivation using a fluorescence-generating 4-methylumbelliferyl-N-acetyl-<span style=\"color: #333333;\">&beta;<\/span>-D-glucosaminide substrate. Thermal fractionation of hexosaminidase is calculated to differentiate Tay-Sachs disease carriers from non-carriers.<\/p>"
                    },
                    {
                        "globalTextId": 4072121,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072122,
                        "description": "HEXA Panel Negative Result",
                        "longText": "<p><strong>Tay-Sachs disease (Hexosaminidase A)<\/strong><\/p>\r\n<p>Normal (1500 nmoles/hr/mg protein - 57% A)<\/p>"
                    },
                    {
                        "globalTextId": 4072123,
                        "description": "HEXA Panel Negative Interpretation",
                        "longText": "<table cellspacing=\"0\" cellpadding=\"0\" border=\"1\" style=\"border: medium none currentcolor;\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"width: 1.75in;\">\r\n            <p>\r\n            <strong> <\/strong>\r\n            <\/p>\r\n            <\/td>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\r\n            <p style=\"text-align: center;\"><span style=\"font-size: 8pt; text-align: center;\"><strong>Normal Reference Range<\/strong><\/span>\r\n            <\/p>\r\n            <\/td>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\r\n            <p style=\"text-align: center;\"><span style=\"font-size: 8pt; text-align: center;\"><strong>Carrier Reference Range<\/strong><\/span>\r\n            <\/p>\r\n            <\/td>\r\n        <\/tr>\r\n        <tr>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1.75in;\">\r\n            <p><strong><span style=\"font-size: 8pt; text-align: center;\">% Hexosaminidase A: 57<\/span><\/strong><\/p>\r\n            <br />\r\n            <\/td>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\r\n            <p><span style=\"font-size: 8pt; text-align: center;\">55 - 75<\/span><\/p>\r\n            <\/td>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\r\n            <p><span style=\"font-size: 8pt; text-align: center;\">34 - 49<\/span><\/p>\r\n            <\/td>\r\n        <\/tr>\r\n        <tr>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1.75in;\">\r\n            <p><span style=\"font-size: 8pt; text-align: center;\"><strong>Total Activity: 1500 nmoles/hr/mg protein<\/strong><\/span><\/p>\r\n            <\/td>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\r\n            <p><span style=\"font-size: 8pt; text-align: center;\">1023 - 1961<\/span><\/p>\r\n            <\/td>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\r\n            <p><span style=\"font-size: 8pt; text-align: center;\">870 - 1705<\/span><\/p>\r\n            <\/td>\r\n        <\/tr>\r\n    <\/tbody>\r\n<\/table>\r\n<br />\r\n<p>Non-Carrier: Within the limits of this test this patient is NOT a carrier for Tay Sachs Disease.N<\/p>"
                    },
                    {
                        "globalTextId": 4072124,
                        "description": "Hex A Extra FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\"><strong>Hexosaminidase A:<\/strong> This test was developed and its performance characteristics determined by Baylor College of Medicine. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes and should not be regarded as investigational or for research use only. Performing Laboratory: Baylor College of Medicine, 2450 Holcombe Blvd. Houston TX 77021<\/span><\/p>"
                    },
                    {
                        "globalTextId": 4072125,
                        "description": "HEXA Interpretation",
                        "longText": "<table cellspacing=\"0\" cellpadding=\"0\" border=\"1\" style=\"border: medium none currentcolor;\">\n    <tbody>\n        <tr>\n            <td style=\"width: 1.75in;\">\n            <p>\n            <strong> <\/strong>\n            <\/p>\n            <\/td>\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\n            <p style=\"text-align: center;\"><span style=\"font-size: 8pt; text-align: center;\"><strong>Normal Reference Range<\/strong><\/span>\n            <\/p>\n            <\/td>\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\n            <p style=\"text-align: center;\"><span style=\"font-size: 8pt; text-align: center;\"><strong>Carrier Reference Range<\/strong><\/span>\n            <\/p>\n            <\/td>\n        <\/tr>\n        <tr>\n            <td style=\"border-style: solid; border-width: 1px; width: 1.75in;\">\n            <p><strong><span style=\"font-size: 8pt; text-align: center;\">% Hexosaminidase A: 57<\/span><\/strong><\/p>\n            <br />\n            <\/td>\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\n            <p><span style=\"font-size: 8pt; text-align: center;\">55 - 75<\/span><\/p>\n            <\/td>\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\n            <p><span style=\"font-size: 8pt; text-align: center;\">34 - 49<\/span><\/p>\n            <\/td>\n        <\/tr>\n        <tr>\n            <td style=\"border-style: solid; border-width: 1px; width: 1.75in;\">\n            <p><span style=\"font-size: 8pt; text-align: center;\"><strong>Total Activity: 1500 nmoles/hr/mg protein<\/strong><\/span><\/p>\n            <\/td>\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\n            <p><span style=\"font-size: 8pt; text-align: center;\">1023 - 1961<\/span><\/p>\n            <\/td>\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\n            <p><span style=\"font-size: 8pt; text-align: center;\">870 - 1705<\/span><\/p>\n            <\/td>\n        <\/tr>\n    <\/tbody>\n<\/table>\n<br />\n<p>Non-Carrier: Within the limits of this test this patient is NOT a carrier for Tay Sachs Disease.N<\/p>"
                    },
                    {
                        "globalTextId": 4072126,
                        "description": "HEXA Methodology",
                        "longText": "<p>This enzyme assay determines total hexosaminidase and hexosaminidase A activities in leukocytes. The hexosaminidase activities are measured before and after heat inactivation using a fluorescence-generating 4-methylumbelliferyl-N-acetyl-&beta;-D-glucosaminide substrate. Thermal fractionation of hexosaminidase is calculated to differentiate Tay-Sachs disease carriers from non-carriers.<\/p>"
                    },
                    {
                        "globalTextId": 4072127,
                        "description": "HEX A FDA Statement",
                        "longText": "<p>This test was developed and its performance characteristics determined by Baylor College of Medicine. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes and should not be regarded as investigational or for research use only. Performing Laboratory: Baylor College of Medicine, 2450 Holcombe Blvd. Houston TX 77021<\/p>"
                    },
                    {
                        "globalTextId": 4072128,
                        "description": "Hex A Extra Limitations",
                        "longText": "<p><strong>Hexosaminidase A:<\/strong> A small percentage (&lt;0.7%) of Tay-Sachs disease carriers may be identified as non-carriers by this assay (Triggs-Raine et al. NEJM 1990). In addition, Tay-Sachs disease patients or carriers with certain genetic variants such as AB variant (OMIM 272750) and B1 variant (OMIM 272800) will not be detected by this method. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072129,
                        "description": "HEXA Limitations",
                        "longText": "<p>A small percentage (&lt;0.7%) of Tay-Sachs disease carriers may be identified as non-carriers by this assay (Triggs-Raine et al. NEJM 1990). In addition, Tay-Sachs disease patients or carriers with certain genetic variants such as AB variant (OMIM 272750) and B1 variant (OMIM 272800) will not be detected by this method. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072130,
                        "description": "HEXA Interpretation For HL7",
                        "longText": "Non-Carrier: Within the limits of this test this patient is NOT a carrier for Tay Sachs Disease.N <br />\r\n<br />\r\n% Hexosaminidase A: 57<br />\r\n% Hexosaminidase A Normal Range: 55 - 75<br />\r\n% Hexosaminidase A Carrier Range: 34 - 49<br />\r\n<br />\r\nTotal Activity: 1500 nmoles/hr/mg protein<br />\r\nTotal Activity Normal Range: 1023 - 1961<br />\r\nTotal Activity Carrier Range: 870 - 1705"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330522,
                        "componentDefId": 24543,
                        "result": "1500",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330523,
                        "componentDefId": 24551,
                        "result": "1705",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330524,
                        "componentDefId": 24547,
                        "result": "1961",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330525,
                        "componentDefId": 24550,
                        "result": "870",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330526,
                        "componentDefId": 24546,
                        "result": "1023",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330527,
                        "componentDefId": 24552,
                        "result": "Non-Carrier: Within the limits of this test this patient is NOT a carrier for Tay Sachs Disease.N",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330528,
                        "componentDefId": 24542,
                        "result": "57",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330529,
                        "componentDefId": 24549,
                        "result": "49",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330530,
                        "componentDefId": 24545,
                        "result": "75",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330531,
                        "componentDefId": 24548,
                        "result": "34",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330532,
                        "componentDefId": 24544,
                        "result": "55",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 14948
            },
            "male": {
                "resultFlag": "Normal",
                "globos": [
                    {
                        "globalTextId": 3926609,
                        "description": "HEXA Extra Methodology",
                        "longText": "<p><strong>Hexosaminidase A:<\/strong> This enzyme assay determines total hexosaminidase and hexosaminidase A activities in leukocytes. The hexosaminidase activities are measured before and after heat inactivation using a fluorescence-generating 4-methylumbelliferyl-N-acetyl-<span style=\"color: #333333;\">&beta;<\/span>-D-glucosaminide substrate. Thermal fractionation of hexosaminidase is calculated to differentiate Tay-Sachs disease carriers from non-carriers.<\/p>"
                    },
                    {
                        "globalTextId": 3926610,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 3926611,
                        "description": "HEXA Panel Negative Result",
                        "longText": "<p><strong>Tay-Sachs disease (Hexosaminidase A)<\/strong><\/p>\r\n<p>Normal (1311 nmoles/hr/mg protein - 58.6% A)<\/p>"
                    },
                    {
                        "globalTextId": 3926612,
                        "description": "HEXA Panel Negative Interpretation",
                        "longText": "<table cellspacing=\"0\" cellpadding=\"0\" border=\"1\" style=\"border: medium none currentcolor;\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"width: 1.75in;\">\r\n            <p>\r\n            <strong> <\/strong>\r\n            <\/p>\r\n            <\/td>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\r\n            <p style=\"text-align: center;\"><span style=\"font-size: 8pt; text-align: center;\"><strong>Normal Reference Range<\/strong><\/span>\r\n            <\/p>\r\n            <\/td>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\r\n            <p style=\"text-align: center;\"><span style=\"font-size: 8pt; text-align: center;\"><strong>Carrier Reference Range<\/strong><\/span>\r\n            <\/p>\r\n            <\/td>\r\n        <\/tr>\r\n        <tr>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1.75in;\">\r\n            <p><strong><span style=\"font-size: 8pt; text-align: center;\">% Hexosaminidase A: 58.6<\/span><\/strong><\/p>\r\n            <br />\r\n            <\/td>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\r\n            <p><span style=\"font-size: 8pt; text-align: center;\">55 - 75<\/span><\/p>\r\n            <\/td>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\r\n            <p><span style=\"font-size: 8pt; text-align: center;\">34 - 49<\/span><\/p>\r\n            <\/td>\r\n        <\/tr>\r\n        <tr>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1.75in;\">\r\n            <p><span style=\"font-size: 8pt; text-align: center;\"><strong>Total Activity: 1311 nmoles/hr/mg protein<\/strong><\/span><\/p>\r\n            <\/td>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\r\n            <p><span style=\"font-size: 8pt; text-align: center;\">1023 - 1961<\/span><\/p>\r\n            <\/td>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\r\n            <p><span style=\"font-size: 8pt; text-align: center;\">870 - 1705<\/span><\/p>\r\n            <\/td>\r\n        <\/tr>\r\n    <\/tbody>\r\n<\/table>\r\n<br />\r\n<p>Non-Carrier: Within the limits of this test this patient is NOT a carrier for Tay Sachs Disease.<\/p>"
                    },
                    {
                        "globalTextId": 3926614,
                        "description": "Hex A Extra FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\"><strong>Hexosaminidase A:<\/strong> This test was developed and its performance characteristics determined by Baylor College of Medicine. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes and should not be regarded as investigational or for research use only. Performing Laboratory: Baylor College of Medicine, 2450 Holcombe Blvd. Houston TX 77021<\/span><\/p>"
                    },
                    {
                        "globalTextId": 3926616,
                        "description": "HEXA Interpretation",
                        "longText": "<table cellspacing=\"0\" cellpadding=\"0\" border=\"1\" style=\"border: medium none currentcolor;\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"width: 1.75in;\">\r\n            <p>\r\n            <strong> <\/strong>\r\n            <\/p>\r\n            <\/td>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\r\n            <p style=\"text-align: center;\"><span style=\"font-size: 8pt; text-align: center;\"><strong>Normal Reference Range<\/strong><\/span>\r\n            <\/p>\r\n            <\/td>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\r\n            <p style=\"text-align: center;\"><span style=\"font-size: 8pt; text-align: center;\"><strong>Carrier Reference Range<\/strong><\/span>\r\n            <\/p>\r\n            <\/td>\r\n        <\/tr>\r\n        <tr>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1.75in;\">\r\n            <p><strong><span style=\"font-size: 8pt; text-align: center;\">% Hexosaminidase A: 58.6<\/span><\/strong><\/p>\r\n            <br />\r\n            <\/td>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\r\n            <p><span style=\"font-size: 8pt; text-align: center;\">55 - 75<\/span><\/p>\r\n            <\/td>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\r\n            <p><span style=\"font-size: 8pt; text-align: center;\">34 - 49<\/span><\/p>\r\n            <\/td>\r\n        <\/tr>\r\n        <tr>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1.75in;\">\r\n            <p><span style=\"font-size: 8pt; text-align: center;\"><strong>Total Activity: 1311 nmoles/hr/mg protein<\/strong><\/span><\/p>\r\n            <\/td>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\r\n            <p><span style=\"font-size: 8pt; text-align: center;\">1023 - 1961<\/span><\/p>\r\n            <\/td>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\r\n            <p><span style=\"font-size: 8pt; text-align: center;\">870 - 1705<\/span><\/p>\r\n            <\/td>\r\n        <\/tr>\r\n    <\/tbody>\r\n<\/table>\r\n<br />\r\n<p>Non-Carrier: Within the limits of this test this patient is NOT a carrier for Tay Sachs Disease.<\/p>"
                    },
                    {
                        "globalTextId": 3926618,
                        "description": "HEXA Methodology",
                        "longText": "<p>This enzyme assay determines total hexosaminidase and hexosaminidase A activities in leukocytes. The hexosaminidase activities are measured before and after heat inactivation using a fluorescence-generating 4-methylumbelliferyl-N-acetyl-&beta;-D-glucosaminide substrate. Thermal fractionation of hexosaminidase is calculated to differentiate Tay-Sachs disease carriers from non-carriers.<\/p>"
                    },
                    {
                        "globalTextId": 3926620,
                        "description": "HEX A FDA Statement",
                        "longText": "<p>This test was developed and its performance characteristics determined by Baylor College of Medicine. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes and should not be regarded as investigational or for research use only. Performing Laboratory: Baylor College of Medicine, 2450 Holcombe Blvd. Houston TX 77021<\/p>"
                    },
                    {
                        "globalTextId": 3926622,
                        "description": "Hex A Extra Limitations",
                        "longText": "<p><strong>Hexosaminidase A:<\/strong> A small percentage (&lt;0.7%) of Tay-Sachs disease carriers may be identified as non-carriers by this assay (Triggs-Raine et al. NEJM 1990). In addition, Tay-Sachs disease patients or carriers with certain genetic variants such as AB variant (OMIM 272750) and B1 variant (OMIM 272800) will not be detected by this method. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3926623,
                        "description": "HEXA Limitations",
                        "longText": "<p>A small percentage (&lt;0.7%) of Tay-Sachs disease carriers may be identified as non-carriers by this assay (Triggs-Raine et al. NEJM 1990). In addition, Tay-Sachs disease patients or carriers with certain genetic variants such as AB variant (OMIM 272750) and B1 variant (OMIM 272800) will not be detected by this method. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2211649,
                        "componentDefId": 24543,
                        "result": "1311",
                        "resultsDateTime": "2016-07-15T15:29:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2211650,
                        "componentDefId": 24551,
                        "result": "1705",
                        "resultsDateTime": "2016-07-15T15:29:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2211651,
                        "componentDefId": 24545,
                        "result": "75",
                        "resultsDateTime": "2016-07-15T15:29:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2211652,
                        "componentDefId": 24548,
                        "result": "34",
                        "resultsDateTime": "2016-07-15T15:29:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2211653,
                        "componentDefId": 24544,
                        "result": "55",
                        "resultsDateTime": "2016-07-15T15:29:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2211654,
                        "componentDefId": 24547,
                        "result": "1961",
                        "resultsDateTime": "2016-07-15T15:29:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2211655,
                        "componentDefId": 24550,
                        "result": "870",
                        "resultsDateTime": "2016-07-15T15:29:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2211656,
                        "componentDefId": 24546,
                        "result": "1023",
                        "resultsDateTime": "2016-07-15T15:29:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2211657,
                        "componentDefId": 24552,
                        "result": "Non-Carrier: Within the limits of this test this patient is NOT a carrier for Tay Sachs Disease.",
                        "resultsDateTime": "2016-07-15T15:29:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2211658,
                        "componentDefId": 24542,
                        "result": "58.6",
                        "resultsDateTime": "2016-07-15T15:29:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2211659,
                        "componentDefId": 24549,
                        "result": "49",
                        "resultsDateTime": "2016-07-15T15:29:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 14948
            },
            "partner": {
                "resultFlag": "Normal",
                "globos": [
                    {
                        "globalTextId": 4072120,
                        "description": "HEXA Extra Methodology",
                        "longText": "<p><strong>Hexosaminidase A:<\/strong> This enzyme assay determines total hexosaminidase and hexosaminidase A activities in leukocytes. The hexosaminidase activities are measured before and after heat inactivation using a fluorescence-generating 4-methylumbelliferyl-N-acetyl-<span style=\"color: #333333;\">&beta;<\/span>-D-glucosaminide substrate. Thermal fractionation of hexosaminidase is calculated to differentiate Tay-Sachs disease carriers from non-carriers.<\/p>"
                    },
                    {
                        "globalTextId": 4072121,
                        "description": "Inheritance Autosomal Recessive",
                        "longText": "Autosomal Recessive"
                    },
                    {
                        "globalTextId": 4072122,
                        "description": "HEXA Panel Negative Result",
                        "longText": "<p><strong>Tay-Sachs disease (Hexosaminidase A)<\/strong><\/p>\r\n<p>Normal (1500 nmoles/hr/mg protein - 57% A)<\/p>"
                    },
                    {
                        "globalTextId": 4072123,
                        "description": "HEXA Panel Negative Interpretation",
                        "longText": "<table cellspacing=\"0\" cellpadding=\"0\" border=\"1\" style=\"border: medium none currentcolor;\">\r\n    <tbody>\r\n        <tr>\r\n            <td style=\"width: 1.75in;\">\r\n            <p>\r\n            <strong> <\/strong>\r\n            <\/p>\r\n            <\/td>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\r\n            <p style=\"text-align: center;\"><span style=\"font-size: 8pt; text-align: center;\"><strong>Normal Reference Range<\/strong><\/span>\r\n            <\/p>\r\n            <\/td>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\r\n            <p style=\"text-align: center;\"><span style=\"font-size: 8pt; text-align: center;\"><strong>Carrier Reference Range<\/strong><\/span>\r\n            <\/p>\r\n            <\/td>\r\n        <\/tr>\r\n        <tr>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1.75in;\">\r\n            <p><strong><span style=\"font-size: 8pt; text-align: center;\">% Hexosaminidase A: 57<\/span><\/strong><\/p>\r\n            <br />\r\n            <\/td>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\r\n            <p><span style=\"font-size: 8pt; text-align: center;\">55 - 75<\/span><\/p>\r\n            <\/td>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\r\n            <p><span style=\"font-size: 8pt; text-align: center;\">34 - 49<\/span><\/p>\r\n            <\/td>\r\n        <\/tr>\r\n        <tr>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1.75in;\">\r\n            <p><span style=\"font-size: 8pt; text-align: center;\"><strong>Total Activity: 1500 nmoles/hr/mg protein<\/strong><\/span><\/p>\r\n            <\/td>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\r\n            <p><span style=\"font-size: 8pt; text-align: center;\">1023 - 1961<\/span><\/p>\r\n            <\/td>\r\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\r\n            <p><span style=\"font-size: 8pt; text-align: center;\">870 - 1705<\/span><\/p>\r\n            <\/td>\r\n        <\/tr>\r\n    <\/tbody>\r\n<\/table>\r\n<br />\r\n<p>Non-Carrier: Within the limits of this test this patient is NOT a carrier for Tay Sachs Disease.N<\/p>"
                    },
                    {
                        "globalTextId": 4072124,
                        "description": "Hex A Extra FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\"><strong>Hexosaminidase A:<\/strong> This test was developed and its performance characteristics determined by Baylor College of Medicine. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes and should not be regarded as investigational or for research use only. Performing Laboratory: Baylor College of Medicine, 2450 Holcombe Blvd. Houston TX 77021<\/span><\/p>"
                    },
                    {
                        "globalTextId": 4072125,
                        "description": "HEXA Interpretation",
                        "longText": "<table cellspacing=\"0\" cellpadding=\"0\" border=\"1\" style=\"border: medium none currentcolor;\">\n    <tbody>\n        <tr>\n            <td style=\"width: 1.75in;\">\n            <p>\n            <strong> <\/strong>\n            <\/p>\n            <\/td>\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\n            <p style=\"text-align: center;\"><span style=\"font-size: 8pt; text-align: center;\"><strong>Normal Reference Range<\/strong><\/span>\n            <\/p>\n            <\/td>\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\n            <p style=\"text-align: center;\"><span style=\"font-size: 8pt; text-align: center;\"><strong>Carrier Reference Range<\/strong><\/span>\n            <\/p>\n            <\/td>\n        <\/tr>\n        <tr>\n            <td style=\"border-style: solid; border-width: 1px; width: 1.75in;\">\n            <p><strong><span style=\"font-size: 8pt; text-align: center;\">% Hexosaminidase A: 57<\/span><\/strong><\/p>\n            <br />\n            <\/td>\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\n            <p><span style=\"font-size: 8pt; text-align: center;\">55 - 75<\/span><\/p>\n            <\/td>\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\n            <p><span style=\"font-size: 8pt; text-align: center;\">34 - 49<\/span><\/p>\n            <\/td>\n        <\/tr>\n        <tr>\n            <td style=\"border-style: solid; border-width: 1px; width: 1.75in;\">\n            <p><span style=\"font-size: 8pt; text-align: center;\"><strong>Total Activity: 1500 nmoles/hr/mg protein<\/strong><\/span><\/p>\n            <\/td>\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\n            <p><span style=\"font-size: 8pt; text-align: center;\">1023 - 1961<\/span><\/p>\n            <\/td>\n            <td style=\"border-style: solid; border-width: 1px; width: 1in;\">\n            <p><span style=\"font-size: 8pt; text-align: center;\">870 - 1705<\/span><\/p>\n            <\/td>\n        <\/tr>\n    <\/tbody>\n<\/table>\n<br />\n<p>Non-Carrier: Within the limits of this test this patient is NOT a carrier for Tay Sachs Disease.N<\/p>"
                    },
                    {
                        "globalTextId": 4072126,
                        "description": "HEXA Methodology",
                        "longText": "<p>This enzyme assay determines total hexosaminidase and hexosaminidase A activities in leukocytes. The hexosaminidase activities are measured before and after heat inactivation using a fluorescence-generating 4-methylumbelliferyl-N-acetyl-&beta;-D-glucosaminide substrate. Thermal fractionation of hexosaminidase is calculated to differentiate Tay-Sachs disease carriers from non-carriers.<\/p>"
                    },
                    {
                        "globalTextId": 4072127,
                        "description": "HEX A FDA Statement",
                        "longText": "<p>This test was developed and its performance characteristics determined by Baylor College of Medicine. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes and should not be regarded as investigational or for research use only. Performing Laboratory: Baylor College of Medicine, 2450 Holcombe Blvd. Houston TX 77021<\/p>"
                    },
                    {
                        "globalTextId": 4072128,
                        "description": "Hex A Extra Limitations",
                        "longText": "<p><strong>Hexosaminidase A:<\/strong> A small percentage (&lt;0.7%) of Tay-Sachs disease carriers may be identified as non-carriers by this assay (Triggs-Raine et al. NEJM 1990). In addition, Tay-Sachs disease patients or carriers with certain genetic variants such as AB variant (OMIM 272750) and B1 variant (OMIM 272800) will not be detected by this method. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072129,
                        "description": "HEXA Limitations",
                        "longText": "<p>A small percentage (&lt;0.7%) of Tay-Sachs disease carriers may be identified as non-carriers by this assay (Triggs-Raine et al. NEJM 1990). In addition, Tay-Sachs disease patients or carriers with certain genetic variants such as AB variant (OMIM 272750) and B1 variant (OMIM 272800) will not be detected by this method. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072130,
                        "description": "HEXA Interpretation For HL7",
                        "longText": "Non-Carrier: Within the limits of this test this patient is NOT a carrier for Tay Sachs Disease.N <br />\r\n<br />\r\n% Hexosaminidase A: 57<br />\r\n% Hexosaminidase A Normal Range: 55 - 75<br />\r\n% Hexosaminidase A Carrier Range: 34 - 49<br />\r\n<br />\r\nTotal Activity: 1500 nmoles/hr/mg protein<br />\r\nTotal Activity Normal Range: 1023 - 1961<br />\r\nTotal Activity Carrier Range: 870 - 1705"
                    }
                ],
                "reportTexts": [],
                "results": [
                    {
                        "componentResultId": 2330522,
                        "componentDefId": 24543,
                        "result": "1500",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330523,
                        "componentDefId": 24551,
                        "result": "1705",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330524,
                        "componentDefId": 24547,
                        "result": "1961",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330525,
                        "componentDefId": 24550,
                        "result": "870",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330526,
                        "componentDefId": 24546,
                        "result": "1023",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330527,
                        "componentDefId": 24552,
                        "result": "Non-Carrier: Within the limits of this test this patient is NOT a carrier for Tay Sachs Disease.N",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330528,
                        "componentDefId": 24542,
                        "result": "57",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330529,
                        "componentDefId": 24549,
                        "result": "49",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330530,
                        "componentDefId": 24545,
                        "result": "75",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330531,
                        "componentDefId": 24548,
                        "result": "34",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    },
                    {
                        "componentResultId": 2330532,
                        "componentDefId": 24544,
                        "result": "55",
                        "resultsDateTime": "2016-11-30T00:00:00",
                        "concurrencyId": 1,
                        "amended": false
                    }
                ],
                "reproRisk": 14948
            },
            "perfLabId": "101",
            "componentDefs": [],
            "rules": [],
            "name": "HEXAT4",
            "description": "PREPARENT CARRIER SCREEN \u2013 Hexosaminidase A",
            "placeHolderCode": "2201T4P",
            "reportDescriptionIndividual": "<strong>PREPARENT&trade; CARRIER SCREEN &ndash; Hexosaminidase A<\/strong>",
            "reportDescriptionPanel": "<strong>Tay-Sachs disease (Hexosaminidase A)<\/strong>",
            "isPanel": false,
            "methLimText": "<p><strong><span style=\"font-size: 14px; font-family: 'Avenir Book';\">METHODOLOGY<\/span><\/strong><\/p>\n<p><span style=\"font-size: 14px; font-family: 'Avenir Book';\">This enzyme assay determines total hexosaminidase and hexosaminidase A activities in leukocytes.&nbsp; The hexosaminidase activities are measured before and after heat inactivation using a fluorescence-generating 4-methylumbelliferyl-N-acetyl-&beta;-D-glucosaminide substrate.&nbsp; Thermal fractionation of hexosaminidase is calculated to differentiate Tay-Sachs disease carriers from non-carriers.<\/span><\/p>\n<p><span style=\"font-size: 14px; font-family: 'Avenir Book';\"><strong><span>LIMITATIONS<\/span><\/strong><\/span><\/p>\n<p><span style=\"font-size: 14px; font-family: 'Avenir Book';\">A small percentage (&lt;0.7 %) of Tay-Sachs disease carriers may be identified as non-carriers by this assay (Triggs-Raine et al. NEJM 1990).&nbsp; In addition, Tay-Sachs disease patients or carriers with certain genetic variants such as AB variant (OMIM 272750) and B1 variant will not be detected by this method.<\/span><\/p>",
            "fdaStatement": "<p>This test was developed and its performance characteristics determined by Baylor College of Medicine Medical Genetics Laboratories, 2450 Holcombe Blvd Houston, Texas 77021&nbsp;(CAP# 2109314/ CLIA# 45D0660090). It has not been cleared or approved by the FDA. The laboratory is regulated under CLIA as qualified to perform high-complexitytesting. This test is used for clinical purposes. It should not be regarded as investigational or for research.<\/p>",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 39,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": false,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": true,
            "isCustomPanel": false,
            "customAbbreviation": "B",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "assayTypeId": 3,
            "requiredInterpretation": false,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 34
        },
        {
            "female": {
                "resultFlag": "TSO Report",
                "globos": [],
                "reportTexts": [],
                "results": []
            },
            "partner": {
                "resultFlag": "TSO Report",
                "globos": [],
                "reportTexts": [],
                "results": []
            },
            "perfLabId": "104",
            "componentDefs": [],
            "rules": [],
            "name": "AFPQ1",
            "description": "Quest - AFP",
            "placeHolderCode": "2900Q1P",
            "reportDescriptionIndividual": "Quest - AFP",
            "reportDescriptionPanel": "",
            "isPanel": false,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": true,
            "active": true,
            "concurrencyId": 2,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": false,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": false,
            "neededInCopia": true,
            "isCustomPanel": false,
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": false,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 34
        }
    ],
    "samples": {
        "femaleSamples": [
            {
                "sampleId": "1611300003",
                "sampleTypeId": 24,
                "sampleType": {
                    "sampleTypeId": 24,
                    "name": "Whole Blood",
                    "concurrencyId": 0,
                    "externalSampleTypeId": 6
                },
                "referenceNumber": "1611300003          ",
                "collectionDateTime": "2016-11-30T10:07:00",
                "receivedDateTime": "2016-11-30T10:07:00",
                "concurrencyId": 1,
                "orderId": "16114141"
            },
            {
                "sampleId": "1611300001",
                "sampleTypeId": 24,
                "sampleType": {
                    "sampleTypeId": 24,
                    "name": "Whole Blood",
                    "concurrencyId": 0,
                    "externalSampleTypeId": 6
                },
                "referenceNumber": "1611300001          ",
                "collectionDateTime": "2016-11-30T10:07:00",
                "receivedDateTime": "2016-11-30T10:07:00",
                "concurrencyId": 1,
                "orderId": "16114141"
            },
            {
                "sampleId": "1611300004",
                "sampleTypeId": 24,
                "sampleType": {
                    "sampleTypeId": 24,
                    "name": "Whole Blood",
                    "concurrencyId": 0,
                    "externalSampleTypeId": 6
                },
                "referenceNumber": "1611300004          ",
                "collectionDateTime": "2016-11-30T10:07:00",
                "receivedDateTime": "2016-11-30T10:07:00",
                "concurrencyId": 1,
                "orderId": "16114141"
            },
            {
                "sampleId": "1611300002",
                "sampleTypeId": 23,
                "sampleType": {
                    "sampleTypeId": 23,
                    "name": "None",
                    "concurrencyId": 0,
                    "externalSampleTypeId": 13
                },
                "referenceNumber": "1611300002          ",
                "collectionDateTime": "2016-11-30T10:07:00",
                "receivedDateTime": "2016-11-30T10:07:00",
                "concurrencyId": 1,
                "orderId": "16114141"
            },
            {
                "sampleId": "1611300005",
                "sampleTypeId": 24,
                "sampleType": {
                    "sampleTypeId": 24,
                    "name": "Whole Blood",
                    "concurrencyId": 0,
                    "externalSampleTypeId": 6
                },
                "referenceNumber": "1611300005          ",
                "collectionDateTime": "2016-11-30T10:07:00",
                "receivedDateTime": "2016-11-30T10:07:00",
                "concurrencyId": 1,
                "orderId": "16114141"
            },
            {
                "sampleId": "1611300006",
                "sampleTypeId": 26,
                "sampleType": {
                    "sampleTypeId": 26,
                    "name": "Serum",
                    "concurrencyId": 0,
                    "externalSampleTypeId": 2
                },
                "referenceNumber": "1611300006          ",
                "collectionDateTime": "2016-11-30T10:07:00",
                "receivedDateTime": "2016-11-30T10:07:00",
                "concurrencyId": 1,
                "orderId": "16114141"
            }
        ],
        "maleSamples": [
            {
                "sampleId": "1607110205",
                "sampleTypeId": 24,
                "sampleType": {
                    "sampleTypeId": 24,
                    "name": "Whole Blood",
                    "concurrencyId": 0,
                    "externalSampleTypeId": 6
                },
                "referenceNumber": "1607110205          ",
                "collectionDateTime": "2016-07-11T10:07:00",
                "receivedDateTime": "2016-07-11T10:06:00",
                "concurrencyId": 1,
                "orderId": "16073546"
            },
            {
                "sampleId": "1607110204",
                "sampleTypeId": 24,
                "sampleType": {
                    "sampleTypeId": 24,
                    "name": "Whole Blood",
                    "concurrencyId": 0,
                    "externalSampleTypeId": 6
                },
                "referenceNumber": "1607110204          ",
                "collectionDateTime": "2016-07-11T10:07:00",
                "receivedDateTime": "2016-07-11T10:06:00",
                "concurrencyId": 1,
                "orderId": "16073546"
            },
            {
                "sampleId": "1607110202",
                "sampleTypeId": 24,
                "sampleType": {
                    "sampleTypeId": 24,
                    "name": "Whole Blood",
                    "concurrencyId": 0,
                    "externalSampleTypeId": 6
                },
                "referenceNumber": "1607110202          ",
                "collectionDateTime": "2016-07-11T10:07:00",
                "receivedDateTime": "2016-07-11T10:06:00",
                "concurrencyId": 1,
                "orderId": "16073546"
            },
            {
                "sampleId": "1607110203",
                "sampleTypeId": 23,
                "sampleType": {
                    "sampleTypeId": 23,
                    "name": "None",
                    "concurrencyId": 0,
                    "externalSampleTypeId": 13
                },
                "referenceNumber": "1607110203          ",
                "collectionDateTime": "2016-07-11T10:07:00",
                "receivedDateTime": "2016-07-11T10:06:00",
                "concurrencyId": 1,
                "orderId": "16073546"
            },
            {
                "sampleId": "1607110206",
                "sampleTypeId": 24,
                "sampleType": {
                    "sampleTypeId": 24,
                    "name": "Whole Blood",
                    "concurrencyId": 0,
                    "externalSampleTypeId": 6
                },
                "referenceNumber": "1607110206          ",
                "collectionDateTime": "2016-07-11T10:07:00",
                "receivedDateTime": "2016-07-11T10:06:00",
                "concurrencyId": 1,
                "orderId": "16073546"
            }
        ]
    },
    "panels": [
        {
            "female": {
                "resultFlag": "Normal",
                "globos": [],
                "reportTexts": [],
                "results": []
            },
            "male": {
                "globos": [],
                "reportTexts": [],
                "results": []
            },
            "partner": {
                "resultFlag": "Normal",
                "globos": [],
                "reportTexts": [],
                "results": []
            },
            "perfLabId": "104",
            "componentDefs": [],
            "rules": [],
            "name": "HEMOGLOBQ3",
            "description": "PREPARENT CARRIER SCREEN \u2013 Hemoglobinopathy Evaluation",
            "placeHolderCode": "",
            "reportDescriptionIndividual": "<strong>PREPARENT&trade; CARRIER SCREEN &ndash; Hemoglobinopathy Evaluation<\/strong>",
            "reportDescriptionPanel": "<strong>PREPARENT&trade; CARRIER SCREEN &ndash; Hemoglobinopathy Evaluation<\/strong>",
            "isPanel": true,
            "methLimText": "<p><strong><span style=\"font-size: 10pt; font-family: 'Arial Narrow', sans-serif;\">METHODOLOGY<\/span><\/strong><\/p>\n<p><span>High Performance Liquid Chromatography (HPLC) followed by, if necessary, alkaline and acid Hemoglobin Electrophoresis on agarose gel.<\/span><\/p>",
            "fdaStatement": "<span style=\"font-size: 8pt; font-family: 'Arial Narrow', sans-serif;\">Performing Laboratory: Quest Diagnostics-Wood Dale, 1355 Mittel Blvd, Wood Dale, IL 60191-1024 &nbsp;Laboratory Director: Anthony V Thomas, M.D.<\/span>",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 5,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": true,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": false,
            "doNotBillSubChoice": false,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": false,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": false,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 34
        },
        {
            "female": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072142,
                        "description": "GCS V5 Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing (exceptions noted below). All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies.<\/p>"
                    },
                    {
                        "globalTextId": 4072143,
                        "description": "GCS V5 Limitations",
                        "longText": "<p>These interpretations are based on the current understanding of the molecular genetics of these disorders. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism.  Rare genetic variants may show results of pseudogene amplification.  Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens (exceptions are noted below). No test can detect 100% of genetic conditions or carrier status of all individuals. &nbsp;There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072144,
                        "description": "GCS V5 FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. Performing Laboratory: Progenity, Inc., 5230 S. State Road, Ann Arbor, MI 48108<\/span><\/p>"
                    },
                    {
                        "globalTextId": 4072145,
                        "description": "GCS V5 Global Additional Info",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-global-102016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global 102016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072146,
                        "description": "GCS V5 Global Negative Intro",
                        "longText": "<p>This patient tested negative for the mutations analyzed on this panel. Please see progenity.com/preparent-global-102016 for the list of diseases and mutations. A residual risk table is included for negative results. These results reduce, but do not eliminate the risk of carrier status. Interpretations are based on a negative family history and the absence of symptoms.<\/p>\r\n<br />\r\n<p>These results are subject to the limitations section below. For a full list of conditions tested please see the <strong>RISK CALCULATIONS<\/strong> section.<\/p>\r\n<br />\r\n<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>"
                    },
                    {
                        "globalTextId": 4072147,
                        "description": "GCS V5 Global Positive Negative Intro",
                        "longText": "<p>This patient tested negative for the other mutations analyzed on this panel. Please see progenity.com/preparent-global-102016 for the list of diseases and mutations. A residual risk table is included for negative results. These results reduce, but do not eliminate the risk of carrier status. Interpretations are based on a negative family history and the absence of symptoms.<\/p>\r\n<br />\r\n<p>These results are subject to the limitations section below. For a full list of conditions tested please see the <strong>RISK CALCULATIONS<\/strong> section.<\/p>\r\n<br />\r\n<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": []
            },
            "male": {
                "resultFlag": "Positive",
                "globos": [
                    {
                        "globalTextId": 3927123,
                        "description": "Quest Hemoglobinopathy Interpretation",
                        "longText": "<p><strong>Hemoglobinopathy Carrier Screening Interpretation:<\/strong><\/p>\n<p>Normal hemoglobin distribution.<\/p>"
                    },
                    {
                        "globalTextId": 3927124,
                        "description": "GCS V5 Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing (exceptions noted below). All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies.<\/p>"
                    },
                    {
                        "globalTextId": 3927125,
                        "description": "GCS V5 Limitations",
                        "longText": "<p>These interpretations are based on the current understanding of the molecular genetics of these disorders. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism.  Rare genetic variants may show results of pseudogene amplification.  Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens (exceptions are noted below). No test can detect 100% of genetic conditions or carrier status of all individuals. &nbsp;There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 3927126,
                        "description": "GCS V5 FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. Performing Laboratory: Progenity, Inc., 5230 S. State Road, Ann Arbor, MI 48108<\/span><\/p>"
                    },
                    {
                        "globalTextId": 3927127,
                        "description": "GCS V5 Global Additional Info",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-global-042016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global 042016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 3927128,
                        "description": "GCS V5 Global Negative Intro",
                        "longText": "<p>This patient tested negative for the mutations analyzed on this panel. Please see progenity.com/preparent-global-042016 for the list of diseases and mutations. A residual risk table is included for negative results. These results reduce, but do not eliminate the risk of carrier status. Interpretations are based on a negative family history and the absence of symptoms.<\/p>\r\n<br />\r\n<p>These results are subject to the limitations section below. For a full list of conditions tested please see the <strong>RISK CALCULATIONS<\/strong> section.<\/p>\r\n<br />\r\n<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>"
                    },
                    {
                        "globalTextId": 3927129,
                        "description": "GCS V5 Global Positive Negative Intro",
                        "longText": "<p>This patient tested negative for the other mutations analyzed on this panel. Please see progenity.com/preparent-global-042016 for the list of diseases and mutations. A residual risk table is included for negative results. These results reduce, but do not eliminate the risk of carrier status. Interpretations are based on a negative family history and the absence of symptoms.<\/p>\r\n<br />\r\n<p>These results are subject to the limitations section below. For a full list of conditions tested please see the <strong>RISK CALCULATIONS<\/strong> section.<\/p>\r\n<br />\r\n<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": []
            },
            "partner": {
                "resultFlag": "Negative",
                "globos": [
                    {
                        "globalTextId": 4072142,
                        "description": "GCS V5 Methodology",
                        "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing (exceptions noted below). All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies.<\/p>"
                    },
                    {
                        "globalTextId": 4072143,
                        "description": "GCS V5 Limitations",
                        "longText": "<p>These interpretations are based on the current understanding of the molecular genetics of these disorders. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism.  Rare genetic variants may show results of pseudogene amplification.  Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens (exceptions are noted below). No test can detect 100% of genetic conditions or carrier status of all individuals. &nbsp;There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
                    },
                    {
                        "globalTextId": 4072144,
                        "description": "GCS V5 FDA Statement",
                        "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. Performing Laboratory: Progenity, Inc., 5230 S. State Road, Ann Arbor, MI 48108<\/span><\/p>"
                    },
                    {
                        "globalTextId": 4072145,
                        "description": "GCS V5 Global Additional Info",
                        "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-global-102016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global 102016. Original report is on file and available upon request.<\/p>"
                    },
                    {
                        "globalTextId": 4072146,
                        "description": "GCS V5 Global Negative Intro",
                        "longText": "<p>This patient tested negative for the mutations analyzed on this panel. Please see progenity.com/preparent-global-102016 for the list of diseases and mutations. A residual risk table is included for negative results. These results reduce, but do not eliminate the risk of carrier status. Interpretations are based on a negative family history and the absence of symptoms.<\/p>\r\n<br />\r\n<p>These results are subject to the limitations section below. For a full list of conditions tested please see the <strong>RISK CALCULATIONS<\/strong> section.<\/p>\r\n<br />\r\n<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>"
                    },
                    {
                        "globalTextId": 4072147,
                        "description": "GCS V5 Global Positive Negative Intro",
                        "longText": "<p>This patient tested negative for the other mutations analyzed on this panel. Please see progenity.com/preparent-global-102016 for the list of diseases and mutations. A residual risk table is included for negative results. These results reduce, but do not eliminate the risk of carrier status. Interpretations are based on a negative family history and the absence of symptoms.<\/p>\r\n<br />\r\n<p>These results are subject to the limitations section below. For a full list of conditions tested please see the <strong>RISK CALCULATIONS<\/strong> section.<\/p>\r\n<br />\r\n<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>"
                    }
                ],
                "reportTexts": [],
                "results": []
            },
            "perfLabId": "9",
            "componentDefs": [],
            "rules": [],
            "name": "GCSEP5",
            "description": "PREPARENT CARRIER SCREEN \u2013 Global Panel",
            "placeHolderCode": "",
            "reportDescriptionIndividual": "<strong>PREPARENT&trade; CARRIER SCREEN &ndash; Global Panel<\/strong>",
            "reportDescriptionPanel": "<strong>PREPARENT&trade; CARRIER SCREEN &ndash; Global Panel<\/strong>",
            "isPanel": true,
            "methLimText": "",
            "fdaStatement": "",
            "references": "",
            "carrierFrequency": "",
            "footNoteNegative": "",
            "footNotePositive": "",
            "detectionRate": "",
            "residualRisk": "",
            "externalReport": false,
            "active": true,
            "concurrencyId": 4,
            "residualRiskTable": "",
            "positiveIntroParagraph": "",
            "negativeIntroParagraph": "",
            "notPerformedIntroParagraph": "",
            "eligibleForSummary": true,
            "isAutoApproved": false,
            "clientServicesResultable": false,
            "canBeAutoNegative": false,
            "autoReleasePercent": 0,
            "autoAddSubchoices": true,
            "neededInCopia": false,
            "isCustomPanel": false,
            "customAbbreviation": "",
            "doNotBill": true,
            "doNotBillSubChoice": true,
            "showInCRM": false,
            "showInCRMSubChoice": false,
            "fsaNotBillable": true,
            "effectiveStartDate": "2016-06-20T12:00:00",
            "requiredInterpretation": true,
            "globalTextDefChoiceDefs": [],
            "testGroupId": 24
        }
    ],
    "partnerTexts": [
        {
            "globalTextId": 3925560,
            "description": "Inheritance Autosomal Recessive",
            "longText": "Autosomal Recessive"
        },
        {
            "globalTextId": 3925561,
            "description": "GCS Individual FDA Statement",
            "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
        },
        {
            "globalTextId": 3925562,
            "description": "GCS Individual Methodology",
            "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
        },
        {
            "globalTextId": 3925563,
            "description": "GCS Individual Limitations",
            "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
        },
        {
            "globalTextId": 3925564,
            "description": "GCS Individual Additional Information",
            "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
        },
        {
            "globalTextId": 3925565,
            "description": "Inheritance Autosomal Recessive",
            "longText": "Autosomal Recessive"
        },
        {
            "globalTextId": 3925566,
            "description": "GCS Individual FDA Statement",
            "longText": "<p><span style=\"font-size: 8pt;\">This laboratory-developed test was developed and its performance characteristics validated by Progenity, Inc. under federal CLIA laboratory guidelines. The test has not been cleared or approved by the U.S. Food and Drug Administration. This test is used for clinical purposes. It should not be regarded as investigational or for research only. <\/span><\/p>"
        },
        {
            "globalTextId": 3925567,
            "description": "GCS Individual Methodology",
            "longText": "<p>This assay uses purified genomic DNA, solution based circular capture probes, exonuclease cleanup and PCR barcoding/indexing followed by massively parallel sequencing.&nbsp;All mutations detected by Progenity's NextGen Sequencing platform are confirmed using sequencing or alternate methodologies (excluding hemochromatosis).<\/p>"
        },
        {
            "globalTextId": 3925568,
            "description": "GCS Individual Limitations",
            "longText": "<p>This interpretation is based on the current understanding of the molecular genetics of this disorder. This analysis does not rule out the presence of disease-causing mutations in other regions of the gene analyzed (e.g. large genomic deletions, promoter mutations) or in other genes, and does not detect germline mosaicism. Rare genetic variants may show results of pseudogene amplification.&nbsp;Although DNA-based testing provides highly accurate results, rare diagnostic findings may occur. Examples such as the following may confound interpretation: rare polymorphisms or genetic variants, blood transfusion, organ or bone marrow transplant, or mislabeled specimens. No test can detect 100% of genetic conditions or carrier status of all individuals.  There is a chance that you could be a carrier of or have a genetic condition even if the test results are negative.<\/p>"
        },
        {
            "globalTextId": 3925569,
            "description": "GCS Individual Additional Information",
            "longText": "<p>Please contact Progenity at 855-293-2639 if you wish to consult with a laboratory director or genetic counselor regarding these results.<\/p>\r\n<br />\r\n<p>A list of references, mutations tested, ethnicity-based detection rates, carrier frequencies and residual risks are all available online at: progenity.com/preparent-globalplus-022016<\/p>\r\n<br />\r\n<p>To receive a paper copy, please call Progenity Client Services at +1 855-293-2639 and request the following mutation list: Global Plus 022016. Original report is on file and available upon request.<\/p>"
        }
    ],
    "aoes": {
        "maleAoes": [],
        "femaleAoes": [
            {
                "askOnEnterQuestionId": 39495,
                "orderId": "16114141",
                "askOnEnterQuestionText": "Global1:Ethnicity:",
                "askOnEnterQuestionAnswer": "Caucasian",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 262
            },
            {
                "askOnEnterQuestionId": 39496,
                "orderId": "16114141",
                "askOnEnterQuestionText": "Global1:Ethnicity:",
                "askOnEnterQuestionAnswer": "",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 262
            },
            {
                "askOnEnterQuestionId": 39497,
                "orderId": "16114141",
                "askOnEnterQuestionText": "Global2:Patient/Partner family history \r\nof genetic condition or carrier status?",
                "askOnEnterQuestionAnswer": "Unknown",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 262
            },
            {
                "askOnEnterQuestionId": 39498,
                "orderId": "16114141",
                "askOnEnterQuestionText": "Global2:Patient/Partner family history \r\nof genetic condition or carrier status?",
                "askOnEnterQuestionAnswer": "",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 262
            },
            {
                "askOnEnterQuestionId": 39499,
                "orderId": "16114141",
                "askOnEnterQuestionText": "Global3:Family History:Specify \r\nCondition:",
                "askOnEnterQuestionAnswer": "n/a",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 262
            },
            {
                "askOnEnterQuestionId": 39500,
                "orderId": "16114141",
                "askOnEnterQuestionText": "Global3:Family History:Specify \r\nCondition:",
                "askOnEnterQuestionAnswer": "",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 262
            },
            {
                "askOnEnterQuestionId": 39501,
                "orderId": "16114141",
                "askOnEnterQuestionText": "Global4:Family History:Relationship to \r\nPatient:",
                "askOnEnterQuestionAnswer": "Spouse",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 262
            },
            {
                "askOnEnterQuestionId": 39502,
                "orderId": "16114141",
                "askOnEnterQuestionText": "Global4:Family History:Relationship to \r\nPatient:",
                "askOnEnterQuestionAnswer": "",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 262
            },
            {
                "askOnEnterQuestionId": 39503,
                "orderId": "16114141",
                "askOnEnterQuestionText": "Global5: Name of Reproductive Partner:",
                "askOnEnterQuestionAnswer": "Test, Partner",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 262
            },
            {
                "askOnEnterQuestionId": 39504,
                "orderId": "16114141",
                "askOnEnterQuestionText": "Global5: Name of Reproductive Partner:",
                "askOnEnterQuestionAnswer": "",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 262
            },
            {
                "askOnEnterQuestionId": 39505,
                "orderId": "16114141",
                "askOnEnterQuestionText": "Global6: Partner Date of Birth:",
                "askOnEnterQuestionAnswer": "01/01/1982",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 262
            },
            {
                "askOnEnterQuestionId": 39506,
                "orderId": "16114141",
                "askOnEnterQuestionText": "Global6: Partner Date of Birth:",
                "askOnEnterQuestionAnswer": "",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 262
            },
            {
                "askOnEnterQuestionId": 39507,
                "orderId": "16114141",
                "askOnEnterQuestionText": "Global7: Has the patient had a blood \r\ntransfusion, bone marrow or organ \r\ntransplant in the last 3 months?",
                "askOnEnterQuestionAnswer": "No",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 262
            },
            {
                "askOnEnterQuestionId": 39508,
                "orderId": "16114141",
                "askOnEnterQuestionText": "Global7: Has the patient had a blood \r\ntransfusion, bone marrow or organ \r\ntransplant in the last 3 months?",
                "askOnEnterQuestionAnswer": "",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 262
            },
            {
                "askOnEnterQuestionId": 39509,
                "orderId": "16114141",
                "askOnEnterQuestionText": "Global8: Is the patient pregnant?",
                "askOnEnterQuestionAnswer": "Yes",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 262
            },
            {
                "askOnEnterQuestionId": 39510,
                "orderId": "16114141",
                "askOnEnterQuestionText": "Global8: Is the patient pregnant?",
                "askOnEnterQuestionAnswer": "",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 262
            },
            {
                "askOnEnterQuestionId": 39511,
                "orderId": "16114141",
                "askOnEnterQuestionText": "QAFP1: Date of Birth",
                "askOnEnterQuestionAnswer": "05/11/1989",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 1
            },
            {
                "askOnEnterQuestionId": 39512,
                "orderId": "16114141",
                "askOnEnterQuestionText": "QAFP10: History of Neural Tube Defects",
                "askOnEnterQuestionAnswer": "Not Given",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 1
            },
            {
                "askOnEnterQuestionId": 39513,
                "orderId": "16114141",
                "askOnEnterQuestionText": "QAFP11: Brief History (NTD)",
                "askOnEnterQuestionAnswer": "n/a",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 1
            },
            {
                "askOnEnterQuestionId": 39514,
                "orderId": "16114141",
                "askOnEnterQuestionText": "QAFP12: PREV PREGNANCY DOWN SYND",
                "askOnEnterQuestionAnswer": "No",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 1
            },
            {
                "askOnEnterQuestionId": 39515,
                "orderId": "16114141",
                "askOnEnterQuestionText": "QAFP13: Donor egg",
                "askOnEnterQuestionAnswer": "No",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 1
            },
            {
                "askOnEnterQuestionId": 39516,
                "orderId": "16114141",
                "askOnEnterQuestionText": "QAFP14: Donor Age: Egg Retrieval",
                "askOnEnterQuestionAnswer": "2",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 1
            },
            {
                "askOnEnterQuestionId": 39517,
                "orderId": "16114141",
                "askOnEnterQuestionText": "QAFP15: OTHER ETHNIC INFORMATION",
                "askOnEnterQuestionAnswer": "n/a",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 1
            },
            {
                "askOnEnterQuestionId": 39518,
                "orderId": "16114141",
                "askOnEnterQuestionText": "QAFP2: Collection Date",
                "askOnEnterQuestionAnswer": "11/28/2016",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 1
            },
            {
                "askOnEnterQuestionId": 39519,
                "orderId": "16114141",
                "askOnEnterQuestionText": "QAFP3: Maternal Weight",
                "askOnEnterQuestionAnswer": "155",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 1
            },
            {
                "askOnEnterQuestionId": 39520,
                "orderId": "16114141",
                "askOnEnterQuestionText": "QAFP4: Estimated Date of Delivery",
                "askOnEnterQuestionAnswer": "12/25/2016",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 1
            },
            {
                "askOnEnterQuestionId": 39521,
                "orderId": "16114141",
                "askOnEnterQuestionText": "QAFP5: Estimated Date of Delivery Determined by",
                "askOnEnterQuestionAnswer": "Ultrasound",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 1
            },
            {
                "askOnEnterQuestionId": 39522,
                "orderId": "16114141",
                "askOnEnterQuestionText": "QAFP6: Mother's Ethnic Origin",
                "askOnEnterQuestionAnswer": "Caucasian",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 1
            },
            {
                "askOnEnterQuestionId": 39523,
                "orderId": "16114141",
                "askOnEnterQuestionText": "QAFP7: Number of Fetuses",
                "askOnEnterQuestionAnswer": "1",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 1
            },
            {
                "askOnEnterQuestionId": 39524,
                "orderId": "16114141",
                "askOnEnterQuestionText": "QAFP8: Insulin-Dependent. Diabetic",
                "askOnEnterQuestionAnswer": "No",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 1
            },
            {
                "askOnEnterQuestionId": 39525,
                "orderId": "16114141",
                "askOnEnterQuestionText": "QAFP9: Repeat specimen",
                "askOnEnterQuestionAnswer": "No",
                "askOnEnterQuestionComment": "",
                "concurrencyId": 1
            }
        ]
    }
}